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Abstract 
 
Enterococcus faecalis is a commensal of the mammalian intestine and an 
opportunistic pathogen that infects various locations in the human host.  
Specifically, the organism can infect surgical wounds, the urinary tract, and is an 
agent of endocarditis [1].  Regardless of niche, this organism has access to fatty 
acid sources in the host, which may influence its ability to survive and cause 
infection; yet, the effects of exogenous fatty acids were unknown in E. faecalis.  
We have shown that complex sources of fatty acids such as bile or serum can 
significantly alter the membrane content and protect E. faecalis from acute 
membrane damage [2].  Experiments with individual bile and serum components 
revealed that protection from acute membrane stress could be attributed to 
unsaturated fatty acids found within these host fluids.   
To better discern how complex sources of fatty acids such as bile or 
serum could impact growth and physiology of E. faecalis so dramatically, we 
decided to examine the effects of individual fatty acids on cellular physiology.  To 
date, virtually no studies had examined the role of fatty acids on E. faecalis.  We 
concluded that unsaturated fatty acids are necessary for growth and could 
support growth in the absence of de novo fatty acid biosynthesis.  Saturated fatty 
acids were shown to be toxic to E. faecalis, distorting cell morphology and 
impeding growth.  
The significance of unsaturated fatty acids is evident as even small 
amounts could rescue cells from toxic fatty acids.  These data help clarify why 
bile and serum, which contain a mixture of unsaturated and saturated fatty acids, 
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are not toxic.  Our experiments show not only that E. faecalis has a requirement 
for unsaturated fatty acids, but also that growth can be supported entirely with 
unsaturated fatty acids.  Moreover, toxicity caused by fatty acids is primarily 
attributed to saturation and length.  In conclusion, exogenous fatty acids have 
tremendous impacts on cell physiology and stress survival; furthermore, 
understanding these is critical for developing effective therapeutics. 
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Chapter I: Introduction and Background Information 
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Characteristics of Enterococci 
Enterococci are Gram-positive cocci commonly reported as opportunistic 
pathogens, but these organisms are also commensals of the mammalian 
intestine, and are widely distributed among various animal hosts [3, 4].  
Additionally, these organisms can live outside of an animal host in water, soil, 
fermented foods or on plants [4-6].  Enterococci can utilize different metabolic 
capabilities to adjust to different environments.  These organisms typically grow 
by fermenting sugars, but can also utilize other carbon sources such as glycerol 
and citrate [7, 8].  Lactic acid is the most common metabolic end product, but 
more pH neutral products, such as acetoin, formate, and ethanol, are 
occasionally produced [7, 8].   
Unlike other human adapted pathogens such as Staphylococcus aureus, 
Enterococci do not secrete toxins or possess numerous virulence factors [9]; 
however, these organisms are able to survive changing environments and have 
the ability to form robust biofilms [10].  The infections most commonly seen are 
wound infections at surgical sites, urinary tract infections, bacteremia, and 
infections associated with artificial heart valves [1, 11].  These infections are 
often acquired during hospital stays and are frequently resistant to antibiotics, 
making them difficult to treat [12, 13].  
Enterococci are be resistant to antibiotics through both intrinsic resistance 
mechanisms such as use of efflux pumps and through extrinsic mechanisms via 
the acquisition of genetic elements [14-16].  The use of antibiotics in hospital 
settings has also contributed to the increasing prevalence of resistant strains [17, 
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18], and Enterococci have the potential to contaminate various fomites, which 
can lead to the spread of resistant strains between patients and clinical staff [1].  
Resistant strains of Enterococci have been detected in the environment, in 
animals and water sources [19, 20], adding to the growing concern about the 
spread of antibiotic resistance to other pathogens and susceptible individuals [21, 
22].  
 
Altering Membrane Fatty Acids and Phospholipids Helps E. faecalis and 
Other Pathogens Survive Various Sources of Environmental Stress. 
Changing membrane fatty acids in response to environmental conditions 
is a common trend among bacteria [23].  Membrane fluidity is altered in response 
to temperature, with colder temperatures favoring a higher unsaturated fatty acid 
content [24-26].  At temperatures around 37°C, the membrane is in a liquid-
crystalline state, and saturated fatty acids provide rigidity [27, 28].  Conversely, at 
lower temperatures, the membrane is in a solid-ordered or gel-like phase, and 
unsaturated or branched-chained fatty acids provide increased fluidity [27, 28].  
These adjustments to membrane fluidity allow bacteria to control membrane 
protein composition and the transport of molecules across the membrane [25].   
Early studies of E. faecalis show that it adjusts membrane composition in 
response to temperature [29].  More recent studies in our lab, indicate that E. 
faecalis has a higher saturated content at 37°C compared to membrane content 
at 25°C, and more unsaturated fatty acids at 25°C compared to 37°C [2].  
Similarly, the food-borne pathogen, Listeria monocytogenes, relies on altering its 
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membrane content of branched-chained fatty acids to add membrane fluidity and 
aid its survival while adjusting to refrigeration temperatures in food, as well as 
transitioning to the temperature of the human host [28, 30].  
Adjusting to varying pH is important to the lifestyle of bacteria, and 
alterations in membrane composition are critical for this adjustment.  Enteric 
pathogens must survive the pH of the stomach, then survive the variable pH of 
the intestine.  E. coli strains that lost the ability to synthesize cyclopropane fatty 
acids were more sensitive to acid stress and were less viable than wild-type cells 
[31].  Streptococcus mutans utilizes lactic acid fermentation and adapts to low pH 
by increasing unsaturated fatty acid content which is critical for its low pH survival 
[32, 33].  E. faecalis grows by fermentative means, thus lowering the pH of its 
environment, and has to adapt to the variable pH of the intestine.  Enterococci 
that can convert its unsaturated fatty acids to cyclopropane fatty acids have 
improved survival in low pH [34]. 
Studies have shown that specific polar head groups also aid survival in or 
during environmental stress.  Cardiolipin content has been shown to be important 
for survival at low pH, in studies of mutant and wild type S. mutans [35] and S. 
aureus [36].  In Listeria monocytogenes, a bacterial pathogen known for surviving 
at a range of temperatures, as well as tolerating bile salts [37], the loss of 
lysylphosphatidylglycerol (LPG) impaired growth at high osmolarity and led to 
disregulation of swimming motility at 37°C [38].  Analysis of Enterococcus 
faecium strains with increased resistance to the bacteriocin, mundticin KS, 
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showed decreased levels of PG and CL, and concomitant increases in an 
unidentified amino acid containing phospholipid [39]. 
Enterococci have been shown to alter the membrane content and 
distribution of phospholipids to resist the antibiotic, daptomycin, which specifically 
targets the membrane of Gram-positive bacteria.  Tran et. al. showed that the 
redistribution of negatively charged cardiolipin helps to divert the antibiotic 
daptomycin away from the cell septum and confers resistance [40].  Furthermore, 
daptomycin resistant strains have genetic mutations in cardiolipin synthase (cls) 
and have an altered phospholipid content.  Specifically, they have a decrease in 
phosphatidylglycerol (PG) [41], and increases in glycerolphospho-
diglycodiacylglycerol (GP-DGDAG), as well as an unknown phospholipid were 
observed [42]. 
Furthermore, altering membrane phospholipid content can change the 
membrane from an overall negative charge to more a neutral or positive charge, 
contributing to the ability of pathogenic bacteria to resist cationic antimicrobial 
peptides and to survive in a host.  Experiments using lipid extracts from E. coli 
showed that the presence of negatively charged cardiolipin was key for 
permeation by positively charged rabbit neutrophil defensins [43].  To reduce the 
negative membrane charge, many Gram-negative enteric bacteria have the 
zwitterionic phospholipid, phosphatidylethanolamine (PE), in the membrane.   
While many Gram-positive bacteria lack PE, many important Gram-
positive pathogens have the ability to alter phospholipid charge with the addition 
of amino acids by multiple peptide resistance factor (MprF) [44].  MprF utilizes 
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charged lysyl-tRNAs to add lysine groups to phosphatidylglycerol; occasionally, 
some organisms have an MprF that also utilizes tRNAs charged with other amino 
acids such as arginine or alanine [44].  A previous study has also shown that a 
Staphylococcus aureus strain that lacked MprF were killed faster by human 
neutrophils [45].   
E. faecalis can utilize MprF to modify phospholipids in response to its 
environment.  Human β-defensins interact at cell septa at distinct sites where E. 
faecalis localizes secretion and sortase proteins; modification of anionic 
phospholipids by MprF made cells more resistant to targeting from defensins 
[46].  Additionally, pediocin resistant strains of E. faecalis had altered 
phospholipid content and charge compared to a wild-type strain [47].  However, a 
mouse bacteremia model comparing wild-type E. faecalis and an isogeneic strain 
lacking mprF did not show a significant contribution of MprF to virulence [48].  
The present studies have examined different strains under various conditions; 
the role of MprF in E. faecalis as a commensal and a pathogen has not been fully 
elucidated. 
 
The Fatty Acid and Phospholipid Biosynthetic Pathways in Enterococcus 
faecalis  
The membrane alterations described above are due to changes that 
happen during the de novo synthesis of fatty acids and polar head groups.  A 
description of the biosynthetic pathway in E. faecalis is provided, along with 
some comparative notes to other organisms.  The initial steps of the FASII 
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pathway are well conserved among bacteria (Figure 1.1).  The enzymes 
contained in these initial stages are found in E. faecalis as well as other model 
organisms such as E. coli or S. pneumoniae. The first step of FASII is initiated by 
acetyl-CoA carboxylase, which expends a molecule of ATP to produce malonyl-
CoA.  Next, the FabD enzyme transfers malonyl-CoA to the acyl carrier protein to 
produce malonyl-ACP.   
Next manolyl-ACP can be used to elongate an existing long chain acyl-
ACP by FabF or FabO (Fig. 1.1) or malonyl-ACP and an acyl-CoA chain can be 
joined by FabH, forming β-ketoacyl-ACP [49].  FabH has the highest activity with 
short chain substrates, malonyl-ACP, acetyl-CoA, or a short acyl-ACP, [49, 50] 
and usually cannot accommodate chains longer than 10-carbons in most bacteria 
[51].  After the elongation by FabH, FabF, or FabO, FabG uses the β-ketoacyl-
ACP intermediate as a substrate to form β-hydroxyacyl-ACP, consuming a 
molecule of NADPH in the process (Fig. 1.1) [23, 52].   
The following steps describe the branch point between unsaturated and 
saturated fatty acid formation (Fig. 1.2).  The dehydrogenase enzymes of E. coli 
and S. pneumoniae, FabZ and FabA, typically utilize 10-carbon substrates [53].  
To synthesize saturated fatty acids in E. faecalis, FabZ or FabN acts as a 
dehydrogenase on the hydroxyl group, forming trans-2-enoyl-ACP. Then, trans-
2-enoyl-ACP is reduced by FabI to form a saturated fatty acid (acyl-ACP).  
Recent studies suggest that the role of FabK is limited in E. faecalis and that 
FabI is the “work horse” enzyme at this step [54, 55].  Then, either the fatty acid 
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synthase enzymes, FabF or FabO, can perform the remaining elongation steps 
for saturated fatty acids [52].   
E. faecalis has unique enzymes to complete unsaturated fatty acid 
biosynthesis (Fig. 1.2).  Similar to FabA in E. coli, E. faecalis has FabN which 
can perform both dehydratase and isomerase reactions [56].  FabN can convert 
the β-hydroxyacyl-ACP intermediate formed by FabG into cis-3-enoyl-ACP.  
Then, E. faecalis utilizes FabO, and not FabF, to perform the remaining 
elongation steps to synthesize long chain unsaturated fatty acids [57].  FabO has 
a similar function to FabB in E. coli, which is necessary for unsaturated fatty 
acids production [58].   
After fatty acids are elongated, long chain acyl-ACP are attached to the 1- 
and 2- positions of sn-glycerol-3-phosphate (G3P) by PlsY or PlsC, respectively 
leading to the formation of phosphatidic acid (PA) (Fig. 1.2), which is the 
precursor to the formation of phospholipids in Enterococci (Fig. 1.3).  The 
glycerol-3-phosphate (G3P) backbone can be synthesized from 
dihydroxyacetone phosphate (DHAP), made during glycolysis, via glycerol-3-
phosphate synthase (GpsA) or from exogenous glycerol phosphorylated by GlpK 
[59, 60].  The addition of an acyl chain to the 1- position of G3P creates 
lysophosphatidic acid (LPA); the addition of the second acyl chain creates 
phosphatidic acid (PA), which is the precursor to glycerophospholipids [52] (Fig. 
1.2).  It should be noted that Gram-positive bacteria also form PA by the 
hydrolysis of phosphatidylglycerol (PG) into diacylglycerol (DAG) by LtsA, which 
is then phosphorylated by diacylglycerol kinase [61].   
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Next, cytosine diphosphate-diacylglycerol (CDP-DAG) is formed by 
condensing DAG and cytosine triphosphate (CTP) by CdsA [52] (Fig. 1.3). Then, 
PgsA alters CDP-DAG to form phosphatidylglycerol phosphate by the 
replacement of CMP with G3P, then the phosphatase activity by PgpA forms 
phosphatidylglycerol (PG) [52].  Cardiolipin is subsequently formed by combining 
two moieties of PG by cardiolipin synthase [62].  Although the elucidation of 
phospholipid biosynthesis has been primarily investigated in E. coli, the genes 
responsible for the production of PG, cdsA, pgsA and pgpA, and cardiolipin (CL), 
cls1 and cls2, are encoded in the genome of E. faecalis (published genome of 
OG1RF, NCBI).  Although CDP-DAG is a precursor to phosphatidylserine (PS) 
and phosphatidylethanolamine (PE), which is a major phospholipid in Escherichia 
coli [63], these have not been detected in Enterococci [42, 64]. 
While PG and CL are the two major phospholipids of Enterococci [64], it is 
common to find modified phospholipids in the membrane.  MprF2 can attach 
amino acid groups to PG, forming lys-PG, ala-PG, and arg-PG [48].  
Glycosylated lipids, such as mono- and diglycosyldiacylglycerol (MGlcDAG, 
DglcDAG) and glycerolphospho-diglycodiacylglycerol (GP-DGDAG) have been 
detected in the membrane [42, 48, 64].  The genes encoding for 
glycosyltransferases have been studied in the closely related bacterium 
Streptococcus pneumoniae and homologues have been reported in 
Enterococcus faecalis [65, 66].  Similar species of amino acid and glycosylated 
phospholipids have also been found in Streptococcus mutans [67]. 
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Enterococcus faecalis Has Two Distinct Operons Necessary for Fatty Acid 
Biosynthesis 
E. faecalis has two distinct operons of fatty acid biosynthesis genes 
(Figure 1.4).  The larger operon is conserved among Streptococci and Lactococci 
[68].  This operon contains the beginning enzymatic steps of the FAS II pathway, 
which also contain the enzymes needed for saturated fatty acid biosynthesis.  
However, Enterococci lack the isomerase, FabM, responsible for unsaturated 
fatty acid biosynthesis in Streptococci.  The smaller operon contains three 
enzymes needed for unsaturated fatty acid synthesis (Fig. 1.4).   
The two fatty acid biosynthesis operons may have some overlapping 
regulatory features.  FabT is a global regulator found in several Gram-positive 
genera and acts as a negative regulator of fatty acid synthesis [68].  When 
interacting with long fatty acid chains, this protein will undergo conformational 
changes and interact with palindromic sequences located in the promoter region 
of fabK and fabT in the larger operon [69, 70] (Fig. 1.4).  Bioinformatics reveals 
similar sequences in the second small operon of E. faecalis upstream of the 
synthase (fabO) and reductase (fabI) enzymes; this suggests that the two 
operons may be jointly regulated [56].   
 
Gram-negative and Gram-positive Bacteria Can Uptake and Utilize 
Exogenous Fatty Acids 
In addition to synthesizing fatty acids de novo, bacteria can utilize 
exogenous sources of fatty acids.  Gram-negative species as well as Gram-
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positive organisms that are typically associated with soil environments, such as 
Bacilli sp. and Streptomyces [71] sp., can perform β-oxidation [72], but genome 
sequencing and annotation has not revealed any genes that would allow 
Enterococci to perform the β-oxidation of fatty acids or utilize exogenous fatty 
acids as a carbon source [15, 73].  We previously showed that supplementing 
cultures of E. faecalis with exogenous lipids significantly alters membrane fatty 
acid content [2] while other studies show that exogenous fatty acids down 
regulate biosynthetic genes [74].  Zhu et al. showed that fatty acid 
supplementation can help unsaturated fatty acid auxotrophs continue to grow 
without de novo lipid synthesis [54].  Taken together, these provide evidence that 
Enterococci can incorporate exogenous fatty acids into the membrane.  
The transport and uptake of exogenous fatty acids has been well-studied 
in Gram-negative organisms.  FadL is conserved across Gram-negative species; 
it undergoes conformational changes that allow the diffusion of long chain fatty 
acids (C11-C18) into the periplasm and is also related to the transport of 
hydrophobic molecules [75, 76].  Medium chain fatty acids (C7-C10) can cross 
without the aid of FadL [77].  An inner-membrane associated protein, FadD, 
allows the entrance of fatty acids across the inner membrane [77, 78].  FadD 
requires ATP and may facilitate spontaneous flipping fatty acids [79].  Although 
some Mycobacteria have a fadD homologue [80], this transport system (FadL or 
FadD) has not been found in Gram-positives [71, 81].  
Recent studies in S. aureus, however, provide a mechanism for the 
incorporation of long-chain fatty acids into the membrane of Gram-positive 
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organisms.  Exogenous fatty acids are suggested to passively enter Gram-
positive bacteria [82, 83].  However, free exogenous fatty acids are not useable 
substrates for the enzymes, PlsY and PlsC, which attach fatty acids to 
phospholipids.  Therefore, exogenous fatty acids need to be bound by fatty acid 
kinase B (FakB) and phosphorylated by fatty acid kinase A (FakA), which makes 
them suitable substrates for direct incorporation to the 1-position of glycerol by 
PlsY [82, 84].  Alternatively, the newly formed acyl-phosphate can be attached to 
the acyl-carrier protein (ACP) by PlsX.  After attachment to the acyl carrier 
protein, PlsC can attach it to the 2-position of glycerol or it can be elongated 
before incorporation [82, 84]. 
 
Exogenous Fatty Acids Have Broad Effects on Bacterial Growth and 
Physiology 
Published reports have shown that fatty acid biosynthesis is down 
regulated when E. faecalis has access to a complex source of exogenous fatty 
acids, such as bile or serum [74, 85, 86], but have not focused on the broad 
physiological impacts of host fatty acids on the membrane content.  However, the 
effects of host fatty acids on the membrane and growth in other pathogenic 
organisms has been studied.  The growth in the presence of bile altered the 
phospholipid content of Vibrio cholera, specifically the amount of PE was lowered 
while a concomitant increase in CL and an unknown phospholipid was seen, but 
these changes were not observed in E. coli or Salmonella enterica [87].  Acidic 
phospholipids, particularly cardiolipin, have been shown to bind to the EpsE/cyto-
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EpsL complex stimulating the ATPase activity of EpsE and contributing to the 
extracellular secretion of cholera toxin [88].  Host signals, such as bile, have 
been reported to affect gene expression in V. cholera [89, 90], and the fluctuation 
of bile levels between the intestinal lumen and mucosal could also influence this 
process [87]. 
Chlamydia trachomatis, an intracellular bacterium with a reduced genome, 
has been shown to utilize and modify host lipids [91, 92].  De novo fatty acid 
synthesis contributes to membrane composition and lipid A synthesis [93], the 
membrane of C. trachomatis also contains many eukaryotic lipids, such as 
phosphatidylcholine and cholesterol, while genes necessary for synthesis are not 
encoded in the genome [94].  Chlamydiae have an exceptionally complex 
lifecycle that includes two developmental stages as well as disrupting host cell 
signaling and trafficking [95].  Acquiring nutrients from the host may thus save 
energy and possibly serve as metabolic signals from the host environment.  
Although exogenous fatty acids appear to be beneficial, the toxicity of 
individual fatty acids has been well documented.  Fatty acids have been noted for 
having anti-microbial properties and have been used as food additives for 
considerable length of time [96, 97].  Fatty acids found in skin are also an 
important deterrent of infection [98, 99].  Some of the mechanisms for toxicity 
include the surfactant properties of lipids [100], the inhibition of FabI [101], and 
oxidative stress [102].  To complicate things further, only closely related microbes 
may be susceptible to the same type of fatty acids [101, 103].  
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Recently, Parsons et al. showed that lipids could cause rapid membrane 
depolarization and pore formation with the release of low molecular weight 
molecules from the cell, interfering with synthesis of all major macromolecules in 
Staphylococcus aureus [103].  The authors also suggest that wall teichoic acids 
allow structurally specific fatty acid toxicity patterns [103].  Wall teichoic acids 
structures vary between different Gram-positive organisms [104], which could 
explain why patterns of fatty acid toxicity are only similar between closely related 
organisms.  Three strains of S. aureus and Bacillus subtilis were similarly 
sensitive to unsaturated fatty acids, while saturated fatty acids were more toxic to 
Streptococcus pneumoniae [103].  
 
Fatty Acid Biosynthetic Enzymes as Potential Drug Targets 
There is considerable interest in targeting bacterial fatty acid biosynthetic 
enzymes with therapeutic drugs, due to the lack of conservation between 
eukaryotes, which accomplish fatty acid biosynthesis with an enzyme consisting 
of two dimers, and bacteria, which use separate enzymes to catalyze each step 
[105].  Recent advances in sequencing technology [105] and in elucidating 
enzymatic structures [23] have further highlighted the differences between 
prokaryotic and eukaryotic enzymes, thus making target selection easier.  The 
large number of enzymes in the bacterial fatty acid synthesis (or FAS II) pathway 
presents a wide array of targets and the diversity of enzymes between bacterial 
pathogens presents opportunities for more narrow targets [106]. 
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 The beginning part of the FAS II pathway is conserved between bacterial 
species (Fig. 1.1) so, these enzymes have been considered as broad-spectrum 
targets [106].  Targeting FabD, FabG, or the acyl carrier protein (ACP) could be 
promising as a broad-spectrum target since these lack diversity between 
bacterial species, but are not conserved in eukaryotes [106].  In contrast, FabH 
enzymes have more diversity among bacterial species [107].  For example, the 
FabH of Staphylococci utilize branched-chained substrates [50, 108], and 
Mycobacterium tuberculosis has a substrate pocket that accommodates longer 
chains [109].  However, FabH is still being considered a prospective broad-
spectrum target and there have been studies in the past few years examining 
inhibitors of FabH [110, 111]. 
The most diversity in the FAS II pathway can be found among the 
isomerase, dehydratase, and enoyl-reductase enzymes.  Targeting these 
enzymes will likely produce more narrow spectrum antibiotics.  For example, E. 
coli and E. faecalis, have enzymes that have dual isomerase and dehydratase 
activity, such as FabA and FabN, respectively [56] while S. pneumoniae 
possesses FabM for isomerase activity and FabK for reductase activity [53].  The 
most promising research has been seen with FabI (an enoyl reductase enzyme). 
Triclosan is a FabI inhibitor commonly found in commercial products [107].  A 
FabI inhibitor, AFN-1252, has shown promising results in clinical trials against S. 
aureus [112].  Isoniazid, a FabI inhibitor, remains a first-line antibiotic used 
against M. tuberculosis [113, 114].  Again, targeting FabI would produce a 
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narrow spectrum antibiotic, because organisms lack FabI and use FabK, a 
flavoprotein, to complete this enzymatic step [53].   
Bacteria typically utilize FabF to elongate acyl-ACP products (Fig. 1.2), but 
it is not uncommon for bacteria to possess more than one of these enzymes [23].  
Both E. coli and E. faecalis have two synthase enzymes; both enzymes can be 
used to elongate saturated fatty acids, but each organism has a dedicated 
enzyme for the elongation of unsaturated fatty acids [23].  These fatty acid 
synthase enzymes have conserved active sites, which could be potential drug 
targets [105, 114].  However, the natural occurring inhibitor, cerulenin, also cross 
reacts with the eukaryote enzyme, making these enzymes a less attractive target 
[105, 114].   
There has been a considerable amount of criticism of targeting fatty acid 
biosynthetic enzymes due to the ability of bacterial pathogens to utilize host fatty 
acids [115].  However, the FAS II pathway is essential for Gram-negative 
bacteria to synthesize lipid-A [116, 117].  In Gram-positive bacteria, it was shown 
that the subtle variations in feedback inhibition on the FAS II pathway meant that 
only some species can survive solely on exogenous fatty acids [118].  
Exogenous fatty acids inhibit acetyl-CoA-carboxylase in Streptococci, but not 
Staphylococci [118].  Bacteria with similar regulatory mechanisms, such as 
Enterococci, could potentially survive utilizing exogenous fatty acids.  The recent 
discoveries of novel fatty acid kinases enzymes in Gram-positive bacteria, as 
well as the differences in fatty acid metabolism, show the potential for finding 
therapeutic targets [82, 118]. 
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The Effects of Exogenous Fatty Acids and Membrane Composition in 
Enterococcus faecalis Is Important, but Understudied 
We have sought to understand the typical membrane composition of E. 
faecalis and how exogenous fatty acids change membrane content, affect stress 
responses, growth, and morphology.  Our data, described in subsequent 
chapters, shows that exogenous fatty acids have a tremendous impact on these 
features.  While many studies focus on the transcriptomics in response to host 
bile or serum, the effects of host fatty acids on bacterial membrane fatty acid and 
phospholipid composition is less studied.  Given the discussions regarding fatty 
acid biosynthetic enzymes as drug targets [115, 117], our research attempted to 
address whether a fatty acid auxotroph could exist in the host, the metabolic 
differences between Gram-positive pathogens, and what this means for drug 
design. 
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Appendix. Chapter I Figures 
 
Figure 1.1: The initiation of the fatty acid biosynthetic pathway in 
Enterococcus faecalis.  Fatty acids products and intermediates are enclosed in 
boxes.  Enzymatic reactions are indicated with arrows pointing from a reactant(s) 
and pointing toward products.  Aceyl-CoA Carboxylase (ACC) and other fatty 
acid biosynthesis (Fab) enzymes are shown next to their respective reactions.  
All structures are immediately to the right or above their respective names. 
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Figure 1.1 Continued 
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Figure 1.2: The completion of the fatty acid biosynthetic pathway in 
Enterococcus faecalis.  The red colored boxes and text indicate the branch of 
the pathway that produces saturated fatty acids.  The green colored boxes and 
text show the enzymes and intermediates that lead to the production of 
unsaturated fatty acids.  The completion of the fatty acid biosynthetic pathway, 
which leads to the attachment of acyl-ACP to phospholipids, is shown in purple.  
The incorporation of exogenous fatty acids is shown in orange.  
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Figure 1.3: The Formation of Phospholipids in Enterococcus faecalis.  
Intermediates and substrates are enclosed in boxes.  Enzymatic reactions are 
indicated with arrows pointing from substrate(s) and pointing toward products.   
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Figure 1.4: The fatty acid operons of Enterococcus faecalis.  The number 
above each arrow indicates the number of base pairs in each gene.  Figure not 
drawn to scale.  A: The larger of the two operons, which is also present in 
Streptococci and Lactococci, is shown.  B: The smaller operon, which is 
necessary for the production of unsaturated fatty acids, is illustrated.   
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Chapter II: Incorporation of exogenous fatty acids protects Enterococcus 
faecalis from membrane damaging agents. 
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Abstract 
Enterococcus faecalis is a commensal bacterium of the mammalian 
intestine that can persist in soil and aquatic systems, and can be a nosocomial 
pathogen to humans.  It employs multiple stress adaptation strategies in order to 
survive such a wide range of environments.  Within this study, we sought to 
elucidate whether membrane fatty acid composition changes are an important 
component for stress adaptation.  We noted that E. faecalis OG1RF was capable 
of changing its membrane composition depending upon growth phase and 
temperature.  The organism also readily incorporated fatty acids from bile, 
serum, and media supplemented with individual fatty acids, often dramatically 
changing the membrane composition such that a single fatty acid was 
predominant.  Growth in either low levels of bile or specific individual fatty acids 
was found to protect the organism from membrane challenges such as high bile 
exposure.  In particular, we observed that when grown in low levels of bile, 
serum, or the host-derived fatty acids oleic acid and linoleic acid, E. faecalis was 
better able to survive the antibiotic daptomycin.  Interestingly, the degree of 
membrane saturation did not appear to be important for protection from the 
stressors examined here; instead, it appears that a specific fatty acid or 
combination of fatty acids is critical to stress resistance.    
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Introduction 
Enterococcus faecalis is a Gram-positive bacterium and a member of the 
intestinal flora of mammals.  Since Enterococci are commensals of many 
mammals and capable of survival in water sources, they are used as indicators 
of fecal contamination [5, 119].  E. faecalis is also linked to the fermentation of 
specific cheeses and sausages, and its production of bacteriocins has led to the 
use of the organism and its byproducts in commercial products [5].  Although E. 
faecalis is a human commensal bacterium, this organism frequently causes 
costly nosocomial infections that are difficult to eradicate.  Additionally, 
Enterococci possess efflux pumps and undergo cell wall alterations that 
contribute to routine resistance to antibiotics including vancomycin [1, 120].  
Given that Enterococci are capable of conjugation, there is growing concern that 
they may pass their resistance genes to other organisms [1, 121, 122]. 
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 While Enterococci are considered intestinal commensals, these bacteria are 
clearly well- adapted to survive a wide variety of environmental conditions and 
stressors.  These include low pH, high osmotic stress, a wide range of 
temperatures, and desiccation (reviewed in Fisher et al 2009).  Its survival over a 
range of pH values and salt concentrations enables the organism to colonize, 
and thus cause disease, systemically.  Additionally, the ability to survive a wide 
range of temperatures and desiccation contributes to its persistence in the 
environment, which is important for the transfer of resistant strains between 
hosts.  
 Given that Enterococci naturally inhabit mammalian intestines, they must 
survive growth in bile.  In particular, bile salts can be highly damaging to bacterial 
membranes [123].  Studies with organisms such as Listeria monocytogenes and 
Escherichia coli have identified efflux pumps that are activated by bile salts [37, 
124].  Many efflux pumps are also linked to drug resistance [16].  Studies with E. 
faecalis have shown that this organism alters gene expression and protein 
synthesis when grown in the presence of bile [86, 125] and resistance to bile 
stress also provides cross protection to other sources of stress [126].  However, 
the exact mechanisms for Enterococci’s resistance to bile stress have not been 
completely elucidated. 
 Many bacteria alter their membrane fatty acid composition and/or membrane 
phospholipids as a protective measure from environmental stressors [23].  In 
response to temperature fluctuations, numerous bacterial species will shift the 
ratio of saturated: unsaturated fatty acids within their membranes to increase or 
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decrease fluidity as needed [25].  Chemical inhibition or deletion of specific 
enzymes involved in either cyclopropane fatty acid synthesis or unsaturated fatty 
acid biosynthesis rendered those mutant strains more susceptible to low pH 
stress than the parental strains or the genetically complemented mutant strains 
[31, 32, 127].  E. faecalis also produces cyclopropane fatty acids, and strains 
deficient in the ability to produce cyclopropane fatty acids have been shown to be 
more sensitive to low pH [34].  Furthermore, E. faecalis can modify its membrane 
phospholipids with the addition of amino acids, which affects the overall 
membrane charge and aids in resistance to antimicrobial compounds [48, 128]. 
 The transportation and utilization of extracellular fatty acids has been well 
studied in the model organism E. coli, but is largely unexplored in Gram positive 
organisms [78].  Recent data demonstrated that both Staphylococcus aureus and 
Streptococcus pneumoniae are capable of incorporating exogenous fatty acids 
from the host [103].  However, in depth analysis has suggested that incorporation 
of specific fatty acids has different metabolic effects on these organisms [118].  
Little work, though, has been conducted to examine the effects of exogenously 
supplied fatty acids on the physiology of E. faecalis.   
Considering all of these previous studies, we hypothesized that modification 
of the membrane fatty acid content would be important for resistance to 
membrane damage for E. faecalis.  As E. faecalis also has access to fatty acids 
while residing in the human host, we hypothesized that the organism could 
incorporate extracellular fatty acids thereby altering its membrane content and its 
resistance to membrane stress.  To test these hypotheses, we examined how the 
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membrane fatty acid content changed when growth parameters were altered or 
exogenous fatty acids were added to the growth medium and whether these 
alterations contributed to survival when E. faecalis was exposed to membrane 
damaging agents, including the antibiotic daptomycin.  
 
Materials and Methods 
 
Bacterial Strains and Growth Conditions  
 Enterococcus faecalis OG1RF (gift from J. Lemos, University of Rochester 
Medical Center) was grown statically (without agitation) in brain heart infusion 
medium (BHI, BD Difco) at 37°C unless indicated otherwise.  Overnight cultures 
were used to inoculate medium to an OD600 value of 0.01.  Unless indicated, 
culture supplements were purchased from Sigma-Aldrich.  Cultures were 
supplemented with bovine bile, pooled human serum (ICN Biomedicals), fatty 
acids, bile salts, sodium dodecyl sulfide (SDS) and antibiotics as indicated in the 
text and in Table 2.   
 
Gas Chromatography-Fatty Acid Methyl Ester (GC-FAME) Preparation and 
Analysis 
 E. faecalis was grown as indicated in the text and in Table 2.  When the 
appropriate cellular concentration was reached, 10-20 mL of cells were 
harvested by centrifugation and extensively washed twice with an equal volume 
of 1X phosphate buffered saline (PBS) to ensure no carryover of fatty acids from 
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the cell culture.  Cell pellets were stored at -80°C prior to GC-FAME analysis 
performed by Microbial ID, Inc. (Newark, DE) as described previously [129].  
Briefly, resuspended cell pellets were subjected to saponification using a sodium 
hydroxide-methanol mixture.  This was followed by a methylation step and 
extraction with hexane prior to the analysis.  Averages and standard deviations of 
three independently grown cultures are shown for each condition. 
 
Challenge Assays   
 Cells (2 mL) were harvested from mid-log phase cultures (OD600 ≈ 0.4).  The 
cells were centrifuged and resuspended in 2 mL of a “challenge” medium.  
Challenge medium consisted of BHI with 10% bile, 0.1% sodium dodecyl sulfate 
(SDS), or 30 µg/mL of daptomycin and 100 mM CaCl2 or an equal volume of 
100% ethanol as a solvent control.  Prior to treatment with daptomycin, cultures 
were grown in BHI with 100 mM CaCl2.  Serial dilutions were plated onto BHI 
agar at 0, 15, 30, and 60 min after centrifugation and resuspension in a challenge 
medium.  Each challenge study was performed in triplicate. 
 
Scanning Electron Microscopy   
 Cells were grown in BHI supplemented as indicated until late log phase 
(OD600 ≈ 1.0).  Aliquots (1 mL) were harvested and washed twice with 1X PBS to 
remove media.  Following the washing steps, a primary fixation was performed at 
room temperature with 1X PBS and 3% gluteraldehyde for at least one hour.  
Cells were rinsed in 1X PBS three times for 10 min (or a single overnight rinse); 
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then a secondary fixation in 2% osmium tetroxide and 1X PBS was completed at 
room temperature for a minimum of one hour.  Fixed cells were rinsed in water a 
minimum of two times for 10 min.  During the last rinse, cells were allowed to 
settle onto a 3x4 mm silicon chip. Samples were dehydrated with a series of 
ethanol of increasing concentrations (25%, 50%, 70%, 95%, 100%) for 10 min at 
each grade.  Samples were placed in a Ladd critical point dryer for three cycles.  
Then, silicon chips were coated with gold prior to visualization.  Samples were 
then visualized using a Hitachi SU 3500 or Zeiss Auriga 40 at the Advanced 
Imaging and Microscopy Center at the University of Tennessee.  For 
unsupplemented and bile-grown cultures, three independent cultures were 
analyzed; for oleic-grown cells, two independent cultures were analyzed.   
 
Flow Cytometry Analysis   
Cells were grown as indicated above to OD600 ≈ 0.4.  Cells were then 
treated with daptomycin (30 µg/mL) (Sigma) or ethanol (95%, control).  At 0, 5, 
15, 30, and 60 min post-daptomycin addition, 100 µL aliquots were taken and 
flooded with 4mL of 1X PBS and centrifuged.  Cell pellets were resuspended in 
1mL of 1X PBS and stained with 10 µg/mL DiBAC4(3).  After 20 min incubation in 
the dark at room temperature, cells were washed with 4 mL of 1X PBS and 
analyzed by flow cytometry in a LSR II Flow Cytometer (Beckton Dickinson) with 
a 488 nm laser.  Samples were run at an event rate of 3000 events per second.  
Green fluorescence was collected in the FITC channel.  Differences in 
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daptomycin treated cells stained with DiBAC4(3) were obtained using geometric 
mean fluorescence for six independent experiments. 
 
Results 
 
Growth in Low Levels of Bile Protects E. faecalis OG1RF from Severe Bile 
Stress 
  Enterococcus faecalis inhabits the proximal region of the intestine where it 
encounters the membrane damaging effects of high levels of bile, and in 
particular, bile salts [130].  Previously it was shown that growth in low levels of 
bile salts or bovine bile could protect E. faecalis from severe membrane stress 
[86, 126].  We wanted to establish the mechanism for this protection.  We first 
began by supplementing the growth medium (BHI) of E. faecalis OG1RF with 
0.2% bovine bile, and noted that the growth rate was slightly reduced compared 
to unsupplemented cultures (Table 2.1); however, the bile-grown cultures 
reached a similar optical density as unsupplemented cultures in stationary phase 
(data not shown).  We then tested the ability of our bile-grown and 
unsupplemented cultures to survive membrane damage using 10% bile or 0.1% 
sodium dodecyl sulfate (SDS).  As shown, when challenged with either with 10% 
bile (Fig. 2.1a) or 0.1% SDS (Fig. 2.1b), there were significantly more survivors 
for cultures grown in low bile than those without (P value < 0.005 for all time 
points). 
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 We wanted to verify that the resistance observed in our 0.2% bile cultures 
was due to acclimation and not a selection for a genetic mutant(s).  Following bile 
challenge, cells were grown overnight at 37°C, and then used to inoculate fresh 
cultures containing BHI alone.  The challenge with 10% bile was then repeated.  
Cells from these re-challenged cultures returned to the same level of sensitivity 
as cells not grown in bile  (data not shown).  Therefore, we attributed this 
protection to severe stress as an environmental acclimation and not a selection 
for resistant mutants. 
 
Bile Salts Fail to Provide Protection to Sudden Stress  
 Bile is a complex mixture of various proteins, ions, fatty acids, and bile salts 
[131].  However, it is the amphiphillic properties of bile salts that cause 
membrane damage.  Work by other groups have suggested that growth in the 
presence of low levels of bile salts can induce changes in E. faecalis that 
enhance its survival under severe membrane stress [126].  Other enteric 
organisms possess and activate efflux pumps in response to bile salts that may 
also contribute to drug resistance.  For example, L. monocytogenes upregulates 
mdrT specifically in response to cholic acid [37] and E. coli utilizes ArcAB to 
pump out unconjugated bile salts and decanoate [124]. 
 To determine whether bile salts contributed to the enhanced stress 
resistance in E. faecalis, OG1RF was grown in cholic acid (10 µg/mL) as well as 
a bile salt mixture consisting of 10 µg/mL each of deoxycholate, lithocholic acid, 
taurocholic acid, and glycocholic acid hydrate [37].  The addition of the salts did 
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not noticeably impact growth rates (Table 2.1).  Growth in the bile salt mixture 
(Fig. 2.2a) or cholic acid (Fig. 2.2b) alone did not significantly enhance survival 
when cultures were challenged with 10% bile or 0.1% SDS (data not shown).  
Solvent control experiments also showed no impact of the solvent on cell survival 
or growth (Fig. 2.2, data not shown).  These findings suggested another 
component within bile contributes to protection from membrane damaging 
agents.  
 
Membrane Fatty Acid Content of E. faecalis Is Dependent Upon Growth 
Conditions   
 Fatty acids are another major component found within bile.  Many bacteria, 
including Streptococci, Staphylococci, and Lactococci species are known to 
incorporate exogenous fatty acids into their membrane, altering their membrane 
content [87, 115, 118, 132].  We hypothesized that E. faecalis may incorporate 
fatty acids from bile, and this could provide protection from membrane stress.  
However, we first needed to establish the fatty acid content of OG1RF from 
cultures grown under standard laboratory conditions.  Gas chromatography of 
fatty acid methyl esters (GC-FAME, Microbial ID, Inc.) was performed on BHI 
medium to confirm that there were no detectable fatty acids in the medium (data 
not shown).  Following this, the fatty acid content from cells grown in BHI to 
exponential (OD600 ≈0.4) and stationary phase growth (after 24 hours of growth; 
Table 2.2, Table 2.3) was analyzed in the same fashion.  We note that for all of 
the membrane composition analyses presented in this report, that those fatty 
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acids found in minor amounts (≤ 5%) can have inflated standard deviations.  This 
variation was often because a fatty acid was not detected in one of the replicates.  
However, the fatty acid content tended to be well conserved across replicates, 
especially for those fatty acids that make up the majority of the membrane 
composition.  
 In both exponential and stationary phases of growth, the dominant fatty 
acids, palmitic acid (C16:0) and cis-vaccenic acid (C18:1 cis 11), comprised over 60% 
of the total membrane content (Tables 2.2, 2.3).  The most significant change 
observed between growth phases was an increase in C19:1 cyclo 11 from 1% in 
exponential phase to nearly 11% in stationary phase with a corresponding 
decrease in cis-vaccenic acid (C18:1 cis 11).  Unsaturated fatty acids are known to 
be converted to cyclopropane fatty acids during stationary phase so the decrease 
in cis-vaccenic acid may be attributed to this pathway [29, 133].  
 Growth at low temperatures has been shown to lead to a decrease in the 
proportion of saturated fatty acids and a concomitant increase in the amount of 
unsaturated fatty acids to help maintain membrane fluidity in other organisms 
[25].  Given that E. faecalis can grow at a range of temperatures, we sought to 
determine whether OG1RF undergoes similar changes.  There was a noticeable 
shift towards a lower saturated: unsaturated ratio that occurred with cultures 
grown at 25°C versus 37°C in unsupplemented medium (Tables 2.4, 2.5), 
suggesting that E. faecalis increased the proportion of unsaturated membrane 
fatty acids to acclimate to decreasing temperatures.    
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 When supplemented with 0.2% bile, the membrane content of OG1RF 
was significantly altered compared to cultures grown in medium alone.  Analysis 
of the bile supplemented medium indicated it contained many fatty acids (Table 
2.7), including oleic acid (C18:1 cis 9).  Oleic acid is abundant in human tissues 
through dietary consumption of plant and animal oils.  As noted in Table 2.2, E. 
faecalis did not produce detectable levels of oleic acid when grown in BHI.  
However, when supplemented with bile, 19% of the total membrane fatty acid 
content was composed of oleic acid (Table 2.2).  This suggests that E. faecalis 
incorporates oleic acid from bile into its membrane.  On the other hand, the fatty 
acid cis-vaccenic acid (C18:1 cis 11) comprised approximately 40% of the total 
membrane fatty acid content of OG1RF grown in BHI medium.  But in bile-grown 
cells, cis-vaccenic acid comprised only about 3% of the total membrane fatty acid 
content (Table 2.2).  Thus, not only was there a reduction in the total amount of 
C18:1 fatty acid, the type of C18:1 (i.e., position of the double bond) was 
significantly different when OG1RF was grown in the presence of bile.   
 Additional changes were observed when E. faecalis was grown with bile.  
There was a considerably greater percentage of saturated fatty acids found in 
cultures supplemented with bile during exponential growth in comparison to 
those without, as is indicated in the saturated: unsaturated ratio (Table 2.2, 2.2).  
In exponential phase, there was approximately a five-fold increase in stearic acid 
(C18:0) in bile-grown cells and higher levels of palmitic acid (C16:0).  When 
examining differences in the saturated fatty acid composition from exponential 
and stationary phase, there was very little fluctuation in cultures grown without 
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the fatty acid source.  However, for cultures supplemented with bile in stationary 
phase, there were decreases in the dominant saturated fatty acids, palmitic acid 
and stearic acid, which is indicated in the decrease in the saturated: unsaturated 
ratio for bile grown cells  (Tables 2.2, 2.6, 2.3).  
Exogenously Supplied Oleic Acid Provides Protection from Acute 
Membrane Stress   
 From the above analysis, we noted that OG1RF incorporated fatty acids 
found within bile into its own membrane.  In particular, the organism replaced the 
predominant unsaturated fatty acid cis-vaccenic acid (C18:1 cis 11) with oleic acid 
(C18:1 cis 9).  We hypothesized that the incorporation of oleic acid may be 
impacting cell survival, and decided to examine this by supplementation of the 
growth medium with oleic acid alone.  We noted that medium supplementation 
with oleic acid did not significantly impact generation time, even when 
supplemented at high levels (100 µg/mL) of oleic acid; thus, we chose 20 µg/mL 
for subsequent membrane analysis and survival assays (Table 2.1).   
 Oleic acid comprised more than 70% of the membrane fatty acid composition 
in exponential phase cultures when the growth medium was supplemented solely 
with this fatty acid.  Thus, as was seen for bile-grown cells, E. faecalis readily 
incorporates oleic acid into its membrane from its growth medium.  
Concomitantly, the percentages of palmitic and cis-vaccenic acids, which in 
combination comprised approximately 76% of the total fatty acid content of 
unsupplemented cultures, were greatly reduced (Table 2.2).  In stationary phase, 
the level of oleic acid was reduced to approximately 35% and the level of palmitic 
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acid increased to about 30%, nearly the same level as seen in BHI grown 
cultures (Table 2.3).  This decrease in oleic acid content in the membranes could 
be due to exhaustion of the supply added to the medium.  To support this, 
supplementation with a higher amount of oleic acid (100 µg/ml) maintained a 
higher percentage of this fatty acid in stationary phase cultures (approximately 
52%, data not shown).  
 When challenged with 10% bile, cells grown in oleic acid survived 
significantly better than the unsupplemented control group (Fig. 2.1a; P value < 
0.005 for all time points).  Thus, incorporation of exogenously supplied oleic acid 
alone can provide protection from severe bile stress.  Interestingly, growth in 
oleic acid did provide cross-protection against the detergent SDS (Fig. 2.1b).  
However, cells grown in 0.2% bile survived 0.1% SDS challenge far better than 
those grown in 20 µg/mL of oleic acid (P < 0.005).  Thus, bile offered better 
cross-protection against SDS damage when compared with oleic acid grown 
cells (Fig.2.1b).    
 In addition, cells grown in BHI alone or supplemented with oleic acid 
exhibited typical pair or chain morphology characteristic of E. faecalis, while cells 
grown in 0.2% bile were more likely to be arranged in a curved, long-chain 
formation. Some daptomycin-resistant Enterococci strains have altered cell 
morphology and aberrant placement of cell septa [41]; therefore, we were 
interested to know if the location of cell septa was shifted in bile-grown cells.  
Scanning electron microcsopy confirmed that chain formation was clearly favored 
in bile cultures but not for unsupplemented or oleic-grown cultures (Fig. 2.3).  
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However, transmission electron microscopy (TEM) analysis revealed no aberrant 
placement of cell septa for bile-grown cells (data not shown).  We concluded that 
morphological changes observed did not impact membrane stress survival in the 
conditions tested. 
Not All Exogenously Supplied Unsaturated Fatty Acids Provide Protection 
from Membrane Damage   
 We wanted to know if protection from membrane damage was unique to the 
addition of oleic acid to OG1RF cultures or if the addition of other unsaturated 
fatty acids could result in protection. Thus, we examined the effects of two other 
C18-length unsaturated fatty acids.  Linoleic acid (C18:2 cis 9,12) is a fatty acid found 
in bile and serum (Table 2.7); cis-vaccenic acid (C18:1 cis 11) is a prominent 
component of OG1RF membranes (Tables 2.2, 2.3).  The growth rate of E. 
faecalis was affected by increasing concentrations of linoleic acid (data not 
shown), so 10 µg/mL was chosen for membrane analysis and stress challenge 
assays for both fatty acids (Table 2.1).  
 The addition of these fatty acids significantly altered the membrane fatty acid 
content of OG1RF (Table 2.2).  For cultures supplemented with cis-vaccenic 
acid, this particular fatty acid comprised 90% of the total membrane content in 
cultures grown to exponential phase.  When cultures were supplemented with 
linoleic acid, more than two-thirds of the membrane content consisted of linoleic 
acid.  This result was similar to what we observed when cultures were 
supplemented with oleic acid where the total membrane fatty acid content was 
predominantly this single fatty acid (approximately 72%, Table 2.2).  For cultures 
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supplemented with either oleic, cis-vaccenic or linoleic acid, there were 
decreased amounts of palmitic acid, leading to saturated: unsaturated ratios far 
lower than that for unsupplemented cultures (Table 2.2, 2.6).  In stationary phase 
cultures, we observed an increase in saturated fatty acids and a significant 
decrease in the supplemented unsaturated fatty acids  (Table 2.3), which may be 
due to exhaustion of the supply provided.  Lastly in stationary phase cultures, 
there were increases in the levels of cyclopropane fatty acids, however, these 
increases were not as high as in unsupplemented cultures. 
 After confirming that exogenous linoleic and cis-vaccenic acid impacted the 
overall membrane content, the ability of these fatty acids to improve membrane 
stress survival was tested.  Although not as robust as oleic acid supplementation 
(Fig. 2.1a), supplementation with cis-vaccenic acid improved cell survival after 
exposure to 10% bile for all time points as compared to unsupplemented cultures 
(Fig. 2.4; P < 0.05).  Linoleic-grown cells were more variable in their ability to 
survive 10% bile stress; however, we only observed an increased ability to 
survive bile stress compared to unsupplemented cultures after 30 min of bile 
exposure.  In exponential phase cultures, the portion of the membrane comprised 
of linoleic acid was similar to the level of oleic acid (Table 2.2); therefore, the 
failure of this supplement to rescue from bile damage does not appear to be due 
to inadequate levels of incorporation, but likely due to the individual impact each 
fatty acid has on cellular physiology.  
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Exogenous Saturated Fatty Acids Impact Membrane Content but not 
Survival from High Bile Concentrations   
 We observed that exogenously supplied unsaturated fatty acids were 
incorporated into the membrane of OG1RF and this influenced the ability of the 
bacterium to survive membrane damage.  However, bile-grown cells had a 
significantly higher ratio of saturated: unsaturated fatty acids during exponential 
phase.  We wanted to ascertain if survival was at all linked to the saturated: 
unsaturated ratio or was due to incorporation of a specific fatty acid or 
combination of fatty acids.  To examine this, we supplemented E. faecalis with 
either the saturated fatty acid palmitic acid (C16:0) or stearic acid (C18:0) since 
these are the dominant saturated fatty acids found in the membrane of E. 
faecalis OG1RF, and in particular, stearic acid is of the same chain length as 
oleic acid (both C18).  
 The addition of the selected saturated fatty acids greatly impaired the growth 
rates of OG1RF (Table 2.1).  The addition of 5 µg/ml of palmitic acid doubled the 
generation time when compared to growth in BHI alone (79 vs. 36 min), therefore 
5 µg/mL was used for subsequent experiments.  This observed toxicity is 
consistent with the published observations for S. pneumoniae [103].  The 
addition of stearic acid alone to cultures also increased generation time.  For 
example, when the concentration of stearic acid was increased from 10 to 15 
µg/mL, the exponential phase doubling time increased from 36 min to 54 min 
(Table 2.1); thus we used 10 µg/mL for our analysis. 
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 Exponential phase cultures supplemented with 5 µg/mL of palmitic acid 
(C16:0) had a membrane composition that consisted of approximately 70% of this 
sole fatty acid (Table 2.2).  The ratio of saturated: unsaturated fatty acids was 
similar to cells grown in bile, and much higher than unsupplemented cultures 
(Table 2.2, 2.6).  The proportion of cis-vaccenic acid in the membrane, however, 
was far less (approximately 17%) versus growth without palmitic acid (40%).  The 
addition of stearic acid (C18:0) also altered the membrane content, with 
approximately 65% of the total membrane being comprised of this one fatty acid 
during exponential phase; cells without this supplement contained only 
approximately 4% of stearic acid in their membrane.  Levels of both palmitic 
(decreased from 36 to 14%) and cis-vaccenic (40 to 14%) acids were lower 
compared to unsupplemented cultures during growth with stearic acid.  The ratio 
of saturated: unsaturated fatty acids was much greater for stearic acid grown 
cells than unsupplemented cultures (Table 2.2). 
 After challenge with 10% bile, cultures grown in the presence of 5 µg/mL of 
palmitic acid or 10 µg/mL of stearic acid did not survive better than the controls 
(Fig. 2.4).  Interestingly, cultures supplemented with either palmitic or stearic acid 
had a similar saturated: unsaturated fatty acid ratio observed in bile grown cells; 
yet bile-grown cells survived the high bile concentration far better.  This data, 
along with the results presented above, suggest that the individual fatty acid 
composition, not the overall ratio of saturated to unsaturated fatty acids, 
contributes to membrane stress survival.  
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Membrane Fatty Acid Changes Interfere with Killing by the Antibiotic 
Daptomycin   
 The antibiotic daptomycin targets Gram-positive bacteria through a calcium 
dependent mechanism to form pores within the membrane [134-137].  This 
lipopeptide is approved for treating S. aureus infections [138], but has also been 
used to treat cases involving E. faecalis.  Recent studies examining daptomycin 
resistant strains of E. faecalis reported morphological changes and aberrant 
placement of cell septa [41, 42].  Studies have also described daptomycin-
resistant strains that have mutations in genes related to phospholipid synthesis 
[40-42, 139].  Given these previously published results and our own observations 
with bile-grown cell morphology (Fig. 2.3), we tested the ability of OG1RF grown 
in BHI medium or medium supplemented with fatty acid sources to survive 
daptomycin treatment.   
 When OG1RF was pre-grown in low levels of bovine bile and then 
challenged with daptomycin (30 µg/mL), there were significantly more survivors 
compared to cells grown without bile (Fig. 2.5a; P < 0.005).  Given that 
daptomycin inserts into membranes, and that bile-grown cells have an altered 
membrane fatty acid profile, we examined whether growth supplementation with 
individual fatty acids could protect E. faecalis from daptomycin-mediated killing.  
Indeed, cells pre-grown with 20 µg/ml of oleic acid survived better than cells 
grown without the fatty acid (Fig. 2.5b), implying that the altered membrane fatty 
acid content is protective against the antibiotic.  Each culture was also 
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challenged with an equivalent volume of ethanol (solvent used for daptomycin 
resuspension) to confirm that the ethanol solvent did not contribute to cell death. 
 Since E. faecalis can cause a myriad of infections and because human 
serum is a source of exogenous fatty acids, we wished to determine if growth in 
human serum could protect E. faecalis from daptomycin challenge.  We 
supplemented our cultures with 15% human serum and noted no significant 
differences in growth rate (Table 2.1).  Analysis of cells grown in serum revealed 
an altered membrane profile compared to cells grown without serum (Table 2.2, 
2.3).  The saturated: unsaturated fatty acid ratio in exponential phase cultures 
was similar to that seen in cells grown without supplementation, and in fact the 
levels of individual saturated fatty acids between the two conditions were similar 
(Table 2.2, 2.6).  In contrast, the unsaturated fatty acid composition was different 
than what was observed in either BHI or bile supplemented cultures.  The total 
percentage of 18-carbon unsaturated fatty acids (41%) was similar to other 
conditions tested (41% C18:1 cis 11 in BHI; 34% total C18:1 cis 9 and C18:1 cis 11 in bile).  
However, membranes of serum-grown cells contained a different combination of 
18-carbon unsaturated fatty acids: cis-vaccenic (10%), oleic (18%), and linoleic 
acid (C18:2 cis 9, 12) (13%).  FAME analysis of serum-supplemented medium 
detected the presence of these fatty acids, indicating that they were incorporated 
into the membrane from the medium (Table 2.3).   
 When subjected to daptomycin challenge, there was a higher percentage of 
survival for those cells grown in serum (Fig. 2.5a) versus without the supplement.  
This was similar to cells grown with either bile or oleic acid, even though there 
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were significant membrane fatty acid differences between the three groups 
(Table 2.2).  This suggests that a variety of altered fatty acid compositions are 
able to protect against damage from daptomycin. 
 Given that serum grown cells had a significant amount of linoleic acid within 
their membranes, we examined its effects on protection from daptomycin.  
Similar to what was observed with cultures pre-grown with bile or oleic acid, cells 
grown with linoleic acid were significantly better at surviving daptomycin 
challenge over the control (Fig. 2.5b, P < 0.0005).  Thus, a variety of fatty acid 
supplements are capable of enhancing resistance to daptomycin. 
 Another major component in both bile and serum was stearic acid  (C18:0, 
Table 2.1).  We examined whether supplementation of this fatty acid could 
protect from daptomycin-induced damage.  Stearic acid gave the weakest level 
of protection of all supplements tested (Fig. 2.5b).  The only significant difference 
between BHI and supplementation with stearic acid was found 15 minutes post-
challenge.  The other fatty acid sources (bile, serum, linoleic, and oleic acid) 
provided more robust protection and had statistically more survivors 15, 30, and 
60 minutes post-challenge (P < 0.005).  These findings were interesting because 
despite the vast differences in the individual membrane compositions of the cells 
grown with the different supplements, their ability to protect from bile stress was 
not indicative of their ability to protect from daptomycin.     
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Depolarization Rates Upon Daptomycin Treatment Are Dependent Upon 
Membrane Composition  
 Addition of daptomycin leads to rapid membrane depolarization [136].  We 
further examined membrane permeability of selected samples to better examine 
the kinetics of this damage.  We utilized DiBAC4(3) which enters cells upon 
membrane depolarization, and results in increased fluorescence [140, 141].  
Immediately upon the addition of daptomycin (t=0), the sample grown in BHI 
alone had a statistically significant increase in fluoresence versus its paired 
control sample (no daptomycin) as determined by flow cytometry (Fig. 2.6).  For 
cultures grown with oleic or linoleic acid, measureable differences in permeability 
did not occur until five minutes post treatment, and gradually those differences 
became more severe over time (Fig. 2.6c, 2.6d).  Surprisingly, both bile and 
stearic acid supplemented cultures showed no major differences in 
depolarization compared to control until 60 min post daptomycin treatment, 
despite the fact there was cell loss as indicated by our colony count data (Fig. 
2.5, 2.6b, 2.6e).  For stearic acid, there seems to be significant depolarization 
over time even for the control, implying that the supplement may have negative 
effects overall (see Discussion).  Although cultures supplemented with linoleic 
acid had a similar log ratio of survivors after daptomycin treatment when 
compared to bile-grown cells (Fig. 2.5), cells supplemented with bile showed far 
fewer changes in membrane permeability (Fig. 2.6b, 2.6d).  Thus there may be 
additional factors contributing to the protective mechanism of fatty acids other 
than preventing rapid changes in membrane permeability.    However, this 
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analysis indicates that the rapid membrane depolarization experienced by BHI 
grown cells can be slowed if oleic or linoleic acid are provided, which may explain 
the enhanced survival of these cultures as well (Fig. 2.5b).  
 
Discussion 
 Here, we confirmed that E. faecalis OG1RF alters its membrane fatty acid 
composition depending on growth environment and through the incorporation of 
exogenous fatty acids from a variety of sources.  These membrane changes 
have a significant impact on cellular survival when challenged with membrane 
damaging agents.  Specifically, growth in bile, oleic acid, or linoleic acid leads to 
membrane alterations that can enhance resistance to the antibiotic daptomycin.  
The precise mechanism of protection still remains to be elucidated. 
 
Membrane Changes: De Novo   
Many studies have shown that bacteria can alter their membrane fatty acid 
composition depending upon growth temperature, phase of growth as well as 
changing environmental conditions [23, 25].  As we have illustrated here, the 
membrane profile of E. faecalis does change throughout its growth cycle: 
specifically, when grown at 37°C, cells in exponential phase have a membrane 
profile dominated by palmitic acid and cis-vaccenic acid.  When those cells are in 
stationary phase, we and others report a significant increase in cyclopropane 
fatty acids (Table 2.2, 2.3; [133]).  This increase in cyclopropane fatty acids could 
be a protective measure against acidification of the medium as the culture enters 
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stationary phase.  E. coli synthesizes cyclopropane fatty acids in stationary 
phase which serves to increase its resistance to low pH [31].  Other Gram-
positive bacteria, such as lactobacilli, also increase the proportion of membrane 
cyclopropane fatty acids in response to low pH [33].  Many oral Streptococci do 
not make cyclopropane fatty acids but instead increase the proportion of 
unsaturated fatty acids in their membranes in response to acidification [32, 33, 
142].  
Additionally, we confirmed that OG1RF increases the amount of unsaturated 
fatty acids within its membrane when the growth temperature is decreased.  This 
likely maintains membrane fluidity, and is a common cold temperature adaptation 
for many bacteria.  This mechanism has been well studied in E. coli and Bacillus 
subtilis, yet each organism achieves the same outcome through a different route.  
E. coli increases the amount of unsaturated fatty acids at the biosynthetic level; 
B. subtilis actually modifies fatty acid tails already within the membrane using a 
membrane phospholipid desaturase encoded by the des gene [24].  We have not 
identified a des gene homolog in OG1RF; however, it is also not clear if OG1RF 
utilizes the E. coli pathway to increase its unsaturated fatty acids in response to 
low growth temperature.  Further experimentation is needed to determine the 
exact mechanism E. faecalis employs to maintain membrane fluidity in response 
to temperature changes. 
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Membrane Changes: Incorporation of Exogenous Fatty Acids   
As we show in this report, E. faecalis, like many bacteria, can incorporate 
exogenous fatty acids into its membrane.  However, OG1RF does not encode 
genes for beta-oxidation based on homology searches, thus it cannot degrade 
fatty acids for use as a carbon source [122, 143].  Vibrio cholerae changes its 
phospholipid profile in response to growth in bile; these changes are attributed to 
exogenous fatty acids and not other bile components [87].  Streptococcus 
agalactia incorporates a variety of fatty acids into its membrane after growth in 
serum [115].  S. aureus and S. pneumoniae can incorporate a variety of 
exogenous fatty acids, notably oleic acid, and use these to replace a significant 
amount of the membrane fatty acid content [103, 118].  Our data demonstrate 
that exogenous long chain fatty acids (≥16:0) are incorporated into the 
membrane of E. faecalis without elongation and can significantly alter the 
membrane content (Table 2.2, 2.3).  This finding is further validated by work 
showing that an E. faecalis fatty acid auxotroph could be maintained when the 
culture medium was supplemented by oleic acid [144].  
In addition to membrane changes, exogenous fatty acids had varying effects 
on growth rates and stress responses.  Medium supplementation with bile, 
saturated fatty acids, and linoleic acid, a C18:2 fatty acid, impacted growth rates, 
while C18:1 fatty acids had a less noticeable effect.  Although the growth rates 
were reduced when OG1RF was supplemented with either the saturated fatty 
acids palmitic or stearic acid, the organism was not more resistant to the 
membrane damaging agents tested here.  Slow-growing bacteria are often better 
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protected from antibiotics because many antibiotics target actively growing cells 
by inhibiting protein synthesis, RNA synthesis, etc.  The agents examined in this 
study are membrane damaging; they lead to dissipation of proton motive force 
and ion imbalance, which will eventually cause cellular death.  This “non-specific” 
nature of damage may explain why reduced growth rates did not enhance 
resistance to these agents.  
A previous study reported the impact of a variety of different fatty acids on 
the growth of S. aureus and S. pneumoniae [103].  In contrast to these 
organisms, E. faecalis did not follow the same sensitivity pattern.  It is important 
to note that the natural niche of E. faecalis is the intestine, which is a far different 
environment than the nares or nasal pharynx for S. pneumoniae and S. aureus; it 
is likely that organisms have adapted to the most abundant host-derived fatty 
acids in their normal habitat.  These varying responses to different fatty acids 
between the organisms are likely linked to alterations in membrane fluidity, 
membrane protein content, and/or possible negative feedback on the fatty acid 
biosynthetic genes.  
 
Exogenous Fatty Acids and Stress Resistance   
For organisms like L. monocytogenes, bile salts are known triggers of efflux 
pumps, which lead to membrane stress resistance [37].  Other groups have 
shown that growth of E. faecalis within bile salts can protect cells from membrane 
damaging agents.  We did not observe a similar protection with OG1RF. It is 
important to note that the strain we examined was not the same one used in the 
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previous study, and the concentration of bile salts also varied, which may explain 
the opposing finding; furthermore, there is large variation in sequenced strains of 
E. faecalis, which could also contribute to the different results [126, 143, 145].  
Nonetheless, growth in oleic acid alone can significantly increase resistance 
to bile (Fig. 2.1a).  Given that oleic acid is present in bile, it is often encountered 
by E. faecalis and may be preferentially used by the bacterium in the host.  In 
fact, a recent report indicated that a small colony variant isolated from a patient 
grew significantly better when provided with oleic acid (oleate) in vitro [144].   
Supplementing cultures with 0.2% bile protected against both bile and SDS 
challenge. As compared to oleic acid-grown cells, protection from SDS was 
significantly better for bile-grown cultures.  This suggests that there are other 
components within bile, besides oleic acid, that are responsible for the strong 
cross-protection against SDS. Indeed, previous studies have shown that bile 
treatment can impact the expression of numerous genes and proteins [86, 126]; 
however, the global impact of exogenous fatty acids on gene expression or 
protein levels have not been explored.  It may be that growth in bile induces the 
expression of additional genes versus growth in fatty acids (oleic) alone or even 
bile salts, and induction of these additional genes are responsible for the cross-
resistance against detergents such as SDS.   
 When examining resistance to the lipopeptide daptomycin, an array of 
membrane fatty acid compositions protected the cells.  Specifically, growth in 
bile, serum, oleic acid or linoleic acid could provide protection from daptomycin 
challenge.  Upon examination of the individual membrane fatty acid profiles, we 
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could not identify a specific increase or decrease in a particular fatty acid that 
correlated with protection across all conditions (Table 2.2).  Levels of cis-
vaccenic acid were lowered for all protected compositions compared to 
unsupplemented controls, but reduced levels of cis-vaccenic acid were also 
observed for cultures grown in stearic acid, which were not significantly 
daptomycin-resistant.  
 Supplementation with bile gives a more saturated membrane fatty acid 
profile that is protective against daptomycin while the unsaturated fatty acids 
oleic and linoleic were also beneficial.  How such different compositions protect 
E. faecalis from daptomycin challenge is not clear.  Perhaps, exogenous fatty 
acids induce changes in gene expression, and those changes may be critical for 
the protection.  However, stearic acid did not show a similar protection and was 
not well tolerated by the organism at high concentrations.  The membrane 
depolarization data for stearic acid-grown cells showed that even untreated cells 
experienced a fairly high amount of depolarization compared to cells grown with 
other fatty acids (Fig. 2.6).  The stearic acid-supplemented cultures had a 
saturated: unsaturated ratio even higher than bile-grown cells.  As these findings 
indicate that there is no correlation between membrane saturation and 
resistance, other aspects of the membrane content including phospholipid 
composition and/or membrane proteins and their activities may be responsible 
for the observed resistance.   
Growth in bile and specific fatty acids resulted in an altered morphology of 
OG1RF.  In particular, cells were found in long chains that had curvature to them 
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(Fig. 2.3).  However, this altered morphology did not necessarily confer 
resistance to the membrane damaging agents that we tested, including the 
antibiotic daptomycin.  For example, growth in oleic acid protected cells from 
both bile challenge and daptomycin when compared to control, yet these cells 
had a “normal” morphology.  Previous studies of daptomycin-resistant 
Enterococci strains showed aberrant placement of cell septa and altered cell 
morphology [41, 42].  Our findings though suggest that while altering the 
membrane composition may lead to morphological changes, these did not 
correlate to the increased daptomycin resistance we observed.  Genetic analysis 
of daptomycin-resistant strains also revealed mutations related to cell membrane 
changes [40, 41, 139].  Among these are mutations to cardiolipin synthase.  
While this mutation may enhance survival to daptomycin, this mutation alone was 
not enough to confer resistance in all strains [40].  Our results support this 
observation and suggest that resistance to daptomycin may be enhanced by 
supplementation with host-derived fatty acids.   
 
Role of Exogenous Fatty Acids in Microbial Killing   
The ability to utilize exogenous fatty acids has significant therapeutic 
relevance.  Bacterial fatty acid biosynthesis has long been considered an 
attractive drug target because each step occurs through the action of an 
individual enzyme unlike the eukaryotic approach [107, 117].  However, studies 
have shown that S. pneumoniae could completely utilize exogenous fatty acids to 
support its growth, while S. aureus cannot, indicating that inhibition of fatty acid 
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biosynthesis may not be effective against all pathogens [118].  In the same study, 
there were significant impacts upon cellular physiology when either organism 
was grown in the presence of exogenous fatty acids, and the same fatty acid 
affected each organism differently [103, 118].  As noted previously, we have also 
observed growth alterations attributed to exogenous fatty acids (Table 2.1).  
These data show that both the effects of supplementation with exogenous fatty 
acids on the ability to overcome fatty acid biosynthetic inhibition and the specific 
consequences of exogenous fatty acid supplementation on cellular physiology is 
unique for each pathogen. 
Our data demonstrate that E. faecalis can utilize host fatty acids to 
enhance its resistance to specific membrane damaging agents.  The combined 
effects of fatty acid uptake and utilization may contribute to the resilience of E. 
faecalis within the host and external environment.  Further experiments to reveal 
the mechanism and consequences of fatty acid incorporation would provide 
information towards understanding the persistence of this organism. 
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Appendix. Chapter II Tables 
 
Table 2.1: Generation time for E. faecalis OG1RF with various supplements  
Media Content Concentration Generation Time 
(Minutes) 
Growth Rate 
(Hours-1) 
BHIa NA 36.0±3.0 1.2±0.07 
Bile 0.2% Bile 49.5±4.5 0.8±0.07 
C18:1 cis 11 (cis-vaccenic acid) 10 µg/mL 34.9±1.2 1.2±0.04 
C18:2 cis 9,12 (linoleic acid) 10 µg/mL 60.5±9.8 0.7±0.1 
C18:1 cis 9 (oleic acid) 10 µg/mL 29.7±1.0 1.4±0.05 
C18:1 cis 9 (oleic acid) 20 µg/mL 34.1±1.0 1.2±0.03 
C18:1 cis 9 (oleic acid) 100 µg/mL 34.0±1.5 1.2±0.05 
C16:0 (palmitic acid) 5 µg/mL 79.3±8.2 0.5±0.06 
C18:0 (stearic acid) 10 µg/mL 36.5±1.9 1.1±0.06 
C18:0 (stearic acid) 15 µg/mL 54.0±3.0 0.7±0.04 
Serum 15% Serum 36.1±0.8 1.2±0.02 
Cholic acid 10 µg/mL 41.1±2.2 1.0±0.05 
Bile salt mixtureb Each 10 µg/mL 39.4±1.6 1.1±0.04 
aFor all other conditions, BHI was supplemented as listed. 
bBile salt mixture contained 10 µg/mL each of the following: deoxycholic acid, lithocholic acid, glycocholic acid 
hydrate, taurocholic acid sodium hydrate. 
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Table 2.2: E. faecalis OG1RF membrane fatty acid composition during exponential phase growtha 
Fatty Acid BHI Bileb C18:1 cis 9c 
(oleic acid)
 
C18:1 cis 11d 
(cis-vaccenic 
acid) 
C18:2 cis 
9,12
d 
(linoleic acid)
 
C16:0e 
(palmitic acid) 
C18:0f 
(stearic acid) 
Serumg 
C12:0 0.8±0.3 ND 0.7±0.2 0.6±0.5 2.3±1.5 0.1±0.1 0.2±0.0 ND 
C14:0 5.1±0.9 0.5±0.1 2.0±1.5 0.4±0.4 3.4±0.6 2.4±0.2 2.0±0.2 3.3±0.1 
C15:1 <0.1±0.1 ND ND ND 2.0±3.5 ND ND ND 
C16:1 8.1±2.2 0.8±0.1 1.5±0.7 0.8±0.1 2.7±0.4 3.5±0.2 2.3±0.4 4.9±0.1 
C16:0 36.0±3.8 51.2±1.4 10.3±8.3 2.0±0.2 10.0±1.5 69.0±3.3 14.9±4.4 40.6±0.2 
C17:0 iso 3OH ND ND ND ND ND ND ND 1.5±0.2 
C17.1 ND 0.5±0.1 0.8±0.5 0.3±0.6 1.4±2.5 0.2±0.4 0.2±0.2 0.7±0.0 
C17:0 <0.1±0.05 1.6±0.0 ND ND ND 0.1±0.1 0.1±0.1 0.3±0.0 
C17:0 2OH 2.5±0.4 0.1±0.1 0.3±0.3 1.9±0.4 0.3±0.5 1.3±0.4 1.2±0.7 0.6±0.1 
C18:1 cis 9 ND 19.3±0.6 71.9±12.6 ND ND 0.6±0.2 0.1±0.1 17.5±0.6 
C18:1 cis 11 40.6±1.9 2.7±0.2 4.0±3.5 91.9±1.3 5.3±0.2 17.3±2.6 13.9±4.6 9.7±0.5 
C18:0 4.2±1.7 20.8±0.9 1.4±1.0 0.9±0.1 2.2±2.6 4.0±0.3 64.6±10.4 7.5±0.3 
C20:1 0.1±0.2 ND 0.3±0.2 ND 2.8±2.6 ND ND ND 
C20:0 ND 0.2±0.1 5.0±3.3 ND ND ND <0.1±0.1 ND 
C18:2 0.1±0.1 ND ND 0.1±0.2 67.1±5.3 0.2±0.1 ND 12.5±0.3 
C19 cyclo 1.0±0.3 0.4±0.7 1.9±0.3 1.1±0.2 0.3±0.4 0.7±0.1 0.5±0.1 ND 
Othersh 1.4±0.8 2.1±0.7 ND ND 0.2±0.4 0.6±0.7 <0.1±0.1 0.9±0.2 
Sat.:Unsat. 0.9±0.2 3.2±0.2 0.3±0.1 <0.1±0.0 0.2±0.1 3.5±0.5 5.0±2.9 1.1±0.0 
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Table 2.2 continued 
 
a Percentage of total membrane content as determined by GC-FAME by Microbial ID, 
Inc; shown are averages ± standard deviations of three independent experiments. 
b Bovine bile was added to a final concentration of 0.2%. 
c Oleic acid was added to a final concentration of 20 µg/mL. 
d cis-vaccenic or linoleic acid was added to a final concentration of 10 µg/mL.  
e Palmitic acid was added to a final concentration of 5 µg/mL.  
f Stearic acid was added to a final concentration of 10 µg/mL.  
g Human serum was added to a final concentration of 15%. 
h “Others” indicates the total of all fatty acids comprising <1% of the total membrane 
content individually. 
 57 
Table 2.3: OG1RF membrane fatty acid composition during stationary phase growtha 
Fatty Acid BHI Bileb C18:1 cis 9c 
(oleic acid) 
C18:1 cis 11d 
(cis-vaccenic 
acid) 
C18:2 cis 9,12d 
(linoleic acid)
 
C16:0e 
(palmitic acid) 
C18:0f 
(stearic acid) 
Serumg 
C14:0 6.7±0.4 0.6±0.1 5.2±0.1 4.6±0.1 6.8±0.3 5.0±0.1 3.7±0.1 3.6±0.2 
C16:1 8.7±1.7 1.5±0.2 2.7±0.1 3.4±0.1 4.9±0.1 4.9±0.0 3.7±0.1 4.3±0.1 
C16:0 36.3±2.2 43.1±3.7 30.1±0.8 26.3±0.6 31.1±0.6 50.3±1.2 24.1±0.2 39.1±1.8 
C17:0 iso 3OH ND ND ND ND 1.2±2.1 ND ND 0.8±1.3 
C17:1 iso cis 12 ND ND 1.1±0.2 1.2±0.0 ND ND ND ND 
C17:1 0.36±0.6 1.2±0.3 0.7±0.1 ND 0.4±0.4 ND 0.6±0.0 0.7±0.1 
C17.0 0.1±0.0 0.9±0.1 0.2±0.0 ND 0.3±0.2 0.2±0.0 0.2±0.0 0.5±0.0 
C17:0 2OH 2.7±2.4 0.2±0.0 1.4±1.2 2.6±2.3 ND 3.5±0.2 3.1±0.3 0.8±0.1 
C18:1 cis 9 ND 24.0±4.5 35.2±3.0 ND ND ND ND 15.7±0.8 
C18:1 cis 11 28.4±0.7 5.3±0.1 13.4±0.5 48.6±1.5 16.7±0.8 18.8±0.7 14.5±0.8 7.2±0.5 
C18:0 3.4±1.0 11.3±0.5 4.5±0.2 3.0±0.1 3.1±0.2 5.9±0.2 42.2±0.8 7.0±0.2 
C20:1 0.1±0.2 0.8±0.2 0.1±0.0 ND 0.2±0.3 ND ND ND 
C20:4 0.0±0.0 0.9±0.2 ND ND ND ND ND 1.3±0.2 
C20:0 ND 3.3±1.1 3.3±0.5 ND ND ND 0.1±0.0 0.2±0.0 
C18:2 ND 2.3±4.0 ND 0.1±0.1 29.1±2.4 ND ND 17.5±010 
C19 cyclo 10.8±2.0 1.8±3.2 1.2±2.0 7.2±0.5 3.3±0.7 9.3±0.1 6.1±0.3 ND 
Othersh 2.4±1.3 2.8±1.1 1.2±0.4 2.9±0.3 3.0±1.2 2.1±0.3 2.3±0.2 1.3±0.1 
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Table 2.3 continued 
aPercentage of total membrane content  as determined by GC-FAME by Microbial ID, 
Inc; shown are averages ± standard deviations of three independent experiments. 
 bBovine bile was added at 0.2% final concentration. 
 cOleic acid was added to a final concentration of 20 µg/mL. 
dCultures containing cis-vaccenic or linoleic acid were supplemented at a final 
concentration10 µg/mL.  
ePalmitic acid was added to a final concentration of 5 µg/mL of palmitic acid.  
fCultures were supplemented with a final concentration of 15 µg/mL of stearic acid.  
gHuman sera was added to a final concentration of 15%. 
h”Others” indicates the total of all fatty acids comprising <1% of the total membrane 
content individually. 
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Table 2.4: OG1RF membrane fatty acid composition during 25°C growtha 
 Exponential Stationary 
 BHI Bileb BHI Bileb 
C14:0 6.4±0.6 0.9±0.4 78.0±1.4 1.1±0.2 
C16:0 30.6±1.0 44.6±9.0 28.0±1.2 43.0±0.3 
C16:1 12.3±1.5 1.2±0.7 13.2±2.8 1.0±0.1 
C17:0 ND 1.3±0.5 0.1±0.0 1.2±0.3 
C18:0 2.4±0.4 17.1±5.0 1.9±0.6 16.7±4.2 
C18:1 cis 9 ND 26.7±11.2 ND 24.3±670 
C18:1 cis 11 46.1±1.2 3.5±0.9 38.3±0.7 5.1±1.1 
C20:0 ND 0.3±0.3 <0.1±0.0 1.8±1.3 
Othersc 2.3±0.8 4.4±2.1 10.6±2.9 5.7±2.3 
aPercentage of total membrane content as determined by GC-FAME by Microbial ID, Inc; shown are averages ± 
standard deviations of three independent experiments.  bBovine bile was added at 0.2% final concentration.  
c”Others” indicates the total of all fatty acids comprising <1% of the total membrane content individually. 
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Table 2.5: Temperature comparison of saturated: unsaturated ratios 
 BHI Bilea 
 Exponential Stationary Exponential Stationary 
25°C 0.7±0.0 0.7±0.0 2.5±1.9 2.0±0.4 
37°C 1.0±0.2 1.2±0.1 3.2±0.2 1.7±0.1 
aBovine bile was added to BHI to a final concentration of 0.2%.
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Table 2.6: Lengths, saturated, and unsaturated fatty acid content during exponential growtha 
Total BHI Bileb C18:1 cis 9c 
(oleic acid) 
C18:1 cis 11d 
(cis-vaccenic 
acid) 
C18:2 cis 
9,12
d 
(linoleic acid) 
C16:0e 
(palmitic acid) 
C18:0f 
(stearic acid) 
Serumg 
C14 5.1±0.9 0.5±0.1 2.0±1.5 0.4±0.4 3.4±0.6 2.5±0.2 2.0±0.2 3.3±0.1 
C16 44.4±1.7 52.1±1.4 11.7±9.0 2.8±0.2 12.7±1.9 72.4±3.2 17.2±4.8 45.6±0.4 
C18 44.8±0.5 42.9±0.9 77.3±8.1 92.9±1.2 74.5±6.4 22.1±2.9 78.7±15.2 47.2±0.3 
C20 0.2±0.4 0.3±0.2 5.3±3.1 ND  2.8±2.6 0.1±0.2 0.1±0.1 0.4±0.1 
Saturated 46.1±4.3 74.9±1.5 19.4±7.8 3.9±0.6 18.0±5.9 75.7±2.7 82.0±15.2 52.1±0.3 
Unsaturated 49.1±3.4 23.4±0.8 78.4±7.7 93.1±1.0 81.3±5.3 21.9±2.3 16.6±5.3 45.7±0.4 
Saturated: 
Unsaurated 
0.9±0.2 3.2±0.2 0.3±0.1 <0.1±0.0 0.2±0.1 3.5±0.5 5.0±2.9 1.1±0.0 
aPercentage of total membrane content  as determined by GC-FAME by Microbial ID, Inc; shown are averages ± 
standard deviations of three independent experiments. 
 bBovine bile was added at 0.2% final concentration. 
cOleic acid was added to a final concentration of 20 µg/mL. 
dCultures containing cis-vaccenic or linoleic acid were supplemented at a final concentration of 10 µg/mL.  
ePalmitic acid was added to a final concentration of 5 µg/mL of palmitic acid.  
fCultures were supplemented with a final concentration of 10 µg/mL of stearic acid.  
gHuman serum was added to a final concentration of 15%. 
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Table 2.7: GC-FAME analysis of mediaa 
 Bileb Serumc 
C16:0 31.7±1.0 27.5±1.1 
C16:1 2.2±0.1 3.4±0.3 
C17:0 1.3±0.02 0.5±0.1 
C17:0 2OH ND 1.0±1.1 
C18:0 16.9±1.0 5.5±0.8 
C18:1 cis 9 23.6±1.3 17.4±1.5 
C18:1 cis 11 ND 3.2±0.4 
C18:1 5.0±0.2 ND 
C18:2 14.9±0.8 33.1±1.7 
C20:0 iso ND 1.0±1.8 
C20:4 1.7±0.2 3.9±3.3 
Othersd 2.9±0.7 4.6±3.6 
aGC-FAME was performed by Microbial ID Inc.  Presented are averages ± standard deviations of three 
independent media batches. 
bBHI was supplemented with to a final concentration of 0.2%bovine bile.  
cHuman serum was added to a final concentration of 15% in BHI. 
dOthers indicates the total of all fatty acids comprising <1% of the total membrane content individually 
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Appendix. Chapter II Figures 
 
 
 
 
Figure 2.1: Fatty acid supplementation protects OG1RF from membrane 
damaging agents. (A) Challenge with 10% bovine bile. Cells were grown in BHI 
or BHI supplemented with 0.2% bovine bile, oleic acid, or ethanol (solvent 
control) as indicated in Table 2.  Cultures (n=3) were then challenged with 10% 
bile and the log ratios of viable cells were determined.  *  indicates statistical 
significance between BHI and the supplemented culture; P <0.005 as determined 
by Student’s t-test for all time points.  There was no statistical significant 
difference in survival between BHI and the ethanol control. (B) Challenge with 
0.1% SDS.  Cells were grown as in (A) and challenged with 0.1% SDS and the 
log ratio of viable cells were determined (n=3). * indicates statistical significance 
between supplemented and unsupplemented cultures as determined by 
Student’s t-test, P <0.0001.  Note that the log ratio of viable cells grown in bile 
was significantly higher than those grown in oleic acid (P <0.005). 
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Figure 2.2: Growth in bile salts does not protect form acute bile stress.  (A) 
Cells were grown in BHI, or in BHI supplemented with 10 µg/mL of each of the 
following: deoxycholic acid, lithocholic acid, glycocholic acid hydrate, taurocholic 
acid sodium hydrate, or solvent control. Cells were then treated with 10% bile as 
described in the Materials and Methods (n=3).  (B) Cells were grown in BHI or 
BHI supplemented with 10 µg/mL of cholic acid or methanol control.  Cultures 
were challenged with 10% bile as described in the Materials and Methods, and 
the log ratios of viable cells were determined.  In both (A) and (B), there was no 
statistically significant difference in survivors as determined by Student’s t-test 
between BHI and the supplemented cultures or the solvent control. 
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Figure 2.3: Morphology of OG1RF grown under different conditions.  
OG1RF was grown as described in the Materials and Methods and cells were 
prepared and analyzed via SEM.  Shown are representative figures of three 
independently grown BHI and BHI + 0.2% bile cultures; shown are representative 
figures for two independently grown cultures supplemented with oleic acid.  
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Figure 2.4: Specific membrane fatty acid compositions protect OG1RF from 
high bile exposure.  Cells were grown as indicated in BHI or BHI supplemented 
with the different fatty acids (as indicated in Table 2) or ethanol (solvent control).  
Cultures (n=3) were subjected to 10% bile challenge and the log ratios of 
survivors were determined. As determined by Student’s t-test, there were 
significantly more survivors in cultures supplemented with cis-vaccenic acid than 
unsupplemented cultures at all time points, (P <0.05).  Survival of cultures 
supplemented with linoleic acid versus BHI-only grown cultures was significantly 
different only at T30 (P <0.005).  No statistical difference in survivors was 
observed between any other supplementation versus unsupplemented cells at 
any time point. 
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Figure 2.5: Growth in specific fatty acid sources can protect from 
daptomycin-induced killing.  (A) Cells were grown in BHI or BHI supplemented 
with 0.2% bovine bile or 15% human serum and challenged with 30 µg/ml of 
daptomycin as indicated in the text.  The log ratio of survivors was statistically 
significant between unsupplemented cultures and cultures supplemented with 
bile or human serum using Student’s t-test: P <0.0005 at all time points, n=3.  (B) 
Cultures (n=3) were supplemented with the indicated fatty acids as described in 
the text and challenged with daptomycin.  There were statistically significant 
differences in survivors between cultures grown in BHI and those supplemented 
with either linoleic acid or oleic acid; for cultures supplemented with linoleic acid 
P <0.0005 for all time points and P <0.005  for all time points with oleic.  For 
stearic acid, statistical analysis showed significantly more survivors when 
compared to unsupplemented cultures only at T30 P <0.05.  
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Figure 2.6: Membrane depolarization can occur quickly upon daptomycin 
exposure.  Cells were grown as described in Table 2: (A) BHI (no 
supplementation); (B) bile (C) oleic acid; (D) linoleic acid; (E) stearic acid.  Five 
minutes (-5) prior to daptomycin exposure cultures were split and stained with 
DiBAC4(3) to determine basal permeability.  At 0 min, daptomycin treated 
cultures (grey) or solvent control (black) was added and immediately following, 
aliquots were taken for analysis.  Aliquots were removed and stained at indicated 
time points. Shown are averages and standard deviations, n=6 for all but stearic 
acid, n=5; * indicates P < 0.05 as determined by Student’s t-test for daptomycin-
treated versus the untreated control.  Flow cytometry experiment performed by 
John Harp. 
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Figure 2.6 Continued 
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Chapter III: The Effects of Exogenous Fatty Acids on the Growth and 
Morphology of Enterococcus faecalis   
 71 
Abstract 
 
Enterococcus faecalis has access to sources of exogenous fatty acids in 
bile while living as a commensal in the mammalian intestine and from serum 
while opportunistically infecting other host niches.  We previously showed that 
complex sources of fatty acids could drastically alter membrane fatty acid content 
and protect E. faecalis from acute membrane damage.  Further investigation 
revealed that individual unsaturated fatty acids could protect from acute 
membrane stress.  In order to determine the mechanism of protection, it was 
necessary to examine the effects of exogenous fatty acids on the physiology of 
E. faecalis.  Our analysis showed that unsaturated fatty acids are necessary for 
growth and can support the growth of E. faecalis in the absence of de novo fatty 
acid biosynthesis.  Saturated fatty acids cannot support growth when de novo 
fatty acid synthesis is inhibited, and indeed, these impede growth, and cause a 
distorted morphology.  Lastly, exogenous sources of fatty acids also lead to 
changes in phospholipid content, but the impact of this on cell growth and 
physiology is unclear. 
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Introduction 
Enterococcus faecalis is a Gram-positive bacterium that is a commensal 
of the mammalian intestine [146].  Upon exit from the host, Enterococci can 
survive a wide range of terrestrial and aquatic environments, such as pH ranging 
from 4.5-9.5, temperatures from 10-45°C, and high salinity (6.5% NaCl) [5, 119].  
Unfortunately, the qualities that allow this bacterium to survive harsh or changing 
conditions also enable it to survive on inanimate objects and contaminate 
surfaces in a clinical setting [147, 148].  Thus, this organism is capable of 
surviving and causing a variety of infections in the human host such as surgical 
sites, endocarditis, and can form biofilms on urinary and intravenous catheters 
[1].  Enterococci are also intrinsically resistant to many antibiotics due to the 
presence of efflux pumps [120]; additionally, some strains are resistant to 
vancomycin and resistant to daptomycin [41]. 
Bacteria commonly alter their membrane fatty acid and phospholipid 
contents to survive changing membrane conditions and resist acute membrane 
stress. Altering the membrane fatty acid content in response to temperature and 
pH has been well-studied in a variety of organisms.  Examples in Bacillus subtilis 
and Escherichia coli show that unsaturated membrane fatty acids are favored at 
lower temperatures to maintain fluidity while saturated fatty acids provide rigidity 
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to membrane at higher temperatures [24, 25, 149].  For low pH survival, both E. 
coli and E. faecalis convert unsaturated fatty acids to cyclopropane fatty acids 
[31, 34].  Studies have also shown that increasing the unsaturated fatty acid 
content, as well as the presence of cardiolipin, help Streptococcus mutans 
survive low pH [35, 142].  These all represent modifications to the membrane that 
originate from de novo fatty acid synthesis and modifications.  Organisms that 
live in a host also have access to exogenous fatty acids that could be used to 
alter the membrane composition; therefore, we wanted to examine the role of 
exogenous fatty acids in adapting to changing environments and sources of 
stress. 
The utilization of exogenous fatty acids by Gram-negative organisms has 
been deduced using the model organism Escherichia coli.  Short chain fatty acids 
passively enter the cell while longer chains are transported through the outer 
membrane via FadL, a dedicated transporter, and the inner membrane via FadD, 
which facilitates transport and activates the exogenous fatty acids with acyl-CoA 
synthetase activity [78].  The acyl-CoA moieties can then be degraded via β-
oxidataion and utilized as a carbon source, which is a common ability among 
Gram-negative organisms [87, 150, 151].  
Although some Gram-positive bacteria associated with soil environments 
can degrade fatty acids [71, 152], many associated with the human host, such as 
Enterococci, Staphylococci, and Streptococci do not possess the necessary 
enzymes for β-oxidation [73, 122, 153], but can incorporate exogenous fatty 
acids into membrane phospholipids [115].  The uptake of exogenous fatty acids 
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is hypothesized to be a passive mechanism in Gram-positive organisms, as a 
novel transporter has not been found [82, 83].  Recently, Parsons et. al. 
demonstrated the presence of a fatty acid kinase in Staphylococcus aureus, 
which activates exogenous fatty acids, making these suitable substrates for 
direct membrane incorporation via PlsY, or attachment to the acyl carrier protein 
via PlsX, and further elongation or attachment via PlsC [84] (Fig. 1.2).  
Homologues of these fatty acid binding proteins and kinase have been found in a 
variety of Gram-positive organisms including Enterococcus faecalis V583 [82]. 
In the human host, E. faecalis has access to host sources of fatty acids 
from bile or serum [131].  Previously, we observed that growth of E. faecalis with 
bile or pooled human serum resulted in the accumulation of eukaryotic fatty acids 
in the membrane and a concomitant decrease in specific native fatty acids in the 
membrane.  Additionally, we noted that these complex sources of fatty acids, as 
well as individual eukaryotic unsaturated fatty acids supplements, were protective 
against acute membrane stress [2].   
However, we observed that saturated fatty acids did not protect E. faecalis 
from stress, and they impeded growth.  A recent publication profiling fatty acid 
toxicity in Staphylococcus aureus, Bacillus subtilis, and Streptococcus 
pneumoniae showed that toxicity patterns differed among organisms and that 
only specific fatty acids contribute to toxicity [103].  A previous study showed that 
wall teichoic acid (WTA) structures confer resistance to toxic fatty acids in S. 
aureus by affecting surface hydrophobicity and pore size in the cell wall [154].  
Similarly, this study shows that eliminating WTA lowers minimum inhibitory 
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concentrations (MIC) to fatty acids [103].  Both WTA and fatty acid metabolism 
vary among Gram-positive organisms [104, 118] so, it can be expected that 
Gram-positive bacteria will respond to fatty acids differently. 
Our hypothesis is that E. faecalis responds to individual fatty acids in 
distinct ways, and prefers growth with monounsaturated fatty acids, specifically 
long-chained (C18) fatty acids commonly found in bile and serum.  The ability to 
respond to exogenous fatty acids in discrete ways has implications for potential 
drugs targeting FASII.  We sought to further characterize the physiological 
consequences of individual fatty acids in regards to growth, morphology, and 
phospholipid content.   
 
Materials and Methods 
 
Bacterial Strains and Growth Conditions 
Enterococcus faecalis OG1RF was grown in brain heart infusion medium 
(BHI; BD Difco) at 37°C unless stated otherwise.  Overnight cultures were used 
to inoculate fresh medium to an optical density (OD600 nm) of 0.01.  All fatty acids 
and chemicals were purchased from Sigma-Aldrich unless noted otherwise.  
 
Lipid Extractions 
Cultures of E. faecalis were grown in BHI broth until a mid-log phase 
OD600 nm value (approximately 0.4).  Cells were pelleted through centrifugation 
(10 minutes at 3500 rpm) and washed carefully with 1X phosphate-buffered 
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saline (PBS).  Pellets were resuspended in 1mL of 1X PBS with 10mg/mL of 
lysozyme and placed at 37°C for 20 minutes.  Cells were subjected to bead 
beating for two 1-minute intervals in the cold.  Lipids were isolated using a 
modified chloroform: methanol extraction as previously described [155].  The 
lysed mixture was added to 4mL of 2:1 chloroform: methanol and centrifuged for 
5 minutes at 3500 rpm.  Liquid fractions were mixed with 1mL of 0.9% saline and 
centrifuged for 5 minutes at 3500 rpm.  Organic phase and lipid interface were 
dried under N2 gas at 37°C.  Dried lipids were reconstituted in 2:1 chloroform: 
methanol.  
 
Thin Layer Chromatography 
Lipid standards (Avanti® Polar Lipids, Inc.) were mixed in equal volumes 
to constitute the ladder.  Aluminum backed silica plates were baked at 99°C 
before and after each pre-run washing step.  Plates were washed with 25mM 
EDTA and 1:1 chloroform: methanol mixture prior to loading samples.  Solvent 
(35mL triethylamine: 30mL chloroform: 35mL ethanol: 7mL water) was added to 
a glass chamber 30-45 minutes prior to the addition of plate.  5µL of each sample 
and standard was loaded onto plates before being placed in glass chamber with 
solvent.  Phospholipids were visualized under UV light after dipping plate in 1:5 
primulin: acetone solution. 
 
 
 
 77 
Gas Chromatograph-Fatty Acid Methyl Ester (GC-FAME) Analysis  
Cells were grown to log phase with the exogenous fatty acid supplement 
as indicated in text.  Cells were pelleted, washed carefully with 1X PBS, and 
stored at -80°C prior to shipment to Microbial ID, Inc (Newark, DE).  Prior to GC-
FAME analysis, cells were subjected to saponification with a sodium hydroxide-
methanol mixture, a methylation step, and a hexane extraction [129].   
 
Electron Microscopy Sample Preparation 
Initial sample preparation and fixations for both scanning and transmission 
electron microscopy were previously described [2] with the indicated 
modifications.  Following osmium tetroxide fixation, SEM samples were added to 
5x5mm silicon chips (Ted Pella, Inc.).  Silicon chips were passed through a 
graded ethanol series (25, 50, 70, 95, 100%) for 15-minutes at each interval; 
then, placed in a LADD Critical Point Dryer for three 10-minute cycles.  Silicon 
chips were coated with gold for 10-seconds prior to visualization.  Samples were 
viewed using a Zeiss Auriga 40 at the Center for Advanced Microscopy and 
Imaging at the University of Tennessee. 
After osmium tetroxide fixation, TEM samples were subjected to a similar 
graded ethanol series before a 15-minute acetone dehydration period.  Cells 
were then mixed into a 2:1 acetone: resin (EMbed or Spurr) for at least one hour.  
Cells were centrifuged (two minutes at 10,000 rpm) and resuspended in 1:2 
acetone: resin overnight at room temperature.  Cells were pelleted and 
transferred to 100% resin for a four-hour incubation at room temperature.  Then, 
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cells were mixed with fresh resin and transferred to Beem® capsules.  Capsules 
were pelleted and incubated at 68°C for 24 hours.  Embedded samples were 
sectioned using Leica EM UC7 microtome and placed onto a copper grid.  Grids 
were stained with 50% uranyl acetate and 50% methanol for at least 30-minutes 
then briefly dipped into water before staining with lead citrate for five minutes.  
Samples were examined using the Zeiss Libra 200MC at the Center for 
Advanced Microscopy and Imaging at the University of Tennessee. 
 
Results 
 
Growth Kinetics and Membrane Content of Cultures Supplied with Toxic 
Myristic (C14:0) or Palmitic Acid (C16:0) Supplements  
Our previous results showed that individual fatty acid supplements could 
protect against acute membrane stress [2].  In order to understand the 
mechanism of protection conferred by fatty acid supplements, it was necessary 
to re-examine the effects of individual fatty acid supplements.  Despite palmitic 
acid (C16:0) being a major component of the E. faecalis membrane, our previous 
analysis showed it could greatly impair the growth rate.  Therefore, we examined 
effects of another saturated fatty acid, myristic acid (C14:0), which comprises a 
small percentage of the total membrane content (approximately 5%).  The 
shorter chain fatty acid, myristic acid (C14:0), produced a similar pattern of growth 
as palmitic acid (C16:0).   
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Cultures supplemented with 5µg/mL of myristic acid (C14:0) reached an 
optical density around 0.1 then entered a period of growth stasis for nearly 20 
hours, before entering exponential phase growth and reaching stationary phase 
(Fig. 3.1, panels A and C, Table 3.1).  When cultures were supplemented with 
5µg/mL of myristic acid (C14:0), the total membrane content comprised 71% of 
this fatty acid, while all other fatty acids were decreased in content compared to 
growth in plain BHI broth (Table 3.2).  The total percentage of membrane 
saturated fatty acids reached 92% of the membrane content, raising the 
saturated: unsaturated ratio to 11.6.  Palmitic acid (C16:0) comprised 17.9% of the 
membrane content, but it is not known if any supplied myristic acid was 
elongated to this or longer chained fatty acids.  Stearic acid (C18:0) only 
comprised 2% of the total membrane content, and arachidic acid (C20:0) was not 
detected in the membrane of myristic acid supplemented cells.  Comparing the 
myristic acid supplemented cultures to growth in plain BHI, the dominant 
unsaturated fatty acids, cis-vaccenic acid (C18:1 cis 11) and palmitoleic acid (C16:1 cis 
9), were reduced from 40.5% to 4.4% and 8.1% to 2.3% of the membrane 
content, respectively.  
Palmitic acid (C16:0) is the dominant saturated membrane fatty acid when 
cultures are grown in plain BHI media and typically comprises around 36% of the 
membrane content during log-phase growth [2].  Like myristic acid, 
supplementation with palmitic acid was quite detrimental to growth.  Again, the 
culture initially reached an O.D. 600 nm of about 0.1 when growth ceased for about 
16 hours (Fig. 3.1, panels B and C).  After this extended time, these cultures did 
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reach a similar stationary phase optical density as cultures in plain media.  The 
doubling times were variable over time due to the initial growth and subsequent 
static period; therefore, reliable calculations could not be made.  We previously 
noted that palmitic acid comprises 69% of the total membrane content when 
supplemented at a concentration of 5µg/mL [2].  The amount of stearic acid 
(C18:0) remained close to 4%, but the amount of cis-vaccenic acid (C18:1 cis 11) was 
reduced from 40.6% to 17.3% (Table 2.2) [2]. 
 
Overnight Recovery is Not Due to Degradation of Toxic Fatty Acid 
Supplements 
To determine if cells recovered from myristic (C14:0) or palmitic acid (C16:0) 
induced toxicity due to degradation of the supplement over time or by a another 
mechanism, media was pre-incubated at 37°C for 12-24 hours with either 
palmitic or myristic acid prior to the dilution of E. faecalis.  Growth kinetics of 
cultures in pre-incubated media followed a comparable pattern to cultures 
supplemented immediately prior to inoculation, as shown in Fig. 3.2 (compare to 
Fig. 3.1, panels A and B).  The only difference was noted in the control culture in 
which cells inoculated into pre-warmed plain BHI with or without the solvent 
control did appear to have a reduced lag phase, likely as they did not have to 
adjust to a temperature change.  Regardless, these results suggested that 
degradation of the fatty acid supplements is not why the cells overcame myristic 
or palmitic acid induced toxicity.  Performing GC-FAME analysis of media could 
 81 
also confirm that the fatty acid supplements do not degrade during over night 
incubation. 
 
Recovery after Growth with Toxic Saturated Fatty Acids is Due to Genetic 
Mutation  
We speculated that cultures supplemented with myristic (C14:0) or palmitic 
acid (C16:0) could recover after such a long period of stasis despite the presence 
of many non-viable cells due to the rise of a genetic mutation in the cell 
population. 
Cultures were supplemented with toxic fatty acids or ethanol (solvent 
control) until saturation (day 1) (typically an O.D. 600 nm value >1.0 after overnight 
growth).  These cells were then diluted into fresh media without supplements and 
incubated overnight (20-24 hours) (day 2).  On day 3, cells were re-inoculated 
into broth containing the original supplement (Fig. 3.3). 
On day 3, cultures of myristic and palmitic acid entered exponential 
phase growth and did not experience any additional lag phases before entering 
stationary phase.  The generation times for cultures supplemented with myristic 
acid or palmitic acid were approximately 50 minutes and 49 minutes, 
respectively.  These results indicated that the cells are no longer sensitive and 
that this is likely due to the rise of genetic mutations within the cultures. 
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Growth Kinetics of Fatty Acids Supplements Added Growing Cultures 
Since palmitic (C16:0) and myristic acid (C14:0) had such acute effects, we 
wanted to determine if supplements could inhibit actively growing cultures.  
Results show that adding palmitic acid to a final concentration of 5µg/mL to 
actively growing cultures did impede growth and resulted in stasis compared to 
cultures given an equivalent amount of ethanol (Fig. 3.4).  Control cultures 
reached stasis at a higher optical density than cultures given palmitic acid upon 
inoculation (O.D. 600 nm 0.3 vs. 0.1 respectively). These observations suggest that 
a larger pool of de novo synthesized fatty acids might exist at this point during 
growth and can accommodate growth for a longer period of time before entering 
growth stasis. 
 
Cultures Supplemented with Saturated Fatty Acids Have Altered 
Morphology 
 Given the severe effects fatty acids can have on growth, we wanted to 
examine whether there were morphological changes associated with this.  
Enterococci typically appeared as lancet-shaped diplococci and occasionally 
form chains; however, we previously noted that growth in bile seemed to 
increase the chain formation [2].  Scanning electron microscopy (SEM) images of 
cells grown in BHI showed cells that were uniformly diplococci (Fig. 3.5, panel A 
on right).  Transmission electron microscopy (TEM) highlighted the cell division 
process with septum formation at the mid-cell line (Fig. 3.5, panel A left).  The 
addition of ethanol (solvent control) did not appear to have a noticeable impact 
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on cell morphology or division.  Moreover, both SEM and TEM images appeared 
to show evenly sized diplococci that are dividing symmetrically (Fig. 3.5, panel 
B). 
In contrast to growth in plain BHI, growth in exogenous saturated fatty 
acids led to drastic morphological changes.  SEM analysis revealed that cells 
grown with palmitic acid (C16:0) or stearic acid (C18:0) were enlarged with multiple 
septa and remained connected to each other (Fig. 3.5).  Furthermore, some cells 
appeared to be dividing asymmetrically, which resulted in abnormally large or 
small cells (underscored by white arrows).  The cells in the BHI and ethanol 
control samples appeared to be consistently lancet-shaped diplococci; in 
contrast, the cells present in the palmitic or stearic supplemented cultures have 
cells which are ‘hyper-lancets’ (shown by yellow arrows) or conversely appear as 
‘dull-lancets’ (highlighted by blue arrows). 
The TEM also showed the appearance of multiple septa in these enlarged 
cells, which failed to separate.  “Ghost” cells, with no cellular contents, were also 
rather prevalent (clarified by red arrows) (Fig. 3.5).  Together, this implies that 
supplementation with saturated fatty acids negatively impacts cell division and 
septum placement (see discussion). 
 
Growth Kinetics and Membrane Content of Less Toxic Saturated Fatty 
Acids 
Lauric acid (C12:0) is a minor component of the membrane when grown in 
plain media and makes up less than 1% of the membrane; the only exception is 
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that lauric acid makes up about 2% of the membrane when cultures are 
supplemented with linoleic acid [2].  Given the above results of toxicity with other 
saturated fatty acids, we speculated whether or not such effects were due to any 
saturated fatty acid, or something specific about myristic (C14:0) or palmitic acid 
(C16:0). 
Results show that lauric acid (C12:0) minimally impacted growth compared 
to cultures of plain BHI media.  At concentrations of 5 or 10µg/mL, the growth 
pattern closely followed the BHI only cultures and generation times were similar 
to cultures containing plain media (Fig. 3.1, panel D).  At the highest 
concentration tested (20µg/mL), the generation time was reduced to 55 minutes 
from 36 minutes in plain BHI media. However, lauric acid does not have the 
same toxicity to E. faecalis as myristic (C14:0) or palmitic acid (C16:0), which may 
be due to lower levels of incorporation (or de novo fatty acid biosynthesis 
continues and lauric acid is elongated before incorporation).  
Membrane analysis of cultures supplemented with 10µg/mL of lauric acid 
shows that this fatty acid does not dominate membrane content and only reaches 
18% of the total membrane content (Table 3.2).  The amount of palmitic (C16:0) 
and stearic acid (C18:0) remain close to levels seen in cultures of BHI.  The 
amount of cis-vaccenic acid (C18:1 cis 11) decreases from 40% to 25% in cultures 
supplemented with lauric acid. 
As lauric acid (C12:0) is shorter than myristic (C14:0) and palmitic acid 
(C16:0), we wanted to examine whether longer-chained saturated fatty acids were 
needed for toxicity.  Stearic acid, like palmitic, is found in the membrane 
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naturally, but at a reduced level.  When cultures were given a low concentration 
of stearic acid (C18:0) at 5µg/mL, the generation time and growth rate were longer 
than those cultures grown in plain BHI, and supplementing with a higher 
concentration of stearic acid at 10 or 20µg/mL extended generation times and 
growth rates even more  (Fig. 3.1, panel E, Table 3.1).  Also, in cultures given 
20µg/mL of stearic acid, there appears to be more variation as these cultures 
transition from lag to exponential phase growth than the cultures supplemented 
with 5 or 10µg/mL of stearic acid.  Our previous study demonstrated that when 
supplemented with 10µg/ml of stearic acid, the membrane composition 
comprised 65% of this one fatty acid, and there was a reduction in all others 
within the membrane [2].  We suspected the decreased toxicity of stearic acid 
could be related to its increased fatty acid chain length. 
Given that the length of the saturated chain seemed to play a critical role 
in terms of toxicity, we tested the effects of arachidic acid (C20:0) (Fig. 3.1, panel 
F).  This fatty acid makes up less than 0.5% when cultures are supplemented 
with 0.2% bile and increases to 5% in cultures supplemented with 20µg/mL of 
oleic acid (C18:1 cis 9); however, arachidic acid is not detected in the membrane of 
exponential phase cells grown in plain BHI or supplemented with 15% serum, or 
other fatty acid supplements [2].  Arachidic acid has the longest chain length of 
the saturated supplements tested and did not noticeably impact on growth, with 
the generation time close to cultures grown in plain BHI media.  
Previously, our results have consistently shown that the membrane 
content of a culture given a single fatty acid supplement overwhelmingly contains 
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that fatty acid [2].  Therefore, it was interesting to observe that arachidic acid 
(C20:0) was an exception.  When cultures were supplemented with 10µg/mL of 
arachidic acid, the total membrane content only reached 10.8% (Table 3.2).  
Palmitic acid (C16:0) remained the dominant saturated fatty acid comprising 
37.5% of the total membrane content.  The percentage of myristic (C14:0) and 
stearic acid (C18:0) also remained similar to values seen in plain media. The 
amount of the dominant unsaturated fatty acid, cis-vaccenic acid (C18:1 cis 11), 
decreased from 40.5% to 30%; the 10.5% drop in cis-vaccenic acid is 
comparable to the 10.8% increase of arachidic acid found in the membrane.  The 
saturated: unsaturated ratio concomitantly shifted from 0.9 to 1.6 when cultures 
were given exogenous arachidic acid.  
Arachidic acid (C20:0) may not dominate the membrane as it may be a poor 
substrate for interaction with FakB/FakA, which activate exogenous fatty acids for 
incorporation, or for the attachment to polar head groups by acyl-transferase 
enzymes (see discussion).  It is noteworthy that arachidic acid is less soluble 
than other fatty acids and when supplemented at higher concentrations, we 
noted that addition of an equal volume of solvent control impacted growth.  
Therefore, higher concentrations were not tested. 
 
Growth Kinetics and Membrane Content of Cultures Supplemented with 
Native Unsaturated Fatty Acids 
Our previous studies demonstrated that like saturated fatty acids, 
individual unsaturated fatty acids supplied exogenously, could dominate the 
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membrane content of E. faecalis.  Furthermore, cultures supplemented with cis-
vaccenic (C18:1 cis 11), oleic (C18:1 cis 9), or linoleic acid (C18:2 cis 9, 12) were able to 
protect the bacterium from membrane damaging agents.  The membrane of E. 
faecalis normally consists of two unsaturated fatty acids, palmitoleic (C16:1 cis 9) 
and cis-vaccenic acid (C18:1 cis 11); therefore, we choose to examine those more 
in-depth.  Additionally, oleic, linoleic, and eicosenoic acid (C20:1 cis 11) are found in 
bile and serum, and we observed previously that the bacterium will incorporate 
these readily into its membrane (See Table 2.2).  Consequently, we choose to 
compare the effects of these eukaryotically-derived unsaturated fatty acids to 
native unsaturated fatty acids.   
Palmitoleic acid (C16:1 cis 9) is the second most common native unsaturated 
fatty acid comprising only 10% of the membrane content during mid-log phase 
growth when cells are grown in plain BHI media, and is the pre-cursor to the 
most dominant fatty acid, cis-vaccenic acid (C18:1 cis 11) [2].  Unexpectedly, we 
observed that exogenous palmitoleic acid was not well-tolerated at 
concentrations higher than 5µg/mL (Table 3.1).  At this concentration, cell growth 
was not altered from unsupplemented cultures (Fig. 3.6, panel A).  However 
cultures supplemented with 10µg/mL grew very slowly and doubling times were 
approximately 81 minutes (Fig. 3.6, panels A and B).  Re-diluting cells upon 
reaching stationary phase into fresh media with 10µg/ml palmitoleic acid did not 
alter the growth kinetics, suggesting that outgrowth is not due to enrichment of 
genetic mutants.  Using overnight cultures of cells previously grown with 
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10µg/mL of palmitoleic acid to inoculate fresh media supplemented with the 
same concentration did not produce different growth kinetics (Fig. 3.4). 
Not surprisingly, supplementation with Palmitoleic acid (C16:1 cis 9) 
produced a membrane dominated with this single fatty acid (68%) (Table 3.2).  
We did note some variation in the amounts in the membrane from biological 
replicates: this may be attributed to the fact that E. faecalis does synthesize the 
fatty acid natively.  The method used here would not distinguish between de 
novo and exogenous.  All other fatty acids were reduced in percentage content, 
palmitic acid (C16:0) and cis-vaccenic acid (C18:1 cis 11) were 12.4% and 10.5% of 
the total membrane content respectively.  Interestingly, palmitoleic acid is the 
pre-cursor to cis-vaccenic acid, but the amount of cis-vaccenic acid is decreased.  
As expected given the high amount of palmitoleic acid in the membrane the 
cultures had a reduced saturated: unsaturated ratio of 0.2 (Table 3.2).   
The most dominant unsaturated fatty acid produced by by E. faecalis is 
cis-vaccenic acid (C18:1 cis 11), which comprises 40.5% of the membrane during 
exponential phase growth.  When added as an exogenous supplement, cis-
vaccenic acid (C18:1 cis 11) fatty acid was well tolerated (Fig. 3.6, panel C).  Note, 
higher concentrations of cis-vaccenic were not tested due to the insolubility of the 
fatty acid.  Additionally, if given as an exogenous supply, this individual fatty acid 
can comprise 91% of the membrane content (Table 2.2).  The membrane 
contained 2% palmitic acid (C16:0) and 1.1% of cyclopropane (C19 cyclo); only trace 
amounts (<1%) of other fatty acids were detected [2]. 
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Growth Kinetics and Membrane Content of Cultures Supplemented with 
Non-Native Unsaturated Fatty Acids 
E. faecalis has access to eukaryotic fatty acids that it cannot synthesize 
de novo in host bile or serum.  We previously reported that unsaturated fatty 
acids of eukaryotic origin were found in the membrane when supplemented with 
0.2% bile or 15% serum and were also found to provide protection from acute 
membrane stress [2].  Therefore, we were interested in examining the affects of 
native and eukaryotic unsaturated fatty acids on growth and physiology.    
Oleic acid (C18:1 cis 9) and linoleic acid (C18:2 cis 9, 12) are fatty acids of 
eukaryotic origin and only appear in the membrane when exogenous sources, 
such as bile or serum supplements, are provided to E. faecalis.  For example 
oleic acid comprises 19.3% of the membrane in cultures supplemented with 0.2% 
bile and when supplemented with 15% pooled human serum, the membrane of 
E. faecalis contains 12% linoleic acid [2].   
Oleic acid (C18:1 cis 9), comparable to cis-vaccenic acid (C18:1 cis 11), was also 
well tolerated even at high concentrations (Fig. 3.6, panels C and D).  
Additionally, adding oleic acid to cultures in exponential phase growth did not 
significantly alter growth patterns compared to controls (Fig. 3.4).  Previously, we 
noted that the membrane contained 71% oleic acid when it was supplemented at 
a concentration of 20µg/mL [2].  Palmitic acid (C16:0) made around 10% of the 
membrane and cis-vaccenic acid (C18:1 cis 11) was reduced to 4% of the total 
membrane content [2]. 
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Linoleic acid (C18:2 cis 9, 12) is a eukaryotic fatty acid commonly found in 
human serum, similar to oleic acid (C18:1 cis 9).  However, linoleic acid impeded 
growth and the generation times increased as the linoleic acid concentration 
increased (Fig. 3.1, panel E, Table 3.1), but cultures reach a similar stationary 
phase density seen in cultures grown in plain media.  Linoleic acid (C18:2 cis 9, 12) is 
readily incorporated into the membrane and more than half of the membrane was 
comprised of this supplement (67.1%).  The membrane content of palmitic (C16:0) 
and cis-vaccenic acid (C18:1 cis 11) were reduced to 10.0% and 5.3% respectively 
(Table 2.2) [2]. 
Pre-incubating flasks with linoleic acid did not show improved growth 
suggesting that the eventual outgrowth is not due to instability of linoleic acid in 
solution (Fig. 3.2).  An extended growth curve of cultures supplemented with 
10µg/mL of linoleic acid showed that cultures grow slowly, but do not enter stasis 
(Fig. 3.6, panel B).  Inoculating cultures from cells previously exposed to linoleic 
acid did not alter growth kinetics, showing that outgrowth from 10µg/mL of linoleic 
acid is not due to a genetic mutation.   
To further complement our studies, we examined the effects of eicosenoic 
acid (C20:1 cis 11).  While not normally found in Enterococci membranes, this fatty 
acid can be formed by the elongation of oleic acid and we noted trace amounts in 
the membrane when cells were specifically supplemented with oleic acid (C18:1 cis 
9) (Table 2.2).  Supplementing with 5, 10, or 20µg/mL did not seem to impact 
growth (Fig. 3.6, panel E).  The generation time (33.8 ± 2.3) of the highest 
concentration tested (20µg/mL) was comparable to the values of cells grown in 
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plain BHI (36 ± 1.2).  It was also noted that this lipid was readily soluble in 
ethanol; unlike it saturated counter part, arachidic acid (C20:0).   
Membrane analysis of cultures supplemented with 10µg/mL of eicosenoic 
acid (C20:1 cis 11) shows that this fatty acid can dominate the membrane content.  
Cultures reached an average membrane composition that was 85% eicosenoic 
acid.  The other common unsaturated fatty acids, palmitoleic (C16:1 cis 9) and cis-
vaccenic acid (C18:1 cis 11), each comprised less than 2% of the membrane 
content.  The dominant saturated fatty acid, palmitic acid (C16:0), had a 
membrane content close to 5%.  Unlike arachidic acid (C20:0), eicosenoic acid 
was incorporated at high levels despite having the same length (see discussion). 
 
Cultures Supplemented with Unsaturated Fatty Acids Do Not Have Altered 
Morphology 
Given the variable effects on growth of unsaturated fatty acids on E. f 
aecalis OG1RF, these could also impact cellular morphology, as was noted with 
some saturated fatty acids supplements.  However, for all of the unsaturated fatty 
acids tested, cis-vaccenic (C18:1 cis 11), oleic (C18:1 cis 9), palmitoleic (C16:1 cis 9), or 
linoleic acid (C18:2 cis 9,12), the cells appeared as symmetrical diplococci similar to 
cells grown in BHI alone or with an ethanol solvent control (compare Fig. 3.7 and 
Fig. 3.5, panels A and B).  The only exception noted is that the cells 
supplemented with palmitoleic acid appear to be more dome- than lancet-shaped 
(Fig. 3.7, panel A) compared to cells grown in plain BHI, an ethanol solvent 
control, or another unsaturated fatty acid (Fig. 3.5, panels A and B, Fig. 3.7, 
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panels B, C, and D).  The TEM images (of the samples shown) did not reveal any 
atypical septum placement or suggest any problems with cell division caused by 
the supplementation of unsaturated fatty acids.  Note, TEM of palmitoleic acid 
supplemented cells is pending. 
 
Only Unsaturated Fatty Acids Allow E. faecalis to Overcome Cerulenin  
Inhibition of fatty acid biosynthesis is an attractive drug target against 
bacteria as there are clear distinctions in fab between prokaryotes and 
eukaryotes.  However, given that E. faecalis readily incorporates exogenous fatty 
acids, it may not be an optimal target.  To test this, we tested if exogenous fatty 
acids could rescue cells inhibited by cerulenin.  Cerulenin targets the fatty acid 
synthase enzymes (FabF and FabO, Introduction Fig. 1.2).  There are of 
examples of Gram-positive bacteria overcoming inhibition of de novo fatty acid 
biosynthesis due to cerulenin by utilizing exogenous fatty acids [115].  
 Although palmitic acid (C16:0) can be toxic to growth, given that it is 
synthesized by the organism and comprises a large portion of the membrane, we 
wanted to determine if it could overcome inhibition by cerulenin.  When cultures 
were given 5µg/mL of palmitic acid (C16:0) as well as cerulenin (2.5, 5, 7.5, or 
10µg/mL), these cultures responded similarly as cells without fatty acid 
supplementation (Fig. 3.8).  In cultures containing only plain media, growth was 
hindered and they did not overcome cerulenin inhibition after 24 hours of 
incubation (Fig. 3.8). 
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We observed that arachidic acid (C20:0) is not incorporated at high levels 
into the membrane (Table 3.2) and had minimal effects of growth.  However, our 
above analysis did not reveal the mechanism that prevented high levels of 
incorporation.  However, the addition of arachidic acid did not allow for 
Enterococcal growth in the presence of cerulenin (Fig. 3.8 panel C).  Taken 
together with the palmitic acid data, this implies that E. faecalis cannot 
circumvent fatty acid inhibitors with saturated fatty acids. 
Unlike saturated fatty acids, supplementation with oleic (C18:1 cis 9) and cis-
vaccenic acid (C18:1 cis 11) have minimal impact on growth, morphology, and are 
readily incorporated (Fig. 3.6, Fig. 3.7).  Consequently, we predicted that these 
would support growth in the presence of cerulenin.  Either supplement could 
rescue cells from cerulenin-inhibition (Fig. 3.8).  Cultures given these fatty acids 
and cerulenin have a final culture density similar to cultures without cerulenin 
(Fig. 3.6).   
However, the unsaturated fatty acids linoleic (C18:2 cis 9, 12) and palmitoleic 
acid (C16:1 cis 9) that were not as well tolerated at high concentrations (Table 3.1) 
could also support growth in the absence of de novo fatty acid synthesis (Fig. 
3.8).  Exogenous concentration of linoleic acid from 5 to 10µg/mL supported 
growth and both cultures reached a final optical density typical of E. faecalis 
cultures in stationary phase (above 1.0).  The concentration of palmitoleic acid 
did impact initial growth in the presence of cerulenin, with a higher concentration 
of 10µg/ml causing an extended lag; however, this culture reached saturation 
after overnight incubation.  This suggests that palmitoleic acid can support 
 94 
growth as an exogenous fatty acid, but growth is inhibited at higher 
concentrations in a manner that is independent of fatty acid biosynthesis.  
Furthermore, overnight recovery is likely observed because fatty acid induced 
growth inhibition is relieved.  Similar to linoleic acid, re-inoculation experiments 
did not change growth kinetics suggesting that outgrowth in cultures 
supplemented with 10µg/mL of palmitoleic acid was not due to a genetic mutation 
(Fig. 3.3). 
 
Phospholipid Content Changes When Cultures Receive Exogenous Fatty 
Acid Supplements (Fig. 3.9) 
In addition to altering fatty acid tails, bacteria also change to the content of 
polar head groups in response to environmental conditions and certain 
phospholipids are associated with specific cell functions.  Comparisons between 
wild-type and isogenic strains lacking cardiolipin synthase, show that wild-type 
strains are better able to survive acid stress [35, 36].  Cardiolipin (CL) can affect 
cell division in Escherichia coli [156] and Bacillus subtilus [157], and a similar 
mechanism has been observed in E. faecalis [40].  Therefore, we wanted to 
investigate if exogenous fatty acid supplements could alter membrane 
phospholipid composition and if this could explain some of the altered growth and 
morphology observed.  To examine phospholipid content, lipid extracts were 
prepared from cultures supplemented with fatty acids and were used for TLC 
analysis.   
 95 
Studies have also shown that CL and PG are the dominant phospholipids 
of E. faecalis and lyso-phosphatidylglycerol (LPG) is seen in smaller amounts 
[64].  Note, E. faecalis is capable of adding lysyl groups to PG forming lysyl-
phoshpatidylgycerol (LPG).  We detected four major lipids when cells were grown 
to mid-exponential phase in BHI (Fig. 3.9).  Two spots did not match the 
standards shown (shown by yellow and red arrows and referenced as Unknown 
1 and Unknown 2 respectively).  The two additional lipids correspond with 
phosphatidylglycerol (PG) and cardiolipin (CL), which are two of the main 
phospholipids present in Enterococci [42, 48].  Although this analysis is not 
quantitative, PG spot appeared to be more prominent than the CL.  While 
previous studies have shown (LPG) to be detected at low levels (approximately 
5% of total phospholipid content) in Enterococci [42, 48], cells for these analyses 
were harvested in stationary phase.  Our cells were collected in exponential 
phase growth and we were unable to detect LPG under this condition. 
 
Phospholipid Profiles with Saturated Fatty Acid Supplements (Fig. 3.9 
cont.) 
When grown in the presence of lauric (C12:0), myristic (C14:0) or palmitic 
acid (C16:0), from the time of inoculation, the lipid contents were similar to cells 
grown in plain BHI (Fig. 3.9).  There was one exception in cells supplemented 
with lauric acid; these extracts have two spots that correspond to unknown 1.  It 
is unclear if this is degradation of unknown 1 or a distinct phospholipid.  
Additionally, unknown 2 for palmitic acid supplemented samples seemed to have 
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traveled a bit farther than the other extracts.  It is important to note that cultures 
supplemented with myristic and palmitic acid have fewer cells and less-yield in 
phospholipid extracts.   
Lipids from the cells supplemented with stearic acid (C18:0) and arachidic 
acid (C20:0) appear similar to each other in that both have extremely bright spots 
for PG and CL (Fig. 3.9).  Since unknowns 1 and 2 also appear more bright 
compared to the cells grown in plain BHI, it is suspected that these samples 
contain more lipids overall.  Stearic acid supplemented cultures have a faint spot 
labeled U3; this spot corresponds with the LPG standard, but could be an artifact 
of the sample smearing as the lipids traveled with the solvent. 
 
Phospholipid Profiles from Cultures Supplemented with Unsaturated Fatty 
Acids (Fig. 3.9 cont.) 
The lipids from cells supplemented with unsaturated fatty acids were 
similar to those supplemented with saturated fatty acids, but they contained 
additional unknown lipids.  Extracts from cultures supplemented with palmitoleic 
(C16:1 cis 9), oleic (C18:1 cis 9), and linoleic acid (C18:2 cis 9, 12) had an additional 
unknown lipid labeled as U4 immediately above unknown 2.  All samples with 
unsaturated fatty acids supplements, except eicosenoic acid (C20:1 cis 11), have an 
additional spot above unknown 1, which is labeled unknown 5.  However, 
unknown 5 seems to travel farther in some samples. 
Although not quantitative, in comparison to cells grown in BHI or ethanol, 
eicosenoic (C20:1 cis 11) grown cells appeared to have more CL versus PG.  These 
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unsaturated supplements did not hinder growth or greatly reduce the amount of 
cells harvested for phospholipid extraction.  Therefore, it would be expected that 
roughly the same amount of cells were used for lipid extraction and a similar 
concentration of phospholipids could be loaded onto the TLC plate.  
 
Phospholipids Changes are Evident After Short Exposure (Fig. 3.10) 
As shown in Figure 3.4, short exposures of fatty acids to exponentially 
grown cells can impact growth.  Additionally (further analysis pending), 
preliminary results shows that cells can incorporate oleic acid (C18:1 cis 9) within 
15-minutes of exposure.  Given that cells can rapidly incorporate exogenous fatty 
acids and that they can alter physiology quickly, we wanted to know if changes to 
phospholipids happened quickly.   Therefore, phospholipid extractions were 
initiated 15-minutes after exogenous fatty acids were supplemented to 
exponentially growing cultures (Fig. 3.10).  Additionally, cultures in mid-log phase 
growth would have a similar number of cells harvested for phospholipid 
extraction, allowing for a more quantitative analysis than extracting phospholipids 
from cultures with varying growth due to the toxic nature of certain supplements. 
 
Phospholipid Profiles After Short Exposure to Saturated Fatty Acids (Fig. 
3.10 cont.) 
The indicated fatty acids were added once cultures reached mid-log phase 
(O.D. 600 nm ≈ 0.4) for 15 minutes prior to lipid extraction (Fig. 3.10).  As seen 
previously, the lipid profiles of cells treated with or without the solvent control 
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contained the same unknowns (U1, U2) as described above (Fig. 3.9).  Again, 
PG and CL were the most dominant phospholipids under these conditions.  Cells 
incubated with lauric acid (C12:0) resembled the BHI grown cells.  In comparison 
to the BHI grown cells, the addition of myristic (C14:0) or palmitic acid (C16:0) 
appeared to have more CL than PG.  However, the longer chain fatty acids, (C18:0 
and C20:0) had a reverse pattern in that they appeared to have far more PG than 
CL.  
 
Phospholipid Exposure Following A Short Exposure to Unsaturated Fatty 
Acid Supplements (Fig. 3.10 cont.) 
Growth in unsaturated fatty acids, regardless of length, had similar lipid 
profiles to each other (Fig. 3.10).  These all contained unknown lipids 1 and 2, 
similar to cells in plain BHI.  When compared to the controls, the unsaturated 
fatty acid supplemented cells appeared to have more CL and less PG.  Again, 
the samples supplemented with palmitoleic (C16:1 cis 9), cis-vaccenic (C18:1 cis 11), 
oleic acid (C18:1 cis 9), and linoleic acid (C18:2 cis 9, 12) have unknowns 4 and 5 
present.   
Additionally, there are two additional unknown species labeled U6 and U7.  
Unknown 6 (next to white arrow) is faint and appears over the CL spot in most of 
the samples supplemented with unsaturated fatty acids; however, some of the 
saturated cultures have very faint bands above CL as well.  Unknown 7 (next to 
green arrow) appeared between PG and CL of the oleic acid supplemented 
cultures and may be unique to cultures containing this fatty acid supplement. 
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Unlike the other unsaturated fatty acids, eicosenoic acid (C20:1 cis 11) 
supplemented cells do not contain U4 or U5.  Similar to the other unsaturated 
fatty acids, the amount of CL appears to be increased and the PG is decreased 
compared to BHI or ethanol controls. 
 
Phospholipid Changes are Concentration Dependent (Fig. 3.11 and Fig. 
3.12) 
As the addition of fatty acids can clearly impact lipid composition, we 
wanted to know if this is a concentration-dependent effect.  As oleic acid (C18:1 cis 
9) is non-toxic, and supplementation alters the lipid content noticeably, we 
supplemented cultures with the fatty acid at concentrations ranging from 5µg/mL 
to 100µg/mL at either the time of inoculation (Fig. 3.11) or at mid-log phase (Fig. 
3.12).  The lipid profile was similar to what was noted in (Fig. 3.9 and Fig. 3.10).  
However, with increasing concentrations of oleic acid, there appeared to be 
increased levels of CL in the membrane.  As expected, there was a decrease in 
PG in these cultures, especially when compared to controls.  However, the 
samples with the highest concentrations have two lipids above PG.  It is not clear 
which lipid is CL and if either of the other lipids corresponds to U7 (labeled with 
U7?). 
The samples that were spiked with different concentrations of oleic acid 
(C18:1 cis 9) in mid-log phase, 15-minutes before lipid extraction (Fig. 3.12), appear 
more similar to each other than samples that were supplemented with oleic acid 
over several hours prior to lipid extraction (Fig. 3.11).  While not quantitative, 
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control cultures may have higher amounts of PG versus the oleic samples, with 
the exception of samples supplemented with 20 µg/ml.  These cultures have 
unknown lipids 1, 2, and 4 which were seen in the Fig. 3.9 and Fig. 3.10.  Again, 
there is a bright spot above PG, which is presumed to be CL, but unknown 7 may 
faintly appear below CL (labeled U7?).   
 
Discussion 
We previously observed the presence of exogenous unsaturated fatty 
acids could increase survival in the presence of membrane stressing agents [2].  
In order to explain this mechanism, we decided to examine the effects of 
exogenous fatty acids on E. faecalis.  Both saturated and unsaturated fatty acids 
could be incorporated in the membrane.  However, saturated fatty acids impeded 
growth and altered morphology.  In contrast, unsaturated fatty acids were non-
toxic and even supported growth in the presence of cerulenin.  Exogenous fatty 
acids greatly influence cell function and growth, and are an important 
consideration for developing effective drug targets against bacterial fatty acid 
biosynthesis. 
 
Saturated Fatty Acids Impede Growth and Are Toxic 
All saturated fatty acids that dominated membrane content impeded 
growth.  Myristic (C14:0) and palmitic acid (C16:0) caused the most severe effects.  
Cultures supplemented with these saturated fatty acids initially grow, but enter 
stasis after three hours of growth and remain there for 16-18 hours (Fig. 3.1).  
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Bacteria control membrane fluidity in response to changes in the environment 
[28, 31].  However, fatty acid biosynthesis is down-regulated in the presence of 
exogenous fatty acids [70, 86].  Therefore, the growth stasis may result from an 
inability to correct an overly saturated membrane in the absence of de novo fatty 
acid biosynthesis. 
Despite high levels of membrane incorporation, stearic acid (C18:0) was not 
as toxic as myristic or palmitic acid supplements (Fig. 3.1).  The cells exposed to 
stearic acid appeared to have a distorted morphology (Fig. 3.5), but cultures do 
not enter growth stasis.  It is not clear if these cultures grow because de novo 
fatty acid synthesis continues or the added length of stearic acid provides greater 
fluidity.  
We also noted that some saturated fatty acids had much less impact on 
growth (Fig. 3.1).  Arachidic acid was not toxic, but is also not found in the 
membrane at high levels (discussed below).  Similarly, lauric acid (C12:0) only 
affected growth at higher concentrations (20µg/mL); moreover, this fatty acid is 
only incorporated at levels of approximately 18% and it is not known if how this 
fatty acids affects de novo fatty acid synthesis.  Together these data imply that E. 
faecalis can only incorporate saturated fatty acids at high levels that are 14-18C 
in length (see below). 
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Exogenous Fatty Acid Chain Length and Saturation Influences 
Incorporation 
With the notable exceptions of arachidic (C20:0) and lauric acid (C12:0), all 
other individual fatty acid supplements tested thus far dominate membrane fatty 
acid content.  Eicosenoic acid (C20:1 cis 11) was incorporated at high levels, 
implying that length and saturation may influence incorporation into the 
membrane.  Arachidic and lauric acid could be poor substrates for enzymes 
needed to incorporate exogenous fatty acids (FakA/B) or acyl-transferases 
(PlsY/C/X).  Alternatively, arachidic acid could be a poor inhibitor of de novo fatty 
acid biosynthesis and lauric acid chains could be elongated prior to incorporation.  
In S. pneumoniae, which has a conserved fatty acid operon with Enterococci, it 
was shown that FabT has increased affinity for the fabK promoter in the 
presence of long chain fatty acids.  Interactions with the fabK promoter lead to 
decreased transcription of the fatty acid biosynthetic operon [158].  Previous 
studies in S. pneumoniae have shown that palmitic acid (C16:0-ACP) and cis-
vaccenic acid (C18:1 cis 11-ACP) are the most potent inhibitors of fatty acids 
biosynthesis via interaction with FabT [158] .  However, the insufficient 
incorporation of arachidic and lauric acid could explain why these fatty acids are 
not as toxic as palmitic (C16:0) and myristic acid (C14:0).  
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Morphology of Cells Supplemented with Toxic Saturated Fatty Acids 
Resemble Strains Lacking Cell Division Proteins 
The SEM and TEM images of cells grown with exogenous palmitic (C16:0) 
or stearic acid (C18:0) showed many cells that were not dividing properly and even 
ghost cells (Fig. 3.5, panels C and D).  These observations strongly suggest that 
these cultures contain cells that are no longer viable.  The abnormal morphology 
we have observed resembles cells that have a null mutation in proteins 
associated with cell division rather than cell wall synthesis [159, 160].  S. 
pneumoniae cells with null mutations in genes encoding cell division proteins 
MapZ or LocZ have abnormal septa placement and appear to divide 
asymmetrically [159, 161].  Additionally, disrupting normal levels of divIVA 
transcription in E. faecalis JH2-2 resulted in cells that formed clusters of enlarged 
cells rather than pairs, and it impaired septum formation [160].  The resemblance 
between these mutant strains and cells supplemented with saturated fatty acids 
strongly suggests that saturated fatty acids prevent cell division proteins from 
proper placement.  Lastly, morphology changes in small-colony variants of 
Staphylococcus aureus did not resemble our observations despite having genetic 
mutations related to membrane phospholipids [162]. 
Other abnormal morphologies have been observed in cells that have 
defects in cells wall synthesis, but these do not resemble the morphology we 
observed.  In ovacocci shaped cells, new cell wall synthesis occurs at the septum 
and on the septum periphery [163].  If only growth at the septum is inhibited, the 
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cells become more rod-shaped; conversely if only growth at the periphery is 
inhibited, ovacocci cells become more spherical [163, 164].  
 
Unsaturated Fatty Acids Are Non-Toxic  
We noted that the exogenous supplements that altered membrane content 
while having the least impact on growth were monounsaturated fatty acids, cis-
vaccenic (C18:1 cis 11), oleic (C18:1 cis 9), and eicosenoic acid (C20:1 cis 11).  Although 
increasing concentrations of linoleic (C18:2 cis 9, 12) or palmitoleic acid (C16:1 cis 9) 
greatly slowed generation time and growth rates, growth is not static and cultures 
do not enter a second lag phase.  SEM and TEM images of cultures 
supplemented with palmitoleic (C16:1 cis 9) and linoleic acid (C18:2 cis 9, 12) (Fig. 3.6 
and 3.7) suggest that these cell are dividing properly and viable.  Moreover, 
experiments with cerulenin (Fig. 3.8) also imply that palmitoleic and linoleic acid 
impede growth in a manner independent of de novo fatty acid synthesis. 
 
Only Unsaturated Fatty Acid Supplements Support Growth without De 
Novo Fatty Acid Synthesis 
We observed that all exogenous mono- and poly-unsaturated fatty acids 
were able to support growth in the absence of de novo fatty acid synthase and no 
saturated fatty acids could overcome the inhibition from cerulenin (Fig. 3.8).  
These observations taken together with the morphology observations strongly 
suggest that unsaturated fatty acids are necessary for growth and that 
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membrane proteins including those necessary for cell division may require a 
certain membrane fluidity or unsaturated fatty acid content.  
 
Exogenous Fatty Acid Supplements Alter Phospholipid Composition 
Certain phospholipids have been shown to be associated with specific cell 
processes, including cell division [165] and modifying phospholipids can change 
membrane charge as well [44].  Also, the fluidity of the membrane depends on 
the type of phospholipid head group as well as the fatty acid tail, because the 
size of the head group will influence membrane curvature [27, 166, 167].  
Exogenous fatty acids could alter the composition or the placement of certain 
phospholipids, through the substrate specificity of cardiolipin synthase, acyl-
transferase enzymes, or fatty acid kinase B interactions.  Altering phospholipid 
quantity or distribution could impact cell division, because specific phospholipids 
are known to interact with membrane protein related to cell division.  Cardiolipin 
has been shown to form domains at the cell poles and sepa [62, 157].  Both 
cardiolipin and phosphatidylglycerol have been shown to facilitate the release of 
DnaA, which facilitates chromosome replication [168, 169].  The cell division 
proteins, MinD and Div, have been shown to associate with phosphatidylglycerol 
in B. subtilis [170]. 
We also observed changes to the phospholipid profile in cultures 
supplemented with various exogenous fatty acids (Fig. 3.9 and Fig. 3.10).  Some 
of these variations were associated with unsaturated fatty acid supplements and 
some changes were unique to specific supplements such as oleic acid (C18:1 cis 9) 
 106 
(Fig. 3.9 - Fig. 3.12).  The TLC analysis showing phospholipids after a short 
exposure to exogenous fatty acids was more easily interpreted because more 
uniform quantities of lipids could be loaded onto the plate (Fig. 3.10).  Also, the 
changes in phospholipid composition in response to exogenous fatty acids may 
also be dependent on the quantity of supplement available (Fig. 3.11 and Fig. 
3.12).  Cultures given supplements at the time of inoculation may initially alter 
membrane phospholipids and these changes could be diluted out over time as 
the lipid supplement is depleted from the media (Fig. 3.10 and Fig. 3.12).  
 
Difficulties of Identifying Phospholipids Species 
Nevertheless, the TLC analysis was limited in determining the quantity of 
phospholipids, as comparing the brightness of spots between lanes was difficult. 
Furthermore, distinguishing phospholipids present in small quantities was 
challenging and many faint spots were noted.  The presence of lysyl-
phosphatidylglycerol (LPG) has been well documented in E. faecalis [48] as well 
as other Gram-positive organisms such as Staphylococcus aureus [44]; however, 
the available LPG standard did not correspond to any lipids detected.  In addition 
to lysine, E. faecalis and E. faecium can modify phosphatidylglycerol by the 
addition of alanine and occasionally arginine [48, 171].  Other studies have used 
advanced methods, such as 2D-TLC in combination with LC/ESI-MS/MS [42] or 
2D-TLC with ninhydrin to stain aminophospholipids [48], to investigate the 
phospholipids of E. faecalis.  Further analysis of our samples could reveal unique 
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phospholipids and those in smaller quantities present naturally and in response 
to exogenous fatty acids. 
Despite efforts using more sensitive analyses, studies have published the 
presence of unknown phospholipids as well as unknown phospholipids 
containing an amino acid-modification.  Modified cardiolipin species have been 
found in other Gram-positive species, such as Listeria monocytogenes [172] and 
Vagococcus fluvialis [173].  The unknown lipids detected by our analysis suggest 
the possibility of these modified phospholipids or other unique species.  Lastly, 
changes to phospholipids in response to exogenous fatty acids could contribute 
to the many ways in which exogenous fatty acids change the physiology and 
growth of Enterococcus faecalis. 
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Appendix. Chapter III Tables 
 
Table 3.1: Exponential phase generation times and growth rates with single fatty 
acid supplements. 
Medium Constituenta Concentration Generation Time  (minutes) 
Growth 
Rate  
(h-1) 
BHI NAb 36.0 ± 3.0 1.2 ± 0.1 
Ethanol Solvent 0.1% 38.1 ± 1.9 1.1 ± 0.1 
    
C12:0 (lauric acid) 5µg/mL 37.4 ± 2.9 1.1 ± 0.9 
C12:0 (lauric acid) 10µg/mL 37.4 ± 2.4 1.1 ± 0.7 
C12:0 (lauric acid) 20µg/mL 54.8 ± 5.3 0.83 ± 0.2 
Ethanol Solvent 0.4% 39.7 ± 0.8 1.2 ± 0.2 
    
C18:0 (stearic acid) 5µg/mL 44.1 ± 2.1 0.9 ± 0.0 
C18:0 (stearic acid) 10µg/mL 57.6 ± 2.6 0.7 ± 0.0 
C18:0 (stearic acid) 20µg/mL 62.0 ± 10.4 0.7 ± 0.1 
    
C20:0 (arachidic acid) 5µg/mL 37.3 ± 2.5 1.1 ± 0.1 
C20:0 (arachidic acid) 10µg/mL 38.7 ± 1.5 1.1 ± 0.0 
C20:0 (arachidic acid) 20µg/mL 41.5 ± 4.2 1.0 ± 0.1 
Ethanol Solvent 0.4% 41.3 ± 1.6 1.0 ± 0.0 
    
C16:1 cis 9 (palmitoleic acid) 5µg/mL 36.31 ± 4.5 1.2 ± 0.1 
C16:1 cis 9 (palmitoleic acid) 10µg/mL 80.7 ± 4.3 0.5 ± 0.0 
    
C18:1 cis 9 (oleic acid) 5µg/mL 33.4 ± 5.0 1.3 ± 0.2 
C18:1 cis 9 (oleic acid) 10µg/mL 37.8 ± 3.2 1.1 ± 0.1 
C18:1 cis 9 (oleic acid) 20µg/mL 36.4 ± 3.3 1.2 ± 0.1 
C18:1 cis 9 (oleic acid) 100µg/mL 37.4 ± 2.1 1.1 ± 0.1 
    
C18:1 cis 11 (cis-vaccenic acid) 5µg/mL 32.3 ± 2.4 1.3 ± 0.1 
C18:1 cis 11 (cis-vaccenic acid) 10µg/mL 33.2 ± 0.9 1.3 ± 0.0 
C18:1 cis 11 (cis-vaccenic acid) 20µg/mL 40.3 ± 2.0 1.0 ± 0.1 
    
C18:2 cis 9,12 (linoleic acid) 1µg/mL 42.0 ± 2.2 1.0 ± 0.1 
C18:2 cis 9,12 (linoleic acid) 5µg/mL 39.6 ± 2.0 0.9 ± 0.5 
C18:2 cis 9,12 (linoleic acid) 10µg/mL 75.7 ± 2.4 0.5 ± 0.1 
    
C20:1 cis 11 (eicosenoic acid) 5µg/mL 37.6 ± 1.8 1.4 ± 0.2 
C20:1 cis 11 (eicosenoic acid) 10µg/mL 33.2 ± 1.4 1.2 ± 0.2 
C20:1 cis 11 (eicosenoic acid) 20µg/mL 33.8 ± 2.3 1.3 ± 0.1 
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Table 3.1 continued 
 
Generation times and growth rates are averages and standard deviations of 
three independent cultures.   a Medium consisted of BHI with indicated 
supplement.  b Not applicable.  
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Table 3.2: Recent GC-GAME data of cells grown with fatty acid supplements 
Fatty Acid BHI C14:0a C20:0b  C12:0c C16:1 cis 9d  C20:1 cis 11e Ethanolf 
C12:0 0.8 ± 0.3 0.4 ± 0.4 0.8 ± 0.1 18.1 ± 3.3 1.1 ± 0.1 1.6 ± 0.1 0.9 ± 0.0 
C14:0 5.1 ± 0.9 71.7 ± 3.3 3.6 ± 0.3 4.7 ± 0.4 1.9 ± 0.4 3.6 ± 0.3 4.5 ± 0.1 
C15:1 cis 7 <0.1 ± 0.1 ND ND ND 2.6 ± 0.4  ND 
C16:1 cis 9 8.1 ± 2.1 2.4 ± 0.3 4.3 ± 0.4 5.8 ± 0.9 67.9 ± 12.1 1.9 ± 0.1 6.2 ± 0.3 
C16:0 36.0 ± 3.8 18.0 ± 1.7*^ 37.6 ± 0.5 37.0 ± 1.1 12.4 ± 6.3*^ 4.7 ± 0.5 39.8 ± 0.3 
C17:1 cis 10 ND ND 1.5 ± 0.2 0.3 ± 0.5 0.1 ± 0.2 ND ND 
C17:0 2OH 2.5 ± 0.4 ND 4.4 ± 0.4 0.5 ± 0.8 0.3 ± 0.5 ND 3.5 ± 0.3 
C18:1 cis 9 ND 1.0 ± 0.2 0.2 ± 0.3 1.8 ± 0.6 0.9 ± 0.2 0.5 ± 0.0 ND 
C18:1 cis 11 40.6 ± 1.9 4.4 ± 0.6**^^ 30.0 ± 1.2 25.5 ± 4.3 10.5 ± 4.0*^ 1.8 ± 0.3 39.1 ± 0.4 
C18:0 4.2 ± 1.7 2.0 ± 0.3*^^ 6.3 ± 0.4 5.2 ± 0.1 1.9 ± 0.8^ 0.9 ± 0.1 5.5 ± 0.3 
C19:1 cyclo 1.0 ± 0.3 ND 0.4 ± 0.3 1.2 ± 1.3 0.5 ± 0.1 ND 0.7 ± 0.0 
C20:1 cis 11 ND ND ND ND ND 84.2 ± 1.3 ND 
C20:0 ND ND 10.8 ± 1.2*^ ND ND ND ND 
Others 1.7 ± 1.3 0.1 ± 0.2 0.3 ± 0.3 ND ND 1.0 ± 0.1 ND 
Sat:Unsat 0.9 ± 1.4 11.7 ± 4.6 1.6 ± 0.1 1.9 ± 0.8 0.2 ± 0.5 0.1 ± 0.7 1.1 ± 1.1 
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Table 3.2 continued 
Membrane content determined by GC-FAME analysis by Microbial ID, Inc.  
Values represent average percentages and standard deviations of three 
independent cultures.  ND indicates fatty acid was not detected.  a Myristic 
acid added to final concentration of 5µg/mL.  bArachidic acid added to a final 
concentration of 10µg/mL.  c Lauric acid added to a final concentration of 
10µg/mL.  dPalmitoleic acid added to final concentration of 5µg/mL.  
eEicosenoic added to a final concentration of 10µg/mL.   d0.1% ethanol.   
*indicates P-value is <0.05 using student’s t-test comparing value to plain BHI. 
^ indicates P-values is <0.05 compared to the ethanol control value. ** 
indicates P-values is <0.00005 comparing value to plain BHI value.  ^^ indicate 
P-value is <0.00005 comparing value to ethanol control value. 
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Appendix. Chapter III Figures 
 
Figure 3.1: Growth curves of E. faecalis supplemented with various 
saturated fatty acids.  Cultures shown are averages of biological triplicate with 
standard deviation; the palmitic acid culture in panel C is N=2.  Cultures 
consisted of plain BHI, the indicated amounts of lauric (C12:0), myristic (C14:0), 
palmitic (C16:0), stearic (C18:0), or arachidic acid (C20:0).  Note, the amount of 
ethanol used as a solvent control is equivalent to the highest volume of fatty acid 
supplement used in that panel.  Other growth conditions are as described in 
material and methods. 
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Figure 3.1 Continued 
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Figure 3.2:  Growth curve with pre-incubated media.  Samples represent 
three independent biological replicates.  Cultures contain indicated amounts of 
palmitic (C16:0), myristic (C14:0), and linoleic acid (C18:2 cis 9, 12). 
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Figure 3.3: Growth kinetics of cultures inoculated with cells previously 
supplemented with saturated or unsaturated fatty acids.  Panel A and B 
show independent biological triplicate cultures supplemented with myristic acid 
(C14:0), palmitic acid (C16:0), linoleic acid (C18:2 cis 9, 12), palmitoleic acid (C16:1 cis 9) 
or an ethanol solvent control.  Note, day 1 ethanol shows N=2 after 120 minutes. 
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Figure 3.4:  Fatty acid supplements or an equivalent amount of ethanol 
were added to growing cultures.  Cultures are represented as averages of 
biological triplicate with standard deviation.  The vertical dotted line on each 
graph indicates the time point that the supplemented was added. Panel A (left) 
shows cultures that received 5µg/mL of either oleic acid (C18:1 cis 9), palmitoleic 
acid (C16:1 cis 9), palmitic acid (C16:0), or an equivalent amount of ethanol.  Panel B 
(right) shows cultures that received 10µg/mL of either oleic acid (C18:1 cis 9), 
arachidic acid (C20:0), or an equal volume of ethanol.  For both panels, BHI only 
cultures did not receive any supplements. 
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Figure 3.5:  Morphology of cultures supplemented with saturated fatty 
acids, BHI, or ethanol.  Left panels show scanning electron microscopy (SEM) 
images at a magnification of approximately 45,000.  Right panels show 
transmission electron microscopy (TEM).  Palmitic acid was added to a final 
concentration of 5µg/mL.  The final concentration of stearic acid was 10µg/mL.  
Palmitic and stearic acid SEM images are representative of three independent 
cultures.  SEM of ethanol are N=2 and BHI are N=4.  TEM sample replicates are: 
BHI N=3, palmitic acid N=2, stearic acid N=3, and ethanol N=1. 
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Figure 3.5 continued 
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Figure 3.6: Growth with unsaturated fatty acid supplements.  Cultures are 
represented as averages of biological triplicate with standard deviation.  Cultures 
consisted of plain BHI, the indicated amounts of palmitoleic acid (C16:1 cis 9), oleic 
acid (C18:1 cis 9), cis-vaccenic acid (C18:1 cis 11), linoleic acid (C18:2 cis 9, 12), eicosenoic 
acid (C20:1 cis 11)or with an amount of ethanol equivalent to the highest volume of 
fatty acid supplement used. 
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Figure 3.6 continued 
 
  
0 60 120 180 240 300 360
0.001
0.01
0.1
1
10
TIme (Minutes)
Lo
g 
O
.D
. 6
00
BHI
Palmitoleic Acid 5µg/mL 
Ethanol
0 60 120 180 240 300 360
0.001
0.01
0.1
1
10
Time (Minutes)
Lo
g 
O
.D
. 6
00
BHI
Oleic Acid 5µg/mL
Oleic Acid 10µg/mL
Oleic Acid 20µg/mL
Oleic Acid 100µg/mL
Ethanol
0 60 120 180 240 300 360
0.001
0.01
0.1
1
10
Time (Minutes)
Lo
g 
O
.D
. 6
00
BHI
Eicosenoic Acid 5µg/mL
Eicosenoic Acid 10µg/mL
Eicosenoic Acid 20µg/mL
Ethanol
0 60 120 180 240 300 360
0.001
0.010
0.100
1
10
Time (Minutes)
Lo
g 
O
.D
. 6
00
BHI
cis-vaccenic Acid 10µg/mL
cis-vaccenic Acid 20µg/mL
Ethanol
cis-vaccenic Acid 5µg/mL
0 60 120 180 240 300 360
0.001
0.010
0.100
1
10
TIme (Minutes)
Lo
g 
O
.D
. 6
00
BHI
Linoleic Acid 1µg/mL
Linoleic Acid 5µg/mL
Linoleic Acid 10µg/mL 
Ethanol
0 60 120 180 240 300 360 420 480 540 600 660 720
0.001
0.01
0.1
1
10
Time (Minutes)
Lo
g 
O
.D
. 6
00
Linoleic Acid 10µg/mL
Palmitoleic Acid 10µg/mL
Ethanol
A B
C D
E F
 121 
Figure 3.7:  Morphology of cultures supplemented with unsaturated fatty 
acids.  Left panels show scanning electron microscopy (SEM) images at a 
magnification of approximately 45,000.  The magnification of the oleic acid image 
is approximately 24,000.  Right panels show transmission electron microscopy 
(TEM).  Palmitoleic acid was added to a final concentration of 5µg/mL, cis-
vaccenic acid and linoleic acid were supplemented to a concentration of 
10µg/mL, and the final concentration of oleic acid was 20µg/mL.  SEM images of 
oleic, linoleic, and palmitoleic acid are representative of three independent 
samples; cis-vaccenic acid is N=2.  TEM images are representative of a single 
sample. 
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Figure 3.7 continued 
Palmitoleic Acid (C16:1 cis 9) 
A 
Cis-Vaccenic Acid (C18:1 cis 11) 
Oleic Acid (C18:1 cis 9) 
Linoleic Acid (C18:2 cis 9, 12) 
B 
C 
D 
 123 
Figure 3.8: Cultures were supplemented with fatty acids and various 
concentrations of cerulenin.  Cultures in each panel were inoculated from a 
single parent culture.  All cultures received 2.5µg/mL, 5µg/mL, 7.5µg/mL, or 
10µg/mL of cerulenin.  Cultures were supplemented with the indicated amounts 
of oleic acid (C18:1 cis 9), palmitic acid (C16:0), palmitoleic acid (C16:1 cis 9), arachidic 
acid (C20:0), linoleic acid (C18:2 cis 9, 12), or cis-vaccenic acid (C18:1 cis 11). 
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Figure 3.8 continued 
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Figure 3.8 continued 
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Figure 3.9:  Thin layer chromatography (TLC) of phospholipid extracts.  For 
both panels, phospholipid standards are shown on the left.  CL is cardiolipin, PG 
is phosphatidylglycerol, and LPG is lyso-phosphatidylglycerol.  U1 (indicated with 
yellow arrow) and U2 (indicated with red arrow) are unknown phospholipids.  
TLC shows lipid extracts from cells grown in media that received fatty acid 
supplements prior to the inoculation of flasks.  Myristic, palmitic, and linoleic acid 
were supplemented to a final concentration of 5µg/mL; all other supplements 
were a final concentration of 10µg/mL.  Each sample was reconstituted with 
100µL of 2:1 chloroform: methanol and 5µL was loaded onto the TLC plate.  The 
only exceptions were that myristic and palmitic extracts were reconstituted with 
50µL.    
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Figure 3.9 continued 
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Figure 3.10: Thin layer chromatography (TLC) of phospholipid extracts 
following 15-minute exposure to fatty acid supplements.  TLC shows 
extracts from cultures that were spiked with 10µg/mL of the fatty acid indicated 
below each lane 15 minutes before the lipid extraction was initiated.  All extracts 
were reconstituted with 100µL of 2:1 chloroform: methanol with 5µL loaded onto 
plate for TLC analysis.  Phospholipid standards are shown on the left side of 
picture: CL is cardiolipin, PG is phosphatidylglycerol, and LPG is lyso-
phosphatidylglycerol.  U1 (indicated with yellow arrow) and U2 (indicated with red 
arrow) are unknown phospholipids.   
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Figure 3.11:  Thin layer chromatography (TLC) of phospholipids from 
cultures supplemented with various concentrations of oleic acid (C18:1 cis 9).  
Phospholipid standards are shown on the left.  CL is cardiolipin, PG is 
phosphatidylglycerol, and LPG is lyso-phosphatidylglycerol.  (Note: the small 
spot between LPG and PG may be the degradation of a lipid standard.)  U1 
(indicated with yellow arrow) and U2 (indicated with red arrow) are unknown 
phospholipids.  Lipid extracts are from cells grown in media supplemented with 
the indicated quantity of oleic acid.  The fatty acid supplement was added to 
media immediately prior to inoculation. 
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Figure 3.12:  Thin layer chromatography (TLC) of phospholipid extracts 
following 15-minute exposure to various concentrations of oleic acid (C18:1 
cis 9).  Phospholipid standards are shown on the left and each lane is indicated 
below.  CL is cardiolipin, PG is phosphatidylglycerol, and LPG is lyso-
phosphatidylglycerol.  (Note: standards contained a small amount of BHI extract.)  
U1 (indicated with yellow arrow) and U2 (indicated with red arrow) are unknown 
phospholipids.  Lipid extracts are from cells grown in media supplemented with 
the indicated quantity of oleic acid 15-minutes prior to lipid extraction. 
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Chapter IV: The Effects of Multiple Exogenous Fatty Acid Supplements on 
Enterococcus faecalis 
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Abstract 
 
Enterococcus faecalis is a commensal organism of the mammalian intestine, 
where it has a rich source of fatty acids from bile.  As an opportunistic pathogen, 
E. faecalis can infect various locations in the human host, including the blood 
stream, the urinary tract, or endocarditic sites.  Throughout the human host, this 
organism has access to fatty acids from serum.  Since this organism has access 
to a rich mixture of fatty acids, which could help it overcome drugs targeting de 
novo fatty acid synthesis, we sought to characterize the effects of multiple fatty 
acid supplements.  Our results showed that a mixture of unsaturated and 
saturated fatty acids support growth without the detrimental effects of single 
saturated fatty acid supplements.  Furthermore, low amounts of unsaturated fatty 
acid supplements were able to prevent growth stasis in the presence of toxic 
saturated fatty acids.  The toxic effects caused by saturated fatty acids is 
primarily due to a lack of unsaturated bonds, but the chain length of saturated 
fatty acids influences the severity of toxicity.  These results clarify how E. faecalis 
is able to thrive in bile or serum with a mixture of saturated and unsaturated fatty 
acid supplements. 
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Introduction 
Enterococcus faecalis is a commensal of the mammalian intestine and an 
opportunistic pathogen causing infections at surgical sites, artificial heart valves, 
and the urinary tract.  In its native niche of the mammalian intestine, E. faecalis is 
exposed to bile, which is a mixture containing bile salts, proteins, and fatty acids 
[89].  Similarly, serum is a complex mixture of proteins, lipids, and electrolytes 
[174, 175].  Whether living as a commensal or a pathogen in the intestine, or its 
potential habitats within the host, E. faecalis has access to fatty acids from bile or 
serum.   
Studies examining the effects of exogenous fatty acids on E. faecalis are 
limited and mainly focus on the global response at the transcriptional or 
translational level(s).  The consensus of these studies is that in the presence of 
exogenous fatty acids from bile or host serum, the transcription of fatty acid 
biosynthesis is significantly decreased [85, 86].  The response to bile salts are 
typically part of a general stress response [126], fab genes are not 
downregulated [176], and some organisms upregulate efflux pumps [37, 177]. 
Our previous studies showed that sources of fatty acids from bile and 
serum were incorporated into the membrane of E. faecalis and tremendously 
influenced cell growth and physiology [2].  Additionally, we showed that sources 
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of unsaturated fatty acids can protect the bacterium from acute membrane 
stress.  In contrast, supplementing with saturated fatty acids resulted in distorted 
cell morphology, which resembled cells that lacked membrane associated cell 
division proteins.  Therefore, we wanted to investigate how E. faecalis could 
survive in the presence of a mixture containing toxic fatty acids; more specifically, 
do the unsaturated fatty acids in bile or serum protect cells from the potential 
toxic effects of saturated fatty acids? 
 
Materials and Methods 
 
Bacterial Strains and Growth Conditions 
Enterococcus faecalis OG1RF was grown in brain heart infusion medium 
(BHI; BD Difco) at 37°C unless stated otherwise.  Overnight cultures were used 
to inoculate fresh medium to an optical density (OD600 nm) of 0.01.  All fatty acids 
and chemicals were purchased from Sigma-Aldrich unless noted otherwise.  
 
Gas Chromatograph-Fatty Acid Methyl Ester (GC-FAME) Analysis  
Cells were grown to log phase with the exogenous fatty acid supplement 
as indicated in text.  Cells were pelleted, washed carefully with 1X PBS, and 
stored at -80°C prior to shipment to Microbial ID, Inc (Newark, DE).  Prior to GC-
FAME analysis, cells were subjected to saponification with a sodium hydroxide-
methanol mixture, a methylation step, and a hexane extraction [129].   
 
 135 
Results 
 
Growth Kinetics with Exogenous C18:1 Monounsaturated and Saturated 
Fatty Acids Supplements 
We noted that E. faecalis could tolerate much higher amounts of the 
unsaturated fatty acids than saturated fatty acids, despite the fact that these 
saturated fatty acids acid are naturally found within the membrane.  Previous 
studies show that bile and serum supplements increased the total amount of 
palmitic (C16:0) and stearic acid (C18:0) within the membrane, especially with bile 
addition (Table 2.2) [2].  Yet, we did not observe strong effects on generation 
times when supplemented with these complex sources, and these sources 
protect from membrane damage [2].  We hypothesized that the reason that these 
complex sources are not toxic is because these also contain oleic acid (C18:1 cis 9), 
which has no growth impacts even at high concentrations and is protective from 
acute membrane damage.  To confirm this, we performed a series of 
experiments where cells were incubated with both a toxic and non-toxic fatty 
acid. 
When supplemented with an 1:1 ratio of 5µg/mL palmitic acid (C16:0) and 
5µg/mL oleic acid (C18:1 cis 9), cultures grew similarly to those without supplement 
or with only oleic acid (Fig. 4.1, panel A) (generation time 33.8 ± 4.0 minutes).  
When given these supplements in a 1:1 ratio, the amount of palmitic acid is 
increased from 36% detected in plain BHI to approximately 55% (Table 4.2).  The 
amount of cis-vaccenic acid (C18:1 cis 11) decreased to 2% and the oleic acid was 
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nearly 37%, which is close to the amount of cis-vaccenic acid (C18:1 cis 11) found in 
the membrane of cultures containing only plain BHI.  It should be noted that this 
membrane analysis cannot distinguish between de novo and exogenous palmitic 
acid.  A similar reduction in toxicity was observed for cultures containing a 1:1 
ratio of cis-vaccenic acid and palmitic acid (Fig. 4.1, panel B) (generation time of 
27.1 ± 3.7 minutes).  However, membrane analysis was not performed, because 
these are both native fatty acids and distinguishing between de novo from 
exogenous supplements would be difficult. 
The benefits of unsaturated fatty acids could be seen even if not added in 
an amount equivalent to saturated fatty acids.  When added in an 1:5 ratio (oleic: 
palmitic acid), 1µg/mL oleic acid (C18:1 cis 9) prevented complete growth stasis in 
the presence of 5µg/mL palmitic (C16:0), but growth appeared to slow before 
cultures entered stationary phase (Fig. 4.1, panel C, Table 4.1).  In these 
cultures, the membrane fatty acid content of oleic acid was around 13% in early 
log phase (at the 120 minute time point) and was reduced to 3.4% in later log 
phase (210 minute time point) (Table 4.2, Fig. 4.1).  The amount of cis-vaccenic 
acid (C18:1 cis 11) shifted from around 3% in early log phase to almost 27% in later 
log phase, indicating that de novo fatty acid synthesis may have increased 
throughout growth.  Although growth slowed overtime, the total amount of 
unsaturated fatty acids shifted from around 20% to 35% between the early and 
later time points (Table 4.3).  Taken together, these data suggest that a small 
amount of oleic acid supported growth until the exogenous supply of oleic acid 
was exhausted; then growth slowed for a short time until de novo fatty acid 
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synthesis resumed at a high enough level to support growth until the cultures 
entered stationary phase.  
While stearic acid (C18:0) was not as toxic as other saturated fatty acids 
(Fig. 3.1), it did increase generation time when added at a concentration of 
20µg/mL (Table 3.1).  This could be reduced if 2µg/ml of oleic acid (C18:1 cis 9) was 
added in combination with 20µg/mL of stearic acid (Fig. 4.1, panel D).  Growth 
with a 1:10 ratio of oleic acid to stearic acid (C18:0) resulted in a restoration of 
growth until late exponential phase.  Stearic acid dominated the membrane 
content of cultures supplemented at a concentration of 20µg/mL, comprising 77% 
of the total membrane content, while the cis-vaccenic acid (C18:1 cis 11) content 
was variable and averaged around 12% (Table 4.2).  Supplementing cultures 
with both 20µg/mL stearic acid and 2µg/mL of oleic acid produced a membrane 
comprised of 70% stearic acid and about 6% of each oleic and cis-vaccenic acid.  
The amount of total unsaturated content remained close to 15% for both cultures.  
Note, membrane analysis was only done in mid-log phase for these conditions.  
Although oleic acid does improve growth, stearic acid is not as toxic as other 
saturated fatty acids likely because the added length allows for greater 
membrane fluidity or perhaps de novo synthesis is not repressed as tightly a 
small amount de novo fatty acid is allowed to continue. 
When cultures were supplemented with a 1:5 ratio (1µg/mL: 5µg/mL) of 
oleic acid (C18:1 cis 9) and myristic acid (C14:0), this low concentration of oleic acid 
seemed to support growth and prevented any growth stasis until stationary phase 
was reached (Fig. 4.1, panel E).  Although membrane analysis was not 
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performed on these cultures, the growth data further supports the conclusion that 
unsaturated fatty acids are necessary for the growth of E. faecalis and can 
reduce potentially toxic effects of saturated fatty acids.   
 
Growth Kinetics with Palmitoleic (C16:1 cis 9) and Saturated Fatty Acids 
Our data to this point suggests that unsaturated fatty acids have a role in 
growth that cannot be filled by saturated fatty acids.  Additionally, as C18-
monounsaturated fatty acids can counter the negative impacts of toxic saturated 
fatty acids, we wanted to expand this and examine other unsaturated fatty acids 
of varying lengths to see if these can function analogously.  In particular, we were 
interested in whether palmitoleic acid (C16:1 cis 9) could rescue from saturated-fatty 
acid toxicity, even though it hindered growth with increasing concentrations (Fig. 
3.6, panel A).  
When cultures were supplemented with equal amounts of a saturated and 
an unsaturated fatty acid of the same length (5µg/mL each), palmitoleic acid 
(C16:1 cis 9) and palmitic acid (C16:0), generation time and growth rate were similar 
to cultures supplemented with only an unsaturated fatty acid (Tables 3.1 and 4.1, 
Fig. 4.2, panel A).  To investigate which fatty acid was having a greater impact, 
cultures were supplemented with unequal amounts of palmitoleic and palmitic 
acid (Fig. 4.2, panels B and C).  Cultures containing a 5:1 ratio of palmitoleic acid 
to palmitic acid (5µg/mL: 1µg/mL) produced a growth curve similar to palmitoleic 
acid alone (Fig. 4.2, panel B), which has a slightly longer lag phase than cultures 
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of BHI alone and a slightly longer generation time (40 minutes compared to 36 
minutes in BHI alone; Tables 3.1 and 4.1).   
Cultures containing a 1:5 ratio of palmitoleic to palmitic acid (1µg/mL: 
5µg/mL) saw growth similar to that of unsupplemented cultures, until late log 
phase when grow slowed down before cultures entered stationary phase (Fig. 
4.2, panel C).  This pattern was also observed in cultures supplemented with a 
1:5 ratio (1µg/mL: 5µg/mL) of oleic acid (C18:1 cis 9) to palmitic acid.  Together 
these observations suggest that palmitoleic acid improved growth and prevented 
growth stasis induced by palmitic acid.   
We also examined the effects of palmitoleic acid (C16:1 cis 9) in combination 
with saturated fatty acids of different lengths.  Although stearic acid (C18:0) was 
not as toxic as other saturated fatty acids, cultures supplemented with both 
stearic and palmitoleic acid appeared to reach stationary phase before cultures 
having stearic acid alone. (Fig. 4.2, panel D).  Despite the high toxicity of myristic 
acid (C14:0), cultures grown with a low concentration of 1µg/mL of palmitoleic acid 
and 5µg/mL of myristic acid grew in a similar pattern to unsupplemented cultures 
(Fig. 4.2, panel E).  These experiments show that palmitoleic acid may relieve 
toxicity from saturated fatty acids through a similar mechanism as an 18C-
monounsaturated fatty acid. 
 
Growth with Multiple Monounsaturated Fatty Acids 
E. faecalis clearly is dependent upon unsaturated fatty acids in its 
membrane for optimal growth and can have a single unsaturated fatty acid 
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dominate its profile, yet not impact growth significantly.  Given this data, does 
supplementation with multiple unsaturated fatty acids impact growth significantly?  
When added together, supplementing cultures with both oleic (C18:1 cis 9) and 
palmitoleic acid (C16:1 cis 9) minimally impacted growth compared to growth with 
only one of these fatty acids (Fig. 4.3, panel A).  These suggested that 
incorporation of multiple unsaturated fatty acids in the membrane does not result 
in an overly fluid membrane.  Similarly, supplementing cultures with a 1:1 ratio 
(5µg/mL each) of cis-vaccenic (C18:1 cis 11) and palmitoleic acid (C16:1 cis 9) did not 
hinder growth more than cultures solely supplemented with palmitoleic acid (Fig. 
4.3, panel B).  Following a similar pattern, cultures supplemented with a 1:1 ratio 
of cis-vaccenic and oleic acid (C18:1 cis 9) do not have differ from individually 
supplemented cultures or the ethanol control (Fig. 4.3, panel C).  Taken together, 
these experiments suggest that E. faecalis can grow in a complex mixture 
containing both saturated and unsaturated fatty acids as well as a mixture 
containing only monounsaturated fatty acids  
 
Growth with Linoleic Acid (C18:2 cis 9, 12) and Palmitic Acid  
Linoleic acid (C18:2 cis 9, 12) is a polyunsaturated fatty acid and the addition 
of a second bond increases membrane fluidity more than monounsaturated fatty 
acids [178].  As noted, cultures supplemented with 15% serum have membranes 
that consist of 12.5% linoleic acid; additionally the generation time for these cells 
is the same for growth plain BHI [2].  Given that our results thus far imply that 
growth in saturated fatty acids increases membrane rigidity and that the addition 
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of monounsaturated could alleviate this, we wondered if linoleic acid (C18:2 cis 9, 12) 
could also fulfill a similar role as monounsaturated fatty acids. 
We grew E. faecalis in the presence of the saturated fatty acid, palmitic 
acid (C16:0) and the polyunsaturated fatty acid, linoleic acid (C18:2 cis 9, 12). The 
combination of linoleic acid and palmitic acid, in 1:5 ratio (1µg/mL: 5µg/mL), did 
not impede growth, and consequently, linoleic acid rescued cells from palmitic 
acid-induced toxicity.  Cultures containing a 1:5 ratio of linoleic acid to palmitic 
acid followed a similar pattern to cultures containing a monounsaturated fatty 
acid and a toxic saturated fatty acid (Fig. 4.4, panel A).  The cultures grew 
unimpeded until late exponential phase when a slight slow down in growth was 
observed immediately prior to stationary phase. 
 
Growth with Linoleic and Monounsaturated Fatty Acids 
E. faecalis can grow in complex mixtures containing both saturated and 
unsaturated fatty acids, such as bile or serum.  Serum contains both oleic (C18:1 
cis 9) and linoleic acid (C18:2 cis 9, 12) and both of these are incorporated into the 
membrane of cells supplemented with 15% serum.  We also noted that 
supplementing with two monounsaturated fatty acids did not impact growth 
(Table 4.1, Fig. 4.3).  When grown with palmitic acid (C16:0), linoleic acid (C18:2 cis 
9, 12) acted in a similar fashion to other monounsaturated fatty acids.  We wanted 
to know if growing cultures with linoleic acid with another monounsaturated fatty 
acid would have the same effect as two monounsaturated fatty acids. 
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At a concentration of 10µg/mL linoleic acid (C18:2 cis 9, 12) impedes growth 
and adding an equal amount of oleic acid (C18:1 cis 9) did not improve growth (Fig. 
4.4, panel B). Growth with 5µg/mL of each palmitoleic (C16:1 cis 9) and linoleic acid 
appeared to be more detrimental to growth in combination than as single 
supplements.  However, the culture containing only 5µg/mL linoleic acid in this 
experiment (in Fig. 4.4, panel D) appears to be slower compared to cultures 
grown with 5µg/mL linoleic acid in Fig. 3.6, panel E, which suggests culture-to-
culture variation or slight variations in fatty acid stocks. 
However, supplementing cultures with an equal amount of cis-vaccenic 
acid (C18:1 cis 11) and linoleic acid (C18:2 cis 9, 12) did improve growth (Fig. 4.4, panel 
C).  This could be due to unequal incorporation rates of cis-vaccenic and linoleic 
acid.  Additionally, we cannot rule out that the effects of native unsaturated fatty 
acids, such as cis-vaccenic acid, can dominate over non-native exogenous fatty 
acids such as linoleic acid. 
 
Growth with Fatty Acid Mixtures Imitating Serum 
We had previously observed that the toxic effects of saturated fatty acids 
could be relieved in the presence of an unsaturated fatty acid and that E. faecalis 
grows well in the presence of bile or serum.  Therefore, we wanted to confirm 
that growth with multiple fatty acids was not toxic without additional bile or serum 
components influencing growth.  We examined growth of fatty acids mixtures 
containing palmitic (C16:0), stearic acid (C18:0), a C18-monounsaturated fatty acid, 
and linoleic acid (Fig. 4.4, panel E).   
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All three fatty acid mixtures had similar generation times.  Cultures 
containing fatty acid mixtures 1 and 2, which contained linoleic acid (C18:2 cis 9, 12), 
had respective generation times of 35.8 ± 3.5 and 37.7 ± 4.2 minutes.  Mixture 3, 
which did not contain linoleic acid had a similar generation time (37.7 ± 2.0, 
Table 4.4).  However, cultures with fatty acids mixtures 1 and 2 reached 
stationary phase (reaching an O.D. 600 nm >1.0) slightly later than mixture 3, which 
did not contain linoleic acid.  These data indicate that mixtures of fatty acids, can 
counteract toxic fatty acids, without other serum components. 
 
Discussion 
 
A Small Amount of Unsaturated Fatty Acids are Needed for Growth 
Previously, we reported that E. faecalis OG1RF was sensitive to growth 
with the saturated fatty acids, myristic (C14:0) and palmitic acid (C16:0), but not with 
cis-vaccenic (C18:1 cis 11) or oleic acid (C18:1 cis 9).  The experiments described here 
demonstrate that exogenous unsaturated fatty acids can alleviate toxicity 
associated with saturated fatty acids.  This data helps explain why growth in 
complex fatty acids sources does not hinder growth despite the presence to toxic 
fatty acids.   
Growth with only myristic (C14:0) or palmitic acid (C16:0) was detrimental to 
growth, but adding any unsaturated fatty acid relieved this toxicity, regardless of 
the chain length (18C- vs. 16C-) or number of unsaturated bonds (mono- vs. 
poly-) (Fig. 4.1, 4.2, 4.4, panel A).  However, cultures supplemented with 1:5 of 
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oleic (C18:1 cis 9) and palmitic acid (C16:0) showed that grow was undeterred until 
the supply of oleic acid was likely exhausted and presumably de novo fatty acid 
biosynthesis resumed.  Cultures supplemented with a 1:10 ratio of oleic acid and 
stearic acid (C18:0) were slightly less informative, because stearic acid was able 
to dominate the membrane content with much less toxicity due to its length 
(discussed more below). 
 
Saturated Fatty Acids Cause Toxicity, but Chain Length Influences the 
Severity of Toxicity 
Our data supports that both saturation and length influence fatty acid 
toxicity.  Arachidic acid (C20:0) and lauric acid (C12:0) likely do not cause toxicity 
due to low levels of incorporation, which is likely due to chain length.  However, 
stearic acid (C18:0) is incorporated at high levels, but the growth effects are not as 
detrimental compared to myristic (C14:0) or palmitic acid (C16:0).  Although the 
cells supplemented with stearic acid show signs of cell division problems, these 
defects do not seem to be as severe (Fig. 3.5, panel D).   
The increased length of stearic acid may somehow contribute to increased 
fluidity or allow de novo fatty acid to continue.  A previous study in S. 
pneumoniae revealed that palmitic acid (C16:0) and cis-vaccenic acid (C18:1 cis 11) 
were the best substrates to interact with a regulator of fatty acid biosynthesis 
[158].  Our preliminary Northern blot results show that sources of fatty acids 
decrease fatty acid synthase transcripts detected, but examining a wider panel of 
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lipids with more careful analysis and comparison could determine if de novo 
synthesis continues in the presence of stearic acid. 
 
Supplementing with Multiple Unsaturated Fatty Acids Do Not Impede 
Growth 
We do not know the specified percentage of membrane composition that 
must be composed of unsaturated fatty acids; however, we wanted to know if the 
entire membrane could be made of unsaturated fatty acids or if there was a 
mechanism that unsaturated fatty acids could overwhelm the cell and become 
toxic.  Surprisingly, supplying multiple monounsaturated fatty acids was not 
detrimental to growth.  Even varying the length of monounsaturated supplements 
did not drastically alter growth (Fig. 4.3), suggesting that a high membrane 
content of unsaturated fatty acids is well tolerated by E. faecalis.  
Linoleic acid (C18:2 cis 9, 12) is a eukaryotic fatty acid found in serum.  When 
added individually, linoleic acid impeded growth at increasing concentrations 
(Table 3.2), but adding cis-vaccenic (C18:1 cis 11) and not oleic acid (C18:1 cis 9) or 
palmitoleic acid (C16:1 cis 9) improved growth (Fig. 4.4).  The structures of cis-
vaccenic and oleic acid are similar and likely contribute the same amount of 
fluidity to the membrane.  However, cis-vaccenic is a native fatty acid, while 
linoleic and oleic acid are eukaryotic, so cis-vaccenic may improve growth in the 
presence of linoleic acid, because it may be a better substrate for incorporation 
(by fatty acid kinases or acyl-transferases) or fulfill another function not fulfilled 
by the non-native species.  
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Despite obstructing growth in combination and as individual supplements, 
we previously observed that palmitoleic (C16:1 cis 9) and linoleic acid (C18:2 cis 9, 12) 
(Fig. 4.4) supplements supported growth in the presence of cerulenin (Fig. 3.8).  
The mechanism of growth inhibition may be independent of de novo fatty acid 
synthesis or membrane fluidity.  Although unsaturated fatty acids can support 
growth in the absence of de novo fatty acid synthesis, palmitoleic and linoleic 
acid may not be suitable substrates to interact with regulatory enzymes or other 
function in E. faecalis.  The fatty acid regulator FabT has increased affinity for the 
fabK promoter in the presence of long acyl-chains.  In S. pneumoniae, cis-
vaccenic (C18:1 cis 11) and palmitic acid (C16:0) were shown to be the most effective 
substrates to increase this interaction [158].  These data show that variations in 
the structure of unsaturated fatty acids may affect cell growth and function 
differently, but all unsaturated fatty acids have a role in growth that cannot be 
fulfilled by saturated fatty acids and are able to counter the effects of toxic 
saturated fatty acids in complex mixtures. 
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Appendix. Chapter IV Tables 
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Table 4.1:  Exponential phase generation time and growth rates of cultures containing two fatty acids 
Mediuma Constituents and Concentrations 
Generation 
Time 
(minutes) 
Growth Rate 
(hr-1) 
C16:0 (palmitic acid) 5µg/mL C18:1 cis 9 (oleic acid) 5µg/mL 33.8 ± 4.0 1.2 ± 0.1 
C16:0 (palmitic acid) 5µg/mL C18:1 cis 11 (cis-vaccenic acid) 5µg/mL 27.1 ± 3.7 1.6 ± 0.2 
    
C16:0 (palmitic acid) 5µg/mL  C16:1 cis 9 (palmitoleic acid) 5µg/mL  42.3 ± 0.9 0.9 ± 0.1 
C16:0 (palmitic acid) 1µg/mL  C16:1 cis 9 (palmitoleic acid) 5µg/mL  31.8 ± 2.3 1.3 ± 0.1 
C16:0 (palmitic acid) 5µg/mL  C16:1 cis 9 (palmitoleic acid) 1µg/mL  40.7 ± 1.2 1.0 ± 0.0 
C16:0 (palmitic acid) 5µg/mL  C16:1 cis 9 (palmitoleic acid) 1µg/mL  103 ± 13.3 0.4 ± 0.1 
    
C18:0 (stearic acid) 5µg/mL C16:1 cis 9 (palmitoleic acid) 5µg/mL  35.8 ± 1.8 1.2 ± 0.1 
C18:0 (stearic acid) 1µg/mL C16:1 cis 9 (palmitoleic acid) 5µg/mL  37.5 ± 4.9 1.1 ± 0.2 
C18:0 (stearic acid) 20µg/mL C18:1 cis 9 (oleic acid) 2µg/mL 57.4 ± 0.6 0.7 ± 0.0 
    
C18:2 cis 9,12 (linoleic acid) 10µg/mL C18:1 cis 9 (oleic acid) 10µg/mL 102.2 ± 19.2 0.4 ± 0.1 
C18:2 cis 9,12 (linoleic acid) 10µg/mL C18:1 cis 11 (cis-vaccenic acid) 10µg/mL 42.1 ± 2.8 1.0 ± 0.1 
C18:2 cis 9,12 (linoleic acid) 5µg/mL  C18:1 cis 9 (oleic acid) 5µg/mL 40.4 ± 0.7 1.0 ± 0.0 
    
C18:1 cis 9 (oleic acid) 10µg/mL C16:1 cis 9 (palmitoleic acid) 5µg/mL 42.3 ± 6.4 1.0 ± 0.1 
aMedium consisted of BHI with indicated supplement.   
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Table 4.2:  Membrane fatty acid content of cultures with saturated and unsaturated supplements 
Mediuma 
Constituents BHI 
C18:1 cis 9  
C16:0  [1:1] b 
C18:1 cis 9   
C16:0 [1:5] c 
C18:1 cis 9 
C16:0 [1:5] c 
 
 
C18:1 cis 9 d 
C18:1 cis 9  
C18:0 [1:10] 
e 
 
C18:0f 
 
C18:1 cis 9e 
Growth Phase Mid-Log Mid-Log Early-Log Late-Log Mid-Log Mid-Log Mid-Log Mid-Log 
Fatty Acid         
C12:0 0.8 ± 0.3 0.8 ± 0.1 0.3 ± 0.3 0.6 ± 0.1 0.6 ± 0.0 0.3 ± 0.0 0.2 ± 0.1 1.2 ± 0.1 
C14:0 5.1 ± 0.9 0.9 ± 1.1 1.5 ± 0.1 3.3 ± 0.0 3.8 ± 0.1 1.6 ± 0.1 1.8 ± 0.4 3.8 ± 0.0 
C16:1 cis 9 8.1 ± 2.1 1.4 ± 0.1 2.3 ± 0.2 4.3 ± 0.4 5.1 ± 0.1 1.8 ± 0.0 2.5 ± 0.7 5.2 ± 0.1 
C16:0 36.0 ± 3.8 54.9 ± 0.7 76.0 ± 2.2 51.3 ± 2.1 37.2 ± 0.1 6.0 ± 0.2 10.5 ± 5.4 32.4 ± 0.7 
C17:1 cis 10 ND 1.4 ± 0.1 0.5 ± 0.1 ND ND ND ND 0.6 ± 0.0 
C17:0 2OH 2.5 ± 0.4 ND ND 2.9 ± 0.2 5.0 ± 0.4 0.2 ± 0.1 1.2 ± 1.1 1.7 ± 0.1 
C18:1 cis 9 ND 36.8 ± 1.2 13.1 ± 1.9 3.4 ± 0.3 5.2 ± 0.5 6.2 ± 0.3 0.2 ± 0.1 23.3 ± 0.9 
C18:1 cis 11 40.6 ± 1.9 1.8 ± 0.3 3.1 ± 0.2 27.0 ± 1.8 37.8 ± 0.3 6.1 ± 0.4 12.2 ± 6.1 26.9 ± 0.5 
C18:0 4.2 ± 1.7 1.5 ± 0.1 2.1 ± 0.2 5.2 ± 0.5 5.7 ± 0.2 77.4 ± 0.7 70.8 ± 14.0 4.1 ± 0.1 
C19:1 cyclo 1.0 ± 0.3 ND ND 1.5 ± 0.2 1.0 ± 0.0 0.1 ± 0.1 0.3 ± 0.1 ND 
Others 1.7 ± 1.3 0.7 ± 0.1 1.1 ± 1.9 0.6 ± 0.8 0.6 ± 0.2 0.4 ± 0.1 0.5 ± 0.3 0.8 ± 0.4 
Sat: Unsat 0.9 ± 1.4 1.4 ± 0.6 4.1 ± 1.2 1.7 ± 0.9 1.0 ± 0.5 6.1 ± 1.4 5.6 ± 2.8 0.7 ± 0.5 
a Media consisted of BHI and fatty acid supplements indicated.  b Supplements were added at a ratio of [1:1].  
Oleic and palmitic acid were each added to a final concentration of 5µg/mL.  c Cultures contained a [1:5] ratio 
of each supplement.  Oleic acid was added to a final concentration of 1µg/mL.  Palmitic acid was added to a 
final concentration of 5µg/mL.  d Oleic acid was added to a final concentration of 1µg/mL.  e Stearic acid and 
oleic acid were added to a final ratio of [1:10].  Stearic acid was supplemented at a concentration of 20µg/mL.  
Oleic acid was supplemented at 2µg/mL.  f Cultures contained 2µg/mL of oleic acid. 
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Table 4.3:  Membrane totals for fatty acids grouped by saturation or length 
Medium 
Constituents
a 
 
BHI 
C18:1 cis 9  
C16:0  [1:1] b 
C18:1 cis 9   
C16:0 [1:5] c 
C18:1 cis 9 
C16:0 [1:5] c 
 
 
C18:1 cis 9 d 
C18:1 cis 9  
C18:0 [1:10] e 
 
C18:0f 
 
C18:1 cis 9e 
Growth 
Phase 
Mid-Log Mid-Log Early-Log Late-Log Mid-Log Mid-Log Mid-Log Mid-Log 
Total Sat. 46.1±4.3 58.7 ± 1.1 80.0 ± 2.8 60.4 ± 2.7 47.6 ± 0.5 85.7 ± 1.0 83.5 ± 19.9 42.1 ± 1.0 
Total Unsat. 49.1±3.4 42.7 ± 1.8 19.6 ± 2.6 35.2 ± 3.2 46.5 ± 1.1 14.1 ± 0.7 14.9 ± 7.2 56.8 ± 1.9 
Total 14 5.1±0.9 0.9 ± 0.1 1.5 ± 0.1 3.3 ± 0.0 3.8 ± 0.1 1.6 ± 0.1 1.8 ± 0.4 3.8 ± 0.0 
Total 16 44.4±1.7 56.3 ± 0.8 79.0 ± 3.5 55.6 42.3 ± 0.2 7.8 ± 0.2 13.0 ± 6.1 37.6 ± 0.9 
Total 18 44.8±0.5 40.1 ± 1.6 18.8 ± 3.1 35.6 ± 2.6 46.7 ± 1.0 89.6 ± 1.4 83.1 ± 20.3 54.3 ± 1.5 
Total 20 0.2±0.4 0.7 ± 0.1 ND ND 0.3 ± 0.2 0.3 ± 0.0 0.1 ± 0.0 0.6 ± 0.1 
a Media consisted of BHI and fatty acid supplements indicated.  b Supplements were added at a ratio of 
[1:1].  Oleic and palmitic acid were each added to a final concentration of 5µg/mL.  c Cultures contained a 
[1:5] ratio of each supplement.  Oleic acid was added to a final concentration of 1µg/mL.  Palmitic acid 
was added to a final concentration of 5µg/mL.  d Oleic acid was added to a final concentration of 1µg/mL.  
e Stearic acid and oleic acid were added to a final ratio of [1:10].  Stearic acid was supplemented at a 
concentration of 20µg/mL.  Oleic acid was supplemented at 2µg/mL.  f Cultures contained 2µg/mL of 
oleic acid.  
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Table 4.4: Generation times and Growth Rates of Fatty Acid Mixtures 
Mediuma Constituents  Generation Time (min.) 
Growth 
Rate (hr-1) 
Mixture 
1 
C18:2 cis 9,12  
(linoleic acid) 
C18:1 cis 9  
(oleic acid) 
C16:0  
(palmitic acid) 
C18:0  
(stearic acid) 37.7 ± 4.2 1.1 ± 0.1 
Mixture 
2 
C18:2 cis 9,12  
(linoleic acid) 
C18:1 cis 11  
(cis-vaccenic acid) 
C16:0  
(palmitic acid) 
C18:0  
(stearic acid) 35.8 ± 3.5 1.2 ± 0.1 
Mixture 
3 
C18:1 cis 11  
(cis-vaccenic acid) 
C18:1 cis 9  
(oleic acid) 
C16:0  
(palmitic acid) 
C18:0  
(stearic acid) 37.7 ± 2.0 1.1 ± 0.1 
a Media consisted of BHI and 5µg/mL of each fatty acid listed above.  All calculations were during mid-log phase  
growth. 
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Appendix. Chapter IV Figures 
 
Figure 4.1: Growth with a C18:1 unsaturated fatty acid and a saturated fatty 
acid.  Cultures are represented as averages of biological triplicate with standard 
deviation.  Cultures contain the indicated concentrations of palmitic acid (C16:0), 
oleic acid (C18:1 cis 9), stearic acid (C18:0), myristic acid (C14:0), or cis-vaccenic acid 
(C18:1 cis 11).  Note, the amount of ethanol used as a solvent control is equivalent 
to the highest volume of fatty acid supplement used.  Other growth conditions are 
as described in material and methods. 
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Figure 4.1 continued 
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Figure 4.2: Growth with palmitoleic acid (C16:1 cis 9) and a saturated fatty 
acid.  Cultures are represented as averages of biological triplicate with standard 
deviation.  Cultures consisted of plain BHI, the indicated amounts of palmitoleic 
acid (C16:1 cis 9), myristic acid (C14:0), palmitic acid (C16:0), stearic acid (C18:0), or 
arachidic acid (C20:0), or with an equivalent amount of ethanol.  Note, amount of 
ethanol is equivalent to the highest volume of fatty acid supplement used.  Other 
growth conditions are as described in material and methods.  Arrows on panel C 
represent when samples were taken for GC-FAME analysis. 
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Figure 4.2 continued 
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Figure 4.3: Growth with two monounsaturated fatty acids.  Cultures are 
represented as averages of biological triplicate with standard deviation.  Cultures 
consisted of plain BHI, the indicated amounts of oleic acid (C18:2 cis 9), cis-
vaccenic acid (C18:1 cis 11), palmitoleic acid (C16:1 cis 9), or with an equivalent 
amount of ethanol.  Note, the amount of ethanol used as a solvent control is 
equivalent to the highest volume of fatty acid supplement used.  Other growth 
conditions are as described in material and methods.   
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Figure 4.3 continued 
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Figure 4.4: Growth with linoleic acid (C18:2 cis 9, 12) and other fatty acids.   
Cultures are represented as averages of biological triplicate with standard 
deviation.  Cultures consisted of plain BHI, the indicated amounts of palmitic 
(C16:0), linoleic (C18:2 cis 9,12), oleic (C18:2 cis 9), cis-vaccenic (C18:1 cis 11), palmitoleic 
(C16:1 cis 9), stearic acid (C18:0).  Panel E shows cultures supplemented with 
5µg/mL of each fatty acid listed.  Note, the amount of ethanol used as a solvent 
control is equivalent to the highest volume of fatty acid supplement used. 
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Figure 4.4 Continued 
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Chapter V: Conclusions and Discussion 
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Stress Survival and the Incorporation of Exogenous Fatty Acids 
Our initial hypothesis was that E. faecalis altered its membrane fatty acid 
composition, and this attributed to its ability to survive environments outside the 
intestine, including in diseased sites.  We initially observed that growth in 
complex sources of exogenous fatty acids, such as bile, resulted in an altered 
membrane fatty acid content.  We then developed an acute membrane stress 
assay to demonstrate that these membrane alterations contributed to cell 
survival.   
We concluded that supplementing cultures with 0.2% total bile, and not 
bile salts, improved cell survival when challenged with a variety of acute 
membrane-damaging agents, including a high concentration of bile, SDS, and 
daptomycin.  Previous studies in Enterococcus faecalis examining global protein 
changes in response to bile stress revealed changes in proteins associated with 
metabolism [1], and that exposure to stress resulted in the presence of stress-
related proteins that could provide cross protection to another type of stress [2, 
3].  Our work furthered the understanding of the role of membrane fatty acid 
composition in the stress survival of E. faecalis. 
We sought to know if the improved survival could be attributed to specific 
fatty acids or non-native lipids.  When supplemented with exogenous fatty acids, 
E. faecalis incorporated eukaryotic fatty acids, such as oleic acid (C18:1 cis 9) and 
linoleic acid (C18:2 cis 9, 12), into its membrane, as well as “native” fatty acids 
including saturated C16:0 and C18:0.  We performed our acute membrane stress 
assay with individual fatty acid supplements and concluded that unsaturated fatty 
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acids and not saturated fatty acids improved cell survival, including non-native 
unsaturated fatty acids.  These results also show that the host environment and 
acquiring nutrient sources are important for stress survival, including resistance 
to daptomycin. 
 
Importance of Membrane Content for Cell Function 
Our work also shows that membrane fatty acids are important not only for 
stress survival, but also affects basic cellular function.  Exogenously applied 
saturated fatty acids did not improve cell survival and are often toxic to growth.  
TEM and SEM images of cells from cultures supplemented with palmitic acid 
(C16:0) or stearic acid (C18:0) shows cells with severe defects in cell shape and 
division, and many of these cells were likely non-viable.  Studies with E. faecalis, 
as well as S. pneumoniae, have shown that cell division relies on the 
coordination of membrane-associated proteins for septum placement and the 
partitioning of newly synthesized DNA [4-6].  The misshapen cells in those 
studies resemble the morphology we observed suggesting that an overly 
saturated membrane prevents the proper placement of divisional proteins and 
possibly others. 
Additionally, studies have shown that specific phospholipids are necessary 
for cell function.  Phospholipids can form distinct domains in bacterial 
membranes, and specific phospholipids have been found to be associated with 
cell division [7].  In E. coli and S. aureus phosphatidylglycerol and cardiolipin 
mediate the release of DnaA, thus enabling chromosome replication [8, 9].  
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Bacillus subtilis relies on a complex of Div and Min proteins to facilitate cell 
division; it was shown that MinD associates with lipid spirals, primarily composed 
of phosphatidylglycerol [10].  Streptococcus pneumoniae and Enterococcus 
faecalis lack Min proteins, but possess Div proteins for cell division [5, 6].   
Related to this, our TLC analysis suggested that phospholipid composition 
of E. faecalis changes in response to exogenous fatty acid supplements.  Some 
of the alterations may be unique to exogenously supplied unsaturated fatty acids 
and specifically oleic acid (C18:1 cis 9).  Further investigation and lipidomic analysis 
comparing the phospholipid profile changes in response to specific exogenous 
fatty acids could connect the requirement for unsaturated fatty acids to 
phospholipids associated with cell division proteins. 
 
The Influence of Fatty Acid Chain Length and Saturation on Cell Function 
The effects of supplemented fatty acids were variable depending upon the 
fatty acid given: this is likely because not all fatty acids examined are suitable 
substrates for membrane incorporation.  For example, arachidic acid (C20:0) did 
not dominate membrane content; therefore, 18-carbons maybe the longest chain 
length that can be incorporated at high levels.  Myristic acid (C14:0) was able to 
dominate membrane content and cause toxicity.  However, lauric acid (C12:0) 
impeded growth at high levels, but did not cause complete growth stasis 
suggesting that de novo fatty acid synthesis was able to continue or this shorter 
chain fatty acid was not incorporated at high levels or itself served as a substrate 
for elongation 
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Our data indicate that the membrane composition of E. faecalis requires 
unsaturated fatty acids for growth and that 18-carbon monounsaturated fatty 
acids, oleic acid (C18:1 cis 9) and cis-vaccenic acid (C18:1 cis 11), may be preferred.  
“Preferred” in the sense that these do not negatively impact cell growth or 
morphology, provide protection from acute membrane stress, and may save 
energy by reducing de novo fatty acid synthesis.   Less toxic supplements, 
stearic acid (C18:0), palmitoleic (C16:1 cis 9), and linoleic acid (C18:2 cis 9, 12), match 
only the length or saturation requirement.  The most toxic supplements, myristic 
(C14:0) and palmitic acid (C16:0), do not meet either preferred criteria.  Overall, 
increasing chain length or saturation lessened the toxicity of fatty acid 
supplements. 
 
Bacterial Niches and Fatty Acid Biosynthetic Enzymes 
More broadly, it can be stated that “preferred” membrane composition is 
relative to the niches occupied by a particular bacterium, the environmental 
conditions present, and essential cellular processes performed.  Enterococci 
reside in the intestinal tract and have fatty acid biosynthetic enzymes that overlap 
in function with E. coli.  Both organisms possess enzymes that perform both 
isomerase and dehydratase functions, FabN and FabA respectively [11].  
Additionally, FabO in Enterococci has a similar function to FabB in E. coli [12]; 
both of these fatty acid synthases can elongate unsaturated or saturated acyl-
chains.  Studies analyzing an FabA temperature sensitive strain of E. coli 
showed that cells require 15-20% unsaturated fatty acids [13, 14].  Our results 
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show that supplementing with a small amount of an unsaturated fatty acid can 
relieve toxicity from a saturated fatty acid supplement, which suggests that 
Enterococci also require a minimum amount of unsaturated fatty acid content.  
Enterococci have a conserved operon of fatty acid biosynthesis found in 
the closely related Streptococci with similar regulatory features [15].  However, 
these organisms occupy different niches and have different pathways for the 
production of unsaturated fatty acids.  Streptococci, which typically reside in the 
oral cavity or respiratory tract, have distinct dehydratase and isomerase enzymes 
contributing to the production of unsaturated fatty acids, FabZ and FabM 
respectively.  Both organisms have FabK, an enoyl reductase enzyme; yet, 
Enterococci rely on a second enzyme, FabI, for this step and the role of FabK 
may be a more regulatory role [16].   
While Enterococci inhabits the intestinal tract and Streptococci are found 
in the upper respiratory tract, Staphylococci inhibit the skin and nares, [17]; 
where they are challenged with high salinity [18].  Unlike Enterococci and 
Streptococci, Staphylococci only synthesize branched or saturated fatty acids 
and only possess FabZ/I/F enzymes to complete its fatty acid cycle [19].  Rather 
than adjusting the saturated: unsaturated ratio or generate cyclopropane fatty 
acids, Staphylococci modulate its branched-chain fatty acid content in response 
to its environment [20].  Additionally, Staphylococcus aureus are more 
susceptible to toxicity from unsaturated fatty acids compared to Streptococci [21], 
and toxicity patterns in E. faecalis more closely matched Streptococci. 
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In response to acid stress in the oral cavity, Streptococcus mutans 
increases unsaturated fatty acid content [22].  Unlike S. mutans,   Enterococci 
utilize cyclopropane fatty acid to survive low pH [23]; a homologue of the fatty 
acid synthase gene is also found in E. coli [24], but not Streptococci [25].  
Cyclopropane fatty acids may provide additional resilience to environmental 
stress than unsaturated fatty acids alone.  A recent study highlighting the 
differences between unsaturated fatty acids and cyclopropane fatty acids showed 
that cyclopropane fatty acids increase fluidity, while also decreasing bond 
rotations close to the cyclopropane ring, thus forming a more ordered, stable 
membrane [26]. 
Gram-positive organisms activate exogenous fatty acids into usable 
substrates for incorporation by fatty acid kinases (Fak enzymes).  The role of 
FakA is to phosphorylate FakB, which binds exogenous fatty acids, producing 
acyl-phosphates [27].  These were first described in Staphylococcus aureus; 
further bioinformatics analysis revealed that many Gram-positive bacteria have a 
single FakA enzyme but multiple FakB enzymes in a single species is common 
[27, 28].  In S. aureus, FakB enzymes can incorporate saturated fatty acids, but 
only FakB2 is used for the incorporation of unsaturated fatty acids [27].  BLAST 
searches reveal four FakB homologues in E. faecalis, while only two were 
reported in S. aureus [27], implying that exogenous fatty acids may be important 
for its niche in the mammalian intestine.   
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The Importance of Studying The Effects of Exogenous Fatty Acids in Gram-
Positive Bacteria 
Given the prevalence of antibiotic resistance, researchers are looking for 
new drug targets [29, 30].  Bacterial fatty acid synthesis (FAS) enzymes have 
long been suggested as possible drug targets [31].  However, there is evidence 
that bacterial organisms can uptake exogenous fatty acids possibly 
circumventing FAS inhibitors [32, 33].  Regulatory feedback on acetyl-CoA 
carboxylase (ACC) can suppress fatty acid biosynthesis in S. pneumoniae and 
not S. aureus; thus, allowing S. pneumoniae and organisms with similar 
regulatory mechanisms, such as Enterococci, to completely replace de novo 
synthesized membrane fatty acids with exogenous fatty acids [33].  Our results 
also confirm the incorporation of exogenous fatty acids and the ability of E. 
faecalis to overcome cerulenin when supplied with unsaturated fatty acids.  
Several studies examining acyl-transferases as potential drug targets 
have produced mixed results.  Acyl-sulfamates were shown to target PlsY in S. 
aureus; these class of molecules were inhibitory to Bacillus anthracis and E. 
faecalis, but likely had off-targets effects [34].  A strain of S. aureus carrying a 
deletion of plsX needed de novo fatty acid as well as exogenous fatty acids to 
acylate both 1- and 2- positions of glycerol-3-phosphate [28].  Conversely, a plsX 
knock-out strain of S. pneumoniae utilized a novel thioesterase to hydrolyze acyl-
ACP, generating free fatty acids which by-passed the requirement for exogenous 
fatty acids [35].  These studies highlight the diversity of enzymes and the 
importance of studying fatty acid biosynthesis in individual pathogens.  The 
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published genome of E. faecalis does not show a homologue of the novel 
thioesterase that allowed S. pneumoniae to compensate for the loss of plsX and 
a plsX knockout has not been reported in E. faecalis. 
Our work highlights the importance of exogenous fatty acids in resisting 
membrane stress.  Our findings show that exogenous fatty acids contribute to 
altering membrane content and provide short-term protection from the antibiotic 
daptomycin, which targets the membrane [36].  Previous studies have also 
shown that resistance to daptomycin has been associated with strains carrying 
mutations that led to cells with an altered membrane phospholipid content [37] 
and a redistribution of cardiolipin away from the cell septum [38].  Altering 
membrane content, through the incorporations of exogenous fatty acids or 
through a genetic mutation, contributes to surviving stress. 
Saturated fatty acids were toxic enough to be lethal to cells, but also 
selected for a resistant population.  Cultures that recovered after overnight 
growth with palmitic (C16:0) or myristic acid (C14:0) no longer exhibited signs of 
static growth when re-inoculated into media containing these toxic supplements.  
Pending sequencing results are expected to show that these cultures were re-
populated with cells containing a genetic mutation that allowed them to resist the 
toxicity of exogenous saturated fatty acids, such as fakA or fakB.  Our data 
suggest that fatty acids need to be incorporated to produce toxicity; furthermore, 
a fakA deletion eliminated all incorporation of exogenous fatty acids in S. aureus 
[27], which could prevent the incorporation of toxic fatty acids.  Our results have 
shown that membrane alterations are influenced by exogenous fatty acids and 
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improve response to stress [36].  Therefore, strains that do not utilize exogenous 
fatty acids would be at a disadvantage in the host where there is a mixed pool of 
saturated and unsaturated fatty acids, and stains possessing multiple fakB genes 
would be at an advantage to utilize exogenous fatty acids. 
 
Future Work 
In our experiments we observed that saturated fatty acids were toxic to E. 
faecalis and that unsaturated fatty acids were necessary for growth.  I 
hypothesize that saturated fatty acids make the membrane too rigid for the 
insertion of membrane proteins and prevents the proper placement of cardiolipin 
(Fig. 5.1).  The underlying mechanism of cardiolipin mislocalization may be 
related to the substrate specificity of cardiolipin synthase.  Additionally, I would 
hypothesize that there is a minimum unsaturated fatty acid content that is 
necessary for E. faecalis to sustain growth and metabolic processes.  
Experiments to test these hypotheses are outlined below. 
 
Do All Fatty Acid Supplements Suppress Fatty Acid Biosynthesis 
When E. faecalis is given saturated fatty acid supplements, fatty acid 
synthesis may be repressed and cells cannot correct an overly rigid membrane.  
It is known that mixed sources of fatty acids such as bile or serum down regulate 
fatty acid biosynthetic genes [39, 40].  We examined transcription of both fatty 
acid synthases (fabF and fabO) when cultures were supplemented with several 
individual fatty acids, oleic (C18:1 cis 9), palmitic (C16:0), and linoleic acid (C18:2 cis 9, 
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12).  Supplemented cultures had fewer detectable transcripts compared to 
unsupplemented cultures.  However, a wider panel of supplements could reveal 
one or more that do not suppress fatty acid synthase.  Although I expect that 
most supplements will repress fatty acid synthesis, the most likely exception to 
this hypothesis is arachidic, which has the least impacts on growth and does not 
dominate membrane content.  Lauric acid (C12:0) may also be an exception, but it 
might also serve as a substrate for longer fatty acids.  These results could 
support the hypothesis that E. faecalis cannot balance its saturated: unsaturated 
ratio. 
 
What Effects Do Exogenous Supplements Have on Fatty Acid Biosynthesis 
 Performing Northern analysis would provide information about the 
regulation of fatty acid biosynthesis at the transcription level.  However, the 
enzymes already synthesized could continue synthesizing fatty acids.  
Developing an assay that utilizes an [14C]-acetate label, previously described 
[28], could provide a tool to examine the effects of exogenous fatty acids have on 
de novo fatty acid biosynthesis.  This would allow us to determine how fast de 
novo synthesis stops after exogenous supplements are added.  We could 
determine if lauric acid (C12:0) is elongated prior to incorporation.  This could be 
helpful in distinguishing native saturated fatty acids and exogenous supplements 
in experiments with multiple fatty acids, such as palmitic (C16:0) and oleic acid 
(C18:1 cis 9). 
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Does Stearic Acid (C18:0) Provide Additional Membrane Fluidity Compared 
to Myristic (C14:0) and Palmitic Acids (C16:0)  
Stearic acid (C18:0) is not as toxic to E. faecalis as palmitic (C16:0) or 
myristic acid (C14:0).  If each of these saturated fatty acids suppresses fatty acid 
biosynthesis, then the difference in toxicity could be explained by the difference 
in length.  The added length of stearic acid may provide additional fluidity 
compared to myristic or palmitic acid.  Experiments comparing the membrane 
fluidity or membrane content between membranes dominated by stearic or 
palmitic acid could explain the difference in toxicity.  Previous studies have 
examined fluidity using anisotropy [41, 42].   
Our published work noted that stearic acid supplemented cells had an 
increase in depolarization, even without daptomycin (Fig. 2.6, panel E) [36].  The 
increase in fluorescence of the no-daptomycin control cells was attributed to the 
toxicity of stearic acid [36].  This same technique could also be utilized to 
examine and compare the toxicity of saturated fatty acids.  These results would 
show that the membrane of E. faecalis is not as rigid when it contains a high level 
of stearic acid as compared to palmitic or myristic acid, and provide an 
explanation for the reduced toxicity of stearic acid. 
 
Does Cardiolipin Have Fewer Saturated Fatty Acids Tails 
The TLC results show that unsaturated fatty acids have reduced PG and 
increased CL content, while saturated fatty acids do not show this increase in CL.  
As stated previously, I hypothesize that saturated fatty acids make the 
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membrane too rigid for the insertion of membrane proteins and saturated fatty 
acids may be poor substrates for cardiolipin synthase.  Identifying the 
phospholipids and determining the fatty acids tails of phospholipids can test this 
hypothesis.  Previous studies have used 2D-TLC in combination with LC/ESI-
MS/MS [37] or 2D-TLC with ninhydrin to stain aminophospholipids [43], to identify 
phospholipids.  Parsons et. al. 2011, determined the position of fatty acid tails by 
isolating phospholipids from a TLC plate, cleaving them with phospholipase A2, 
separating the cleaved products via TLC, and performing GC-FAME analysis 
(see supplemental materials of reference) [33].  These results would provide 
valuable information regarding the identity of phospholipids in E. faecalis and the 
effects of exogenous fatty acids on phospholipids. 
To further explain the mechanism for the increase in cardiolipin when 
exogenous unsaturated fatty acids are present, an in vitro assay comparing 
Cls1/Cls2 activity with different fatty acid supplements could be developed from a 
membrane protein isolation protocol and a modified phosphatidylserine synthase 
assay [44].  [14C]-labeled phosphatidylglycerol (with specific saturated or 
unsaturated fatty acid tails) can be added to crude protein extracts.  Lipids can 
be separated via TLC and scintillation counting can be used to measure the [14C] 
in PG and CL spots scraped from TLC plate.  If phosphatidylglycerol containing 
unsaturated fatty acid tails are better substrates for cardiolipin synthase than 
saturated fatty acids, this could explain why an increase in CL is only seen with 
unsaturated fatty acid supplements.   
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Do Saturated Fatty Acids Disrupt the Placement of Cardiolipin 
Typically cardiolipin forms domains at the cell poles and septa [45].  Other 
papers have indicated that cardiolipin associates with membrane proteins related 
to cell division [9, 46].  Examining the placement of cardiolipin, might reveal how 
fatty acids influence cell process.  If saturated fatty acids dominate the 
membrane and cardiolipin is no longer located at the proper location; this could 
interrupt cell function.  If unsaturated fatty acids are attached to cardiolipin, this 
could explain why unsaturated fatty acids are needed for growth.  Published 
studies have utilized the dye 10-N-nonyl acridine orange (NAO) to examine 
cardiolipin [47] and a modified protocol is in use in the Fozo lab. 
 
How Do Exogenous Fatty Acids Affect Membrane Proteins 
 We previously noted that unsaturated fatty acids protected against 
sources of acute membrane stress.  I would hypothesize that unsaturated fatty 
acids alter membrane proteins and these cells can readily respond to membrane 
stress.  This could be tested by performed membrane protein extractions of 
cultures containing various fatty acid supplements.  SDS-PAGE and Western blot 
analysis for specific efflux pumps [48] or known stress proteins [1, 2] would 
directly address the stated hypothesis. 
 
Why Do Linoleic (C18:2 cis 9, 12) and Palmitoleic Acid (C16:1 cis 9) Impede Growth 
 Although linoleic (C18:2 cis 9, 12) and palmitoleic (C16:1 cis 9) did not produce 
the same severe toxicity observed with saturated fatty acids, these significantly 
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hindered growth.  Surprisingly, these supplements could support growth in the 
presence of cerulenin even though the generation time was still slower than 
unsupplemented cells.  This indicates that the mechanism that is hindering 
growth may be independent of fatty acid biosynthesis.  I would hypothesize that 
these may be impacting another mechanism (or repression of specific genes) 
that impacts cell growth.  Transcriptomics studies would generate extensive data 
sets, but might reveal that genes needed for growth are down regulated in the 
presence of linoleic or palmitoleic acid.  Polyunsaturated fatty acids have been 
reported to cause oxidative stress [49].  The SEM and TEM suggest that these 
cells are not damaged, but increased oxidative stress in the presence of linoleic 
acid could be investigated. 
 
Final Conclusions 
We have described the effects of exogenous fatty acids and have 
observed the necessity of unsaturated fatty acids to E. faecalis.  Although 
changes to phospholipids in response to exogenous fatty acids have been noted, 
the identity, quantity, and alterations of phospholipids in E. faecalis remain to be 
evaluated.  This knowledge could provide insight into the mechanism of the 
protection provided by unsaturated fatty acids and reveal any possible link 
between specific fatty acids and phospholipids associated with certain cellular 
functions.  The effects of exogenous fatty acids could extend beyond 
phospholipid changes and affect membrane proteins and gene regulation, but 
investigating phospholipids could yield more immediate answers. 
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Appendix. Chapter V Figures 
 
Figure 5.1: Schematic of fatty acids and cell function.  Arrows point to the 
features of unsaturated or saturated fatty acids.  Unsaturated fatty acids are 
implied to promote proper cell function.  Underlying mechanisms that cause 
saturated fatty acids to disrupt proper cell function are listed.  
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